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ABSTRACT 
The translocation of GLUT4 from intracellular stores to the plasma membrane in 
response to insulin accounts for the large insulin-mediated glucose uptake in muscle and 
fat tissue. A defect of this translocation mechanism is evident in individuals with insulin 
resistance and type 2 diabetes. Hence, understanding the molecular basis of GLUT4 
localisation and recycling is important in order to assist the design of rational therapies 
for the treatment of this disease. 
Here, we have used iodixanol gradient analysis to examine the intracellular distribution 
of GLUT4. By this method intracellular GLUT4 could be separated into two pools one 
of which is highly insulin sensitive, and corresponds to "GLUT4 storage vesicles" 
(GSV), while the other is less insulin sensitive and is of endosomal origin. We further 
show that during differentiation of 3T3-Ll fibroblasts into adipocytes, the formation of 
the GSV compartment appears to be driven by the expression of GLUT4. 
SNARE proteins are involved in the fidelity of GLUT4 translocation, but little is known 
about how these proteins may be altered in insulin resistance. Using insulin-resistant 
3T3-Ll adipocytes, we show that SNARE protein levels are increased. The potential 
importance of this observation is discussed. Using iodixanol gradient analysis we also 
found that the downregulation of GLUT4 known to occur in insulin-resistant 3T3-Ll 
adipocytes is predominantly from the GSV compartment. The implications of these data 
for the aetiology of insulin resistance are discussed. 
Finally we show that the adaptor protein distribution in 3T3-Ll adipocytes is not 
affected by insulin. Furthermore, we demonstrate that GLUT4 as well as IRAP can 
interact with some of the adaptors known to be important in trafficking at the TGN and 
endosomes. This data therefore supports a role of these adaptor proteins in GLUT4 
recycling. 
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CHAPTER 1 • INTRODUCTION 
1.1 Insulin action in fat and muscle 
Insulin is a key hormone in regulation of fuel metabolism. It is secreted by the 13 cells of 
the pancreas in response to high blood glucose levels. One of the main actions of insulin 
is on muscle and adipose tissue and this will be discussed in detail here, but insulin also 
suppresses gluconeogenesis in the liver and increases glycolysis thereby controlling liver 
glucose output. By these means, insulin plays a key role in whole body glucose 
homeostasis. 
Insulin effects on cells are dependent on the presence of an insulin receptor to which 
insulin binds and this leads to a cascade of events, signalling to the cell the presence of 
high blood glucose levels. In both fat and muscle cells this causes the uptake of glucose 
into those cells. Here glucose is metabolised and either converted into glycogen in 
muscle or fatty acids in adipose tissue. Indeed both muscle and fat are the main energy 
stores of the body and can be used, when blood glucose levels are low. Uptake of 
glucose into tissues is made possible by the presence of glucose transporters in the 
.. 
plasma membrane. Glucose transporters belong to a family of hexose transporters, which 
will be discussed in detail below. The effect of insulin on muscle and fat is mediated by 
the glucose transporter GLUT4. This transporter is insulin-sensitive and in the absence 
of insulin it is localised intracellularly. GLUT4 levels at the plasma membrane increase 
rapidly after insulin binding its receptor and this ensures the uptake of glucose when 
blood glucose levels are high. A defect in GLUT4 translocation will cause a decreased 
1 
uptake of glucose due to insulin and is thought to be the underlying cause of diseases 
such as diabetes mellitus. 
1.2 Diabetes 
Diabetes mellitus can be divided into two different types. Insulin-dependent diabetes 
mellitus (100M) and non insulin-dependent diabetes (NIDDM), now called type 1 and 2 
respectively. Type 1 often manifests itself in childhood and it thought to be genetically 
detennined leading to the destruction of the (3-cells in the pancreas and therefore to 
insulin deficiency. Type 1 can often be treated successfully with the administration of 
insulin. Type 2 on the other hand is often called "late onset diabetes" and it is greatly 
influenced by external factors such as diet and lifestyle. Both types show a phenotype of 
hyperglycemia, but as mentioned earlier type 1 patients produce no insulin, while type 2 
patients are often hyperinsulinaemic. Type 2 as well as obesity is characterised by 
insulin resistance. Studies on nondiabetic offspring of two diabetic patients showed that 
they have a 50% risk of becoming diabetic in later life, suggesting that type 2 diabetes is 
also genetically determined. This risk increased greatly if the individuals were also 
obese suggesting an environmental component in the development of type 2 diabetes (as 
-.. 
reviewed in Kahn 1994). 
Insulin resistance precedes the development of type 2 diabetes. Patients that are diabetic 
have probably been insulin resistant for many years before the disease is diagnosed, 
usually only by the appearance of side effects. These side effects are caused by the 
increased blood glucose levels over a long period of time and include in extreme cases 
2 
kidney failure, blindness and cardiovascular disease. The decreased insulin sensitivity 
in individuals often leads to an increase in insulin production, which again might further 
reduce insulin sensitivity. Often though, before the onset of diabetes, insulin secretion is 
severely impaired. In such patients, insulin treatment is only sometimes successful due 
to the fact that the patients are insulin resistant, therefore there is a great need for drugs 
which can alleviate this by increasing insulin sensitivity. 
A lot of research has therefore gone into finding the molecular basis for insulin 
resistance. Any defect in the insulin signalling cascade or in GLUT4 translocation could 
lead to the development of insulin resistance. Studies using human tissue as well as 
rodent models of diabetes have revealed that there is probably not just one point in the 
cascade of events which is defective. It could be an accumulation of different defects, 
and there might be different reasons for the development of insulin resistance in 
different patients. 
It is now known that a defective glucose transport is the main reason for insulin 
resistance in type 2 patients (Bonadonna et aZ. 1993; Bonadonna et aZ. 1996; Kelley et 
al. 1996). These data suggest a defect in the translocation of GLUT4 to the plasma 
membrane, leading to a reduced number of transporters in the plasma membrane. Indeed 
impaired GLUT4 translocation has been found in muscle of obese, insulin resistant and 
type 2 diabetic patients (Kelley et al. 1996; Garvey et al. 1998). 
Muscle tissue accounts for the majority of post prandial glucose uptake at about 70-80% 
compared to 5-20% in adipose tissue (as reviewed in Hunter & Garvey 1998). 
Downregulation of GLUT4 in those tissues could explain the decreased glucose 
3 
transport in diabetic patients and indeed in adipocytes GLUT4 levels are down by about 
80-90% (Garvey et ai. 1991). On the other hand GLUT4levels in muscle are unchanged 
(Garvey et al. 1992) and GLUT4 depletion can therefore not be the only reason for 
insulin resistance in type 2 diabetes. The defect in GLUT4 translocation in muscle 
therefore could be due to either a defect in the translocation mechanism of GLUT4 or 
due to mis-targeting of GLUT4 to an insulin insensitive location. Diabetes due to 
impaired GLUT4 recycling will be discussed in more detail in section 1.5.5. 
In this study we are going to examine GLUT4 trafficking defects in an insulin resistant 
model system (Chapter 4). We find here that proteins involved in GLUT4 translocation 
are altered as well as some evidence for GLUT4 mis-targeting in insulin resistant cells. 
1.3 Insulin signalling 
Insulin is the only hormone known to regulate GLUT4 translocation. Therefore some 
understanding of the insulin-signalling cascade is necessary to study this mechanism. 
Below, the present state of understanding of this rapidly moving field will be reviewed. 
1.3.1 The insulin receptor 
The insulin receptor is expressed ubiquitously and is made of two ex. and two p subunits 
(reviewed in Virkamaki et ai. 1999; Elmendorf & Pessin 1999). These form a 
heterotetramer linked via disulphide bonds. The ex. subunits are extracellular and contain 
the ligand binding domain. The p subunits span the membrane but the majority of this 
4 
polypeptide is located within the cytosol. This receptor belongs to the tyrosine kinase 
family of receptors, and the intracellular f3 subunits contain tyrosine kinase activity 
(reviewed in Kahn 1994; Virkamaki et al. 1999). Binding of insulin to the ex subunits 
causes a conformational change in the receptor that increases the intrinsic kinase activity 
and leads to the autophosphorylation of the receptor f3 subunits (reviewed in Kahn 
1994). Mutational studies of the tyrosine residues on the receptor that are 
phosphorylated in response to insulin have identified which residues are important for 
the activation of certain downstream pathways. Autophosphorylation of the receptor is 
known to be associated with increased tyrosine kinase activity towards endogenous 
substrates (reviewed in Holman & Kasuga 1997). 
1.3.2 IRS 
The most important downstream targets for the insulin receptor in terms of glucose 
transport are the "insulin receptor substrate" proteins (IRS) (Quon et ai. 1994; Zhou et 
al. 1997). These belong to a family of at least 4 proteins of which IRS-l and IRS-2 are 
thought to be the major mediators of insulin action (Previs et al. 2000; and reviewed in 
Elmendorf & Pessin 1999). All IRS proteins have a similar overall structure, containing 
aN-terminal pleckstrin homology (PH) domain and a phosphotyrosine binding domain 
(PTB), both of which are required for efficient tyrosine phosphorylation of IRS by the 
insulin receptor (Virkamaki et al. 1999). The PH domain recognises polar lipids in the 
membrane and it is known to be important in targeting IRS to the membrane and 
mediating association with the receptor (as reviewed in Shepherd et al. 1998;Virkamaki 
et al. 1999). The PTB domain recognises phosphotyrosine in the amino acid sequence 
NPXp Y that is present in the insulin receptor. This leads to binding of IRS to the insulin 
5 
receptor and the subsequent phosphorylation of IRS on tyrosine residues (Kublaoui et 
al. 1995; Inoue et al. 1998). All IRS proteins contain multiple tyrosine residues many of 
which are located in the consensus sequence YMXM (reviewed in White & Kahn 1994). 
Tyrosines in this sequence are the preferred substrates of the insulin receptor and after 
phosphorylation the phosphotyrosine in this motif is recognised and bound by 
downstream targets (as reviewed in Shepherd et al. 1998). Association of IRS with the 
insulin receptor is only transient and after dissociation IRS can be recognised by proteins 
containing Src homology-2 (SH2) domains. SH2 domains are phosphotyrosine binding 
structures which recognise phosphotyrosine in the context of specific amino acid 
sequences (as reviewed in Virkamaki et al. 1999). There are many proteins that contain 
such SH2 domains and hence can bind to phosphorylated IRS. The most important for 
glucose transport is PI3-kinase (Zhou et al. 1997) and will be discussed in detail below. 
In general, SH2 domains have a higher affinity for phosphotyrosines than PTB domains. 
Hence, the insulin-dependent phosphorylation of tyrosine residues in IRS proteins 
represents a key early signal in the action of insulin. 
Generation of IRS-1 and IRS-2 knockout mice has greatly helped to establish the 
importance and function of these proteins. Mice lacking IRS-1 are severely growth 
retarded, but not diabetic, compensating for insulin resistance by increased insulin 
secretion (Araki et al. 1994; Tamemoto et al. 1994). This data revealed that insulin 
signalling can be independent of IRS-l and led to the discovery of IRS-2 (Araki et al. 
1994). IRS-2 knockout mice on the other hand are diabetic due to insulin resistance both 
in muscle and liver as well as a defect in f3-cell function (Withers et al. 1998). 
6 
When carbohydrate and lipid metabolism was studied in vivo in these animals, it was 
found that IRS-l knockout mice were insulin resistant mainly due to decreased glycogen 
synthesis in muscle, suggesting that IRS-l has its major role in this tissue. In IRS-2 
knockout mice there were defects in muscle and fat metabolism as well as liver glucose 
metabolism suggesting a role of IRS-2 in all three tissues. These data demonstrate that 
the development of glucose intolerance requires defects in multiple sites including 
muscle, liver and adipose tissue (Previs et al. 2000). 
The majority of both IRS-l and IRS-2 is found in the low density fraction in 3T3-Ll 
adipocytes (Heller-Harrison et al. 1995) where they are thought to be associated with the 
cytoskeleton rather then membranes (Clark et al. 1998; Clark et al. 2000). It is thought 
that this localisation is important for the association and subsequent phosphorylation of 
IRS-l and 2 by the insulin receptor, and helps to recruit PI3-kinase from the cytosol to 
the cytoskeleton. This in return may localise this enzyme to its membrane bound 
substrates. Acute insulin treatment causes the release of IRS-l into the cytosol (Heller-
Harrison et al. 1995; Ricort et ai. 1996; Clark et ai. 2000). This translocation of IRS-l to 
the cytosol is probably regulated by serine/threonine phosphorylation of IRS-l (Heller-
Harrison et al. 1995; Inoue et al. 1998) and might function as an "off" switch for IRS-I. 
1.3.3 PI3-kinase 
PI3-kinase is a lipid kinase and a key player in mediating insulin effects on metabolism. 
PI3-kinases can be divided into three classes, but only class la is thought to mediate the 
common insulin responses such as glucose transport, therefore only this class will be 
discussed here. PI3-kinases consist of two subunits,_ both of which have several isoforms 
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(as reviewed in Shepherd et al. 1998). The adaptor/regulatory subunits are between SO 
and BS kDa and contain 2 SH2 domains, an SH3 domain for interaction with other 
proteins, as well as a domain for binding the plIO (catalytic) subunit. As discussed 
below, pBS is the adaptor important in GLUT4 translocation. pllO is the catalytic 
subunit and contains a pBS binding domain as well as the kinase domain. PI3-kinase 
phosphorylates the inositol ring at the D-3 position thereby generating PI(3)P, PI(3,4)P2 
and PI(3,4,S)P3. 
Insulin-stimulation causes the recruitment of pBS to IRS (Kelly & Ruderman 1993) via 
the binding of the SH2 domain to phosphotyrosine residues on IRS present within the 
YMXM motif mentioned above (Figure 1.1). This results in an increased PI3-kinase 
activity (Kelly et al. 1992) by stimulating plIO, and the subsequent formation of 
PI(3,4)P2 and PI(3,4,S)P3 in both adipocytes and muscle (Kelly & Ruderman 1993; Nave 
et al.1996; van der Kaay et ai. 1997). The increase in these phospholipids in membranes 
following insulin challenge causes the activation and recruitment of other proteins 
leading ultimately to an increase in glucose transport (see below). 
Functional data has shown the importance of PI3-kinase in glucose transport. 
Experiments using the PI3-kinase inhibitors wortmannin and L Y294002 have shown 
*$~. 
that PI3-kinase is crucial for insulin mediated glucose uptake (Okada et ai. 1994; 
Cheatham et al. 1994; Clarke et al. 1994). Wortmannin inhibits the exocytosis of 
GLUT4 (Yang et al 1996) and has been shown to completely abolish the insulin-
stimulated increase in PIP2 (Heller-Harrison et ai. 1996) and PIP3 (van der Kaay et al. 
1997; Heller-Harrison et al. 1996). Overexpression 'of a mutant p8S, which lacks the 
plIO-binding site caused decreased PIP3 levels ~s well as impaired insulin-induced 
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glucose transport in eHO cells (Hara et al. 1994). Similarly the microinjection of either 
the SH2 domain of p85 fused to GST or an antibody to plIO into 3T3-Ll adipocytes 
inhibited insulin-stimulated GLUT4 translocation by about 75% (Haruta et al.1995; 
Hausdorff et aI1999). A constitutive active form of PI3-kinase has been shown to cause 
GLUT4 translocation in adipocytes to a similar amount as insulin (Tanti et al1996). 
Recently studies have provided new insight into the role of PIP3 in glucose transport 
(and therefore indirecty the role of PI3-kinase). Firstly, expression of the SH2 domain 
containing inositol phosphatase (SIDP), a 5 'phosphatase, in 3T3-Ll adipocytes 
decreased the intracellular levels of PIP3 and inhibited insulin-induced GLUT4 
translocation by at least 65% (Vollenweider et aI1999). These data indicate that PIP3 is 
a key phospholipid in insulin-stimulated GLUT4 translocation. 
Using synthetic PIP3 analogues introduced into permeabilised 3T3-Ll adipocytes, Jiang 
and colleagues found that these compounds did not have any effect on glucose transport 
when administered alone, but could overcome wortmannin inhibition of glucose 
transport, thereby restoring 90% of the insulin stimulation (Jiang et al 1998). The 
authors conclude from these results, that PIP3 is necessary, but not sufficient for glucose 
transport. 
Collectively, these experiments confirm the need of a functional PI3-kinase in GLUT4 
translocation, but also suggest that there is a second PI3-kinase independent pathway 
necessary for glucose transport, (see section 1.3.6). 
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Interestingly other growth factors such as PDGF can also slightly increase glucose 
transport, but do not cause the translocation of GLUT4 from intracellular stores to the 
plasma membrane (Nave et ai. 1996; Ricort et ai. 1996). Both insulin and PDGF lead to 
the activation of PI3-kinase in 3T3-L1 adipocyte (Wiese et aI. 1995), but the location of 
this activation is different for the two growth factors. In the basal state PI3-kinase is 
found at similar levels in the cytosol, plasma membrane and low density microsomes, 
the fraction which also contains the majority of GLUT4. PDGF decreased the cytosolic 
fraction of p85 and increased its amount at the plasma membrane. Insulin on the other 
hand causes the translocation of p85 from the cytosol to the low density microsomes 
(Nave et al. 1996; Ricort et al. 1996). Similarly PDGF causes an increase of PI3-kinase 
activity in the plasma membrane fraction, while insulin mainly causes increased PI3-
kinase activity in the LDM fraction (Nave et ai. 1996; Ricort et ai. 1996; Clark et al. 
1998). These differences in subcellular localisation of activated PI3-kinase might 
explain how PDGF and insulin can cause different downstream responses using the 
same central enzyme. 
A peptide mimicking the phosphorylated YMXM motif of IRS-l has been shown to 
activate PI3-kinase to the same extent as insulin, but was only able to stimulate glucose 
transport to about 20% of the level of insulin (Herbst et al. 1995). This again highlights 
the importance of the correct cellular location of activated PI3-kinase triggered by the 
association with IRS. 
The association of PI3-kinase with the LDM fraction prompted several laboratories to 
eXamine where PI3-kinase is located in this fraction. One study has reported PI3-kinase 
in GLUT4 vesicles (Heller-Harrison et al. 1996), but it is now thought that the majority 
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of PI3-kinase in this fraction is not membrane associated, but attached to the 
cytoskeleton. The significance of this is not clear yet, but it is thought that the 
arrangement of signalling proteins on a scaffold may help them to interact with each 
other and position them at the right cellular location (Clark et al. 1998). 
1.3.4 PKB and atypical PKC 
As mentioned above PIP3 is the major product of PI3-kinase in vivo in insulin-stimulated 
cells (van der Kaay et al. 1997). Many proteins can bind PIP3 via their PH domain and 
this may recruit or activate these proteins. One such protein is protein kinase B (Akt) a 
serine/threonine kinase that can be activated by a range of growth factors. Insulin has 
been shown to activate PKB in a wortmannin sensitive manner (Wijkander et al. 1997; 
Shepherd et al. 1997). There are three isoforms of PKB and all of these are activated by 
PI3-kinase (as reviewed in Shepherd et al. 1998). Another protein containing a PH 
domain is 3'-polyphosphoinositide-dependent protein kinase (PDK1), which is thought 
to activate PKB by phosphorylation (Alessi et al. 1997). PKB binding to the membrane 
via its PH domain causes a conformational change, required for phosphorylation by 
PDKI. Phosphorylation on a serine and a threonine residue will cause the activation of 
PKB, which then enables PKB to translocate to its target site. PKB is known to be 
involved in many cellular responses such as differentiation, prevention of apoptosis and 
glucose metabolism (as reviewed in Shepherd et al. 1998). 
Data concerning the function of PKB in glucose transport is ambiguous. A dominant 
negative form of PKB, which inhibits endogenous' PKB, had no effect on glucose 
transport (Kitamura et al. 1998). In the same study a dominant negative form of PI3-
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kinase was found to inhibit both PKB and glucose transport. A constitutively active 
form of PKB on the other hand has been shown to cause OLUT4 translocation in 3T3-
Ll adipocytes to nearly the same extent as insulin (see for example Kohn et al. 1996). 
Microinjection of either a PKB substrate peptide or PKB antibody into 3T3-Ll 
adipocytes was found to inhibit insulin-stimulated OLUT4 translocation by - 60% (Hill 
et al. 1999). Furthermore, these authors suggest that insulin-stimulated PKB activity in 
3T3-Ll adipocytes mainly involves the PKBI3 isoform. This isoform is upregulated 
during adipocyte differentiation, and appears to be only poorly activated by POOF in 
these cells, perhaps offering a further clue to the specificity of response to these different 
agonists (Hill et al. 1999). The only partial inhibition mentioned above suggests that 
although PKB is necessary for GLUT4 translocation, there is also a PKB-independent 
pathway in insulin action. 
Other proteins that can bind PIP3, although not via a PH domain, are the atypical protein 
kinase C isoforms (aPKC). PKCs are serinelthreonine kinases and many different 
isoforms of this kinase have been found and classified into subfamilies (as reviewed in 
Mellor & Parker 1998). The conventional (cPKC) and the novel (nPKC) PKCs are 
regulated by diacylglycerol or phorbol ester. These isoforms of PKC are not thought to 
be important in insulin stimulated glucose transport (Gibbs et ai. 1991; Merrall et ai. 
1993; Bandyopadhyay et ai. 1999) and will not be discussed further here. The atypical 
PKCs are not activated by diacylglycerol or phorbol ester, but can be activated by 
insulin and may playa role in glucose transport. The insulin activation of both atypical 
PKC-A and PKC-~ is dependent on PI3-kinase and the formation of PIP3. PKCs can bind 
PIP3 via a mechanism not yet determined, and they are thought to be activated further by 
phosphorylation by POK-l as well as by autophosphorylation (Standaert et ai. 1997; Le 
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Good et al. 1998; Standaert et al. 1999). Overexpression of PKC-~ caused some 
changes in the cellular distribution of GLUT1 and GLUT4 in 3T3-L1 adipocytes 
(Bandyopadhyay et al. 1997) and in rat adipocytes a constitutivly active PKC-~ 
increased insulin-stimulated GLUT4 translocation (Bandyopadhyay et al. 1999). A 
dominant-negative PKC-~ inhibited both basal and insulin-stimulated glucose transport 
in 3T3-L1 adipocytes (Bandyopadhyay et al. 1997) and inhibited insulin stimulated 
GLUT4 translocation in rat adipocytes by about 60 - 70% (Standaert et al. 1997; 
Bandyopadhyay et ai. 1999). Similarily a dominant negative PKC-A also inhibited 
insulin stimulated GLUT4 translocation and this could be reversed by wild type PKC-~ 
and vice versa (Bandyopadhyay et ai. 1999). These data therefore suggest that both 
atypical PKCs might function in supporting insulin stimulated GLUT4 translocation in 
rat adipocytes. Interestingly insulin also increased the levels of both PKC-~ and PKC-
A on GLUT4 vesicles in rat adipocytes (Standaert et ai. 1999), but the significance of 
this is not yet known. 
So far, little is known about the downstream targets of PKC leading to glucose transport. 
A recent study found that PKC-~ could phosphorylate IRS-l and that this might be 
important in a negative feedback pathway (Ravichandran et al. 2001). 
1.3.5 Other PI3·kinase targets 
There are also many other targets of PI3-kinase products. Early-endosomal antigen 
EEA1 is known to bind PI(3)P via its zinc-finger domain (Patki et al. 1998). This protein 
is a rabS effector and therefore links PI3-kinase to rabS (Simonsen. et al. 1998). RabS is 
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a small GTPase which is known to be important in docking and fusion of early 
endosomes. EEAl will only bind rab5-GTP, the active form of rab5 and it is suggested 
that it is recruited to early endosomes and further stabilised by binding of EEAl to 
PI(3)P (Simonsen et ai. 1998). Interestingly it was found that rab5-GTP also binds 
directly to the catalytic subunit of one isoform of PI3-kinase and that this further helps to 
recruit EEAl (Christoforidis et al. 1999). EEAl is known to be important in specifying 
vesicle targeting to early endosomes. 
So far no equivalent mechanism has been found for the insulin-stimulated products of 
PI3-kinase on GLUT4 vesicles. Rab4 is known to be important in. insulin-mediated 
GLUT4 translocation (Vollenweider et al. 1997) and the activation of PI3-kinase by 
insulin leads to an increase in the GTP loading of rab4 (Shibata et al. 1997). Rab4 has 
been implicated as a potential insulin-regulated switch involved in the release of GLUT4 
containing vesicles from their intracellular location (Cormont et ai. 1996; Mora et al. 
1997). It remains to be determined how rab4 and its effectors contribute to the 
translocation mechanism of GLUT4. 
1.3.6 An alternative pathway of insulin signalling. Cbl/CAP complex 
.~" 
Many of the studies described above using introduction of different signalling proteins 
only found a partial inhibition of insulin action. This prompted a search for an 
alternative pathway of insulin signalling involved in glucose transport. 
Cbl is the cellular homologue of the v-CbI onco-protein. It is approximately 120kDalton 
in size, predominantly cytosolic and contains many proline-rich motifs with which it can 
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bind SH3 domains on other proteins. Insulin has been shown to tyrosine phosphorylate 
Cbl in 3T3-Ll adipocytes (Ribon & Saltiel 1997) and this can lead to the binding of Cbl 
with several other proteins. In B cells, Cbl was found to bind p85 and it is therefore 
thought that it might be important in PI3-kinase recruitment and activation in these cells 
(Kim et al. 1995). In 3T3-Ll adipocytes on the other hand, tyrosine phosphorylated Cbl 
was unable to bind PI3-kinase (Ribon & Saltiel 1997). It is now thought that Cbl can 
bind the insulin receptor via the Cbl associated protein (CAP). Interaction of CAP with 
Cbl is mediated by binding of the SH3 domains in CAP to the proline rich motifs in Cbl 
and is independent of insulin action. CAP also binds to the insulin receptor and insulin 
stimulation causes a time-dependent dissociation of the CAP-insulin receptor complex 
(Ribon et al. 1998). After insulin-mediated dissociation of the CAP-Cbl complex from 
the insulin receptor, the complex then moves to caveolin-enriched triton-insoluble 
membrane fractions (Baumann et al. 2000). More interesting is the observation that the 
introduction of CAP lacking the SH3 domains (CAP~SH3) into 3T3-Ll adipocytes had 
no effect on PI3-kinase activity, but was found to inhibit insulin-mediated GLUT4 
translocation by ... 50%-60% (Baumann et ai. 2000). A recent study has found that the 
insulin-mediated translocation of CAP/Cbl to lipid raft domains in the plasma membrane 
activates a small GTP-binding protein TClO, but so far it is not known how this protein 
affects glucose transport (Chiang et al. 2001). These results suggest that insulin can 
generate two independent signals leading to glucose transport, one dependent on and the 
other independent of PI3-kinase. 
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1.3.7 Insulin signalling in diabetes 
Clearly defects in insulin signalling could lead to insulin resistance and diabetes (as 
reviewed in Virkamaki et al. 1999; Saltiel 2001). Although rodent models are important 
in studying insulin resistance and have been used extensively, very few are a real model 
of type 2 diabetes with the same phenotype as that found in human diabetes. Therefore 
recent studies have concentrated on finding signalling defects in diabetic patients. 
Signalling defects that cause insulin resistance are rare, but some will be mentioned 
here. On the other hand it is well established that there are several acquired defects in 
insulin resistance. In type 2 patients a downregulation of insulin receptor as well as 
decreased tyrosine kinase activity have been found, but this can be restored by weight 
loss (Freidenberg et al. 1988). Decreased IRS-l expression has also been found in 
adipocytes of insulin resistant patients, yet interestingly IRS-2 was found to substitute 
for IRS-l and the main insulin-stimulated PI3-kinase activity was now associated with 
IRS-2 (Rondinone et al. 1997). On the other hand in skeletal muscle no changes in IRS-
1 expression was observed, but decreases in its tyrosine phosphorylation in response to 
insulin have been reported, together with a defect in insulin stimulated PI3-kinase 
activity in type 2 diabetic patients (Bjornholm et al. 1997). Another study reported a 
50% decrease in IRS-l associated PI3-kinase activity and a 39% decrease in IRS-2 
.. 
associated PI3-kinase activity in muscle of type 2 diabetic patients (Kim et al. 1999). 
PKB activity and levels have been shown to be unchanged in muscle of diabetic patients 
and this may suggest that PKB is not a major factor in the development of insulin 
resistance (Kim et al. 1999). 
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Genetic defects in insulin signalling proteins, such as the insulin receptor are very 
uncommon and only found in some syndromes such as leprechaunism and type A insulin 
resistance (reviewed in Hunter & Garvey 1998). There are several polymorphisms 
occurring in IRS-l which are increased in type 2 diabetic patients. These do not lead to a 
large defect on IRS-1 function, but decreased PI3-kinase activity has been reported in 
some (Almind et al. 1996; Imai et al. 1997). To date the only mutation found in PI3-
kinase is present at the same frequency in diabetics and normal individuals and it is 
therefore unlikely to be important in the development of insulin resistance and type 2 
diabetes (as reviewed in Shepherd et al. 1998; Virkamaki et al. 1999). 
1.4 Glucose transport 
Glucose is the major energy source for most mammalian cells and, in order to be used in 
the cytosol, has to be transported across the plasma membrane. 
There are two major types of glucose transporters. The sodium-dependent transporters 
Use a Na+ gradient to drive accumulation of glucose (as reviewed in Bell et al. 1993), 
and will not be discussed further here, and the facilitative glucose transporters that move 
glucose down its chemical gradient and do not use energy for this transport. 
1.4.1 The family of glucose transporters 
There are several isoforms of the facilitative glucose transporters. They are products of 
distinct genes, exhibit tissue-specific expression, and are independently controlled. The 
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facilitated glucose transporters are integral membrane proteins and their structure will 
be discussed in some detail below. 
Seven different functional facilitative sugar transporters have been characterised in 
mammals. 
GLUTI was the first to be isolated from red blood cells and is ubiquitously expressed. It 
is the major transporter at the blood-tissue barriers and provides cells with glucose even 
if extracellular glucose levels are low. GLUTI is sometimes called the "house-keeping" 
glucose transporter as it provides tissues with a constant low level of glucose ( as 
reviewed in Gould 1997). 
GLUT2 is a bi-functional glucose/fructose transporter and is mainly expressed in the 
liver, the beta cells of the pancreas and the small intestine. In the liver, it is important for 
both import and export of glucose, depending on the blood glucose levels and thereby 
ensuring the important role of the liver in whole body glucose homeostasis (as reviewed 
in Gould & Holman 1993; Gould 1997). 
GLUT3, the neuronal glucose transporter is crucial for supplying the brain with glucose 
as brain has a high glucose demand and can not use any other energy source. As such it 
has the lowest Krn of all the transporters studied functionally to date (as reviewed in Bell 
et al. 1993). 
GLUT4, the "insulin-sensitive glucose transporter" is the most intensively studied 
member of the family (as reviewed in Rea & James 1997). It is expressed in muscle, 
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heart and fat tissue and undergoes insulin-mediated translocation from an intracellular 
store to the plasma membrane thereby ensuring the insulin responsiveness of those 
tissues. This leads to the uptake of glucose into glucose storage tissues and subsequently 
glycogen is synthesised in muscle and fatty acids and triglycerides are made in fat cells. 
This transporter is discussed further below. 
GLUT5 is a fructose transporter and although expressed in many tissues it is highly 
expressed in the small intestine where it is thought to be important in mediating fructose 
transport from the intestine lumen (as reviewed in Gould 1997). 
GLUT6 does not encode a functional glucose transporter, it being a pseudo gene with 
several stop codons (as reviewed in Gould & Holman 1993). GLUT7 has been 
withdrawn from the database. 
More recently several new members have been cloned. The newly identified GLUTS 
encodes a functional glucose transporter which has a wide tissue distribution with 
highest levels in testis. Interestingly its expression in testis was suppressed by estrogen 
treatment and it is thought that this transporter might have a role in the provision of 
glucose in male genn cells (Doege et al. 2000). So far little is known about GLUT9, but 
.. 
its expression was found to be highest in kidney and liver (Phay et al. 2000). 
1.4.2 Structure 
Analysis of the hydropathy plots of the predicted amIno acid sequences of the different 
isoforms has shown that these proteins adopt sinri1ar structures (Figure 1.2). These 
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studies predict an integral membrane protein with twelve amphipathic helices spanning 
the membrane with both the N- and C-terminus on the cytoplasmic side. There are large 
loops between helices 1 and 2 (extracellular) and 6 and 7 (intracellular) (as reviewed in 
Gould & Holman 1993). The major features of this model have been experimentally 
confirmed (as reviewed in Gould 1997) and it is thought that five of the 12 helices form 
an aqueous channel through which glucose can traverse the membrane (as reviewed in 
Barrett et al. 1999). Conformational studies using chimeras of the different glucose 
transporters isoforms have allocated specific functions to certain sequences, structures or 
even amino acids within these transporters. The substrate binding site is known to be 
made up of different regions of the transporter and binding of substrate to the exofacial 
site causes a conformational change re-orientating the sugar binding site to the 
endofacial conformation and subsequent release of the substrate into the cytoplasm (as 
reviewed in Gould 1997; Barrett et al. 1999). 
1.5GLUT4 
1.5.1 The translocation hypothesis 
-\>>>', 
In contrast to the other glucose transporter isoforms, which are located mainly at the 
plasma membrane, 95 % of GLUT4, the "insulin-sensitive glucose transporter", is found 
in intracellular vesicles and tubules (Slot et al. 1991a; Slot et al. 1991b). Insulin causes 
the translocation of these vesicles to the cell surface resulting in up to 20-fold increased 
levels of GLUT4 at the plasma membrane and therefore increased glucose transport (as 
reviewed in Rea & James 1997). 
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The intracellular location of OLUT4 and the mechanism of its translocation will be 
discussed in detail below. 
1.5.2 Localisation by EM 
In the last years much research has gone into examining the nature of the OLUT4 
containing compartment. Electron microscopy studies, using brown adipose tissue or rat 
cardiac muscle, have shown OLUT4 to be localised to about 40% in tubulo-vesicular 
structures near the Oolgi, some of this probably being TON. Another 50% was found in 
tubulo-vesicular structures scattered throughout the cytoplasm (Slot et at. 1991a; Slot et 
at. 1991b). OLUT410calisation in tubulo-vesicular structures both near the TON as well 
as throughout the cytoplasm has also been confirmed in skeletal muscle (Ploug et al. 
1998). The presence of OLUT4 near the TON led to experiments using rat atrial 
cardiomyocytes, a secretory cell type, in order to determine whether OLUT4 is actually 
localised in this compartment. In these cells a large proportion of OLUT4 (50 - 60%) 
was found in the secretory granules which indicates that OLUT4 traffics through the 
TON during recycling (Slot et at. 1997). However, OLUT4 vesicle purification studies 
argue against the TON being the major intracellular storage compartment in adipocytes 
(Martin et a11994). 
In brown adipose tissue OLUT4 levels at the plasma membrane were observed to be 
around 1 % in the absence of insulin, confirming the idea that OLUT4 is excluded from 
the cell surface in the absence of stimulation. Insulin 'then caused a redistribution of 
OLUT4 from these intracellular structures to the plasma membrane by about 40% (Slot 
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et al. 1991a; Slot et al. 1991b). Insulin stimulation also resulted in increased labelling 
of GLUT4 in clathrin lattices and early endosomes, suggesting that GLUT4 is 
endocytosed via clathrin coated pits, a well described mechanism for other membrane 
proteins (as reviewed in Robinson et al. 1996). 
Recently a new method for the isolation of cytoplasmic sheets from rat adipocytes has 
allowed a 3-D resolution of the intracellular GLUT4 compartments using electron 
microscopy (Ramm et al. 2000). In this study the majority of GLUT4 was found in 
vesicles (60%) while a smaller part of GLUT4 was in tubules (25%). Interestingly 
insulin caused a recruitment of GLUT4 mainly from the small vesicles and translocation 
of GLUT4 is though to occur via fusion of these vesicles with the plasma membrane 
rather then sorting of GLUT4 out of the vesicles (Ramm et al. 2000). 
The presence of GLUT4 in different intracellular compartments will be discussed in 
more detail below. 
1.5.3 Multiple compartments 
The main effort in the last years therefore has been to identify what compartment these 
tubulo-vesicular structures are. One obvious suggestion was that GLUT4 is part of the 
constitutive recycling pathway. It is known that GLUT4 is endocytosed via clathrin 
Coated pits (Slot et al. 1991a; Robinson et al. 1992) and recycles constantly from the 
plasma membrane to intracellular sites both in the presence and absence of insulin 
(Robinson et al. 1992; Yang & Holman 1993). GLUT4 partially colocalises with several 
other proteins such as GLUT1 (Calderhead et al. 1990; Robinson & James 1992), the 
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mannose-6-phosphate receptor (M6PR) (Kandror & Pilch 1996) and the transferrin 
receptor (TfR) (Tanner & Lienhard 1989) in endosomes. These proteins also undergo 
insulin responsive translocation to the cell surface in 3T3-Ll adipocytes (Tanner & 
Lienhard 1987; Tanner & Lienhard 1989; Calderhead et al. 1990; Kandror & Pilch 
1996; Kandror & Pilch 1998; Subtil et al. 2000), however this increase is only about 2-
fold compared to the ... 20-fold increase of GLUT4 (Tanner & Lienhard 1987; 
Calderhead et al. 1990; Piper et al. 1991). This suggests that although GLUT4 is partly 
present in the same compartment as those proteins, a significant fraction is localised to a 
compartment that is distinct from endosomes and which is highly responsive to insulin 
(Yang & Holman 1993). 
The idea that GLUT4 populates at least two different intracellular compartments 
(endosomes and GSVs) has been suggested by data using many different methods. From 
a kinetic point of view, the behaviour of GLUT4 recycling kinetics can only be 
explained by the presence of at least two intracellular GLUT4 pools (Holman et al. 
1994). In this study the membrane impermeant bismannose photolabel ATB-BMPA was 
used to tag GLUT4 at the plasma membrane after insulin treatment, and the subsequent 
re-distribution of the tagged GLUT4 was examined. The behaviour of tracer-tagged 
GLUT4 was then fitted into different models for GLUT4 recycling (Figure 1.3). The 3-
pool model with two intracellular pools, one early endosome pool (Tee) and one tubulo-
vesicular pool (Ttv) , can account for the above mentioned differences in recycling 
between GLUT4 and other proteins. It also allows for a rapid translocation of GLUT4 to 
the plasma membrane and fits into the observation that the main effect of insulin is to 
increase the exocytosis rate of GLUT4 rather then decrease the endocytosis rate (Slot et 
al. 1991a; Yang & Holman 1993). This model involves only one plasma membrane pool 
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of glucose transporter and therefore does not account for the presence of GLUT4 in 
clathrin coats (Slot et al. 1991a; Robinson et ai. 1992) or more importantly for the time-
differences observed between appearance of GLUT4 at the plasma membrane and 
increase in glucose transport (Holman et al. 1994). Therefore two different 4-pool 
models using occluded pools were proposed, where T po (Figure 1.3C) represents vesicles 
that have docked with the plasma membrane, but not yet fused and Tpc (Figure 1.3D) 
represents GLUT4 in clathrin coated pits ready for endocytosis. It is important to note 
here that the ATB-BMP A can access GLUT4 in the occluded pool. The authors of this 
paper propose that the only possible way to explain all the data about GLUT4 trafficking 
is through a 5-pool or multiple-pool model, which contains the two internal pools as well 
as the occluded pools (Holman et al. 1994). 
The recently developed method to visualise the GLUT4 compartments in a 3-
dimensional way has greatly helped to distinguish between the intracellular GLUT4 
pools (Ramm et ai. 2000). As mentioned above, the majority of GLUT4 was targeted to 
small vesicles and this vesicular compartment was shown to be distinct from early and 
late endosomes as well as TGN. Co-localisation studies suggested on one hand that a 
subset of these vesicles fuse with the plasma membrane in response to insulin, but also 
that GLUT4 is found in mannose-6-phosphate receptor (M6PR) positive vesicles and 
,p 
that insulin induced a sorting of GLUT4 out of those vesicles. 
The presence of two intracellular GLUT4 pools, one being endosomes and the other 
highly insulin responsive, has also been confirmed biochemically and some of these 
experiments will be described here. 
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Studies in rat adipocytes have suggested that GLUT4 containing vesicles are 
structurally as well as functionally different from other intracellular endosomes 
(Kandror et al. 1995). Many other studies have tried to separate the insulin-sensitive 
GLUT4 storage vesicles (GSVs) from the endosomal GLUT4 pool. Indeed sucrose 
density gradient studies, which exploit the different density properties of membranes, 
found two pools containing GLUT4 in rat skeletal muscle. Only one of the pools showed 
a 30% decrease in GLUT4 levels due to insulin, while the other pool contained TfR 
(Aledo et al. 1997). The use of hypotonic lysis instead of homogenisation as a method to 
fractionate cells has also allowed the separation of strongly insulin-sensitive vesicles 
(presumably GSVs) from the less insulin-sensitive endosomes (Lee et al. 1999). The 
best method so far to separate GLUT4 in internal membranes into endosomes and GSVs 
is the recent use of iodixanol as a gradient material (Hashiramoto & James 2000) and 
this will be discussed in detail in Chapter 3. 
Another method, which has given similar results, is compartment ablation. Here cells are 
loaded with transferrin bound to horseradish peroxidase (Tf-HRP). The Tf-HRP is taken 
into the cell via the transferrin receptor. Incubation of intact· cells with diamino-
benzidine (DAB) and hydrogen peroxide allows HRP to transfer electrons from DAB to 
peroxide. This produces a highly reactive cross-linker within the lumen of transferrin 
receptor positive vesicles/tubules, and thus any protein in proximity to the transferrin 
receptor is ablated (Livingstone et ai. 1996). Both GLUT1 and the transferrin receptor 
Were ablated to about 70% after 2h incubation with Tf-HRP while GLUT4 was found to 
be ablated by only 40%. This would suggest that the larger proportion of GLUT4 (60%) 
is localised to a TfR-negative compartment, which was also devoid of the endosomal 
markers rab5 and M6PR (Livingstone et ai. 1996). This data supports the kinetic and 
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gradient studies mentioned earlier, and confirms the idea that GLUT4 is localised in 
two intracellular compartments, one being the endosomes and another being the GSV s. 
1.5.4 The GSV model 
The model is therefore that GLUT4 in the basal state is present in an insulin responsive 
compartment now termed GLUT4 storage vesicles (GSVs) (Figure 1.4). Insulin then 
causes a rapid translocation of GLUT4 to the plasma membrane, this occurs both via 
fusion of GLUT4 containing vesicles with the plasma membrane as well as sorting of 
GLUT4 from an endosomal compartment. From the plasma membrane GLUT4 is then 
endocytosed via clathrin coated pits, enters the endosomal recycling pathway, resulting 
in co-localisation with TfR, M6PR and GLUT1. From the endosomes a large proportion 
of GLUT4 is then removed into the GSVs and is stored there until a further insulin 
challenge. 
1.5.5 GLUT4 defects in diabetes 
As mentioned in section 1.2 a defective glucose transport is the main reason for insulin 
resistance in type 2 patients (Bonadonna et al. 1993; Bonadonna et al. 1996; Kelley et 
al. 1996). Decreased GLUT4 levels at the plasma membrane after insulin treatment 
could be due to defects in any stages of GLUT4 recycling and this can therefore lead to 
the development of type 2 diabetes. 
Garvey and co-workers have extensively studied GLUT4 levels and trafficking in both 
adipocytes and muscle cells from type 2 diabetic patients. Although in adipocytes 
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GLUT4 downregulation can explain most of the decrease in insulin-stimulated glucose 
uptake (Garvey et ai. 1991), there is a discrepancy between the amount of transporters 
found at the plasma membrane and glucose transport (Garvey et ai1988). Similar results 
were found in patients with gestational diabetes (abnormal glucose tolerance during 
pregnancy). In these women glucose transport rates both in basal and insulin stimulated 
cells were much lower than expected from the levels of GLUT4 found at the plasma 
membrane (Garvey et ai 1993). This data could be explained in at least two different 
ways; one possibility is that in these patients there is a defect in GLUT4 activity and that 
GLUT4, although present at the plasma membrane, is not functional. Another 
explanation is that GLUT4 is not inserted correctly into the plasma membrane and 
therefore not transporting glucose. The authors favour this explanation and suggest that 
GLUT4 is mis-targeted to a compartment which in subcellular fractionations is isolated 
together with the plasma membrane (Garvey et al 1993). This could, for example, be if 
GLUT4 was present in an occluded pool at the plasma membrane, where GLUT4 
vesicles are docked with the membrane but not yet fused. In this case GLUT4 would be 
isolated in the plasma membrane fraction, but not transport glucose. 
A study from the same labroatory in muscle from insulin-resistant patients also 
suggested that GLUT4 was mis-targeted and that this could be the reason why insulin 
Was unable to recruit GLUT4 to the plasma membrane (Garvey et al. 1998). 
Interestingly in these insulin-resistant patients GLUT4 was mis-targeted to a fraction 
that also contained plasma membrane and this is therefore similar to the study in 
adipocytes described above. 
Further studies to identify the location of GLUT4 in insulin resistant cells are required. 
27 
1.5.6 GLUT4 knock out mice 
The generation of a GLUT4 knock out mouse has lead to the surprising discovery that 
GLUT4 is not actually necessary for maintaining nearly normal blood glucose levels 
(Katz et ai. 1995). These mice are growth-retarded and have decreased longevity, but are 
not diabetic. Examining the other glucose transporters showed that GLUT1, the only 
other glucose transporter present in fat and muscle tissue, was not upregulated. GLUT2 
on the other hand was upregulated in liver and this is thought to indicate an increase 
uptake of glucose into this organ (reviewed in Mueckler & Holman 1995). The reduction 
of adipose tissue in these mice and the likely decrease of glycolysis in muscle, makes it 
unlikely that there is another hitherto unidentified glucose transporter by which these 
tissue transport glucose, and suggests that there is a decrease in glucose uptake into 
peripheral tissues. It is thought that these mice might maintain normal blood through an 
increased uptake of glucose into liver and thereby somewhat compensate for the lack of 
GLUT4. 
Interestingly, heterozygous knockout mice for GLUT4 in contrast to the homozygous 
knockout described above, develop a diabetic phenotype (Stenbit et ai. 1997). The 
reason for this is thought to be that these mice produce normal levels of GLUT4 until 
they are 8 weeks old, but then GLUT4 content declines. As a consequence of this 
heterozygous mice do not develop the compensating mechanism seen in GLUT4 null 
mice and therefore can not cope with the decreased glucose uptake into peripheral tissue. 
A recent study examining mice deficient of GLUT4 in their adipose tissue showed that 
these mice developed insulin resistance (Abel et ai. 2001). Isolated adipocytes from 
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those mice showed reduced glucose uptake both in the presence and absence of insulin, 
while muscle glucose uptake was normal. Interestingly in vivo glucose uptake was not 
only reduced in adipose tissue, but also muscle. This suggests that reduced insulin-
stimulated glucose transport in adipocytes secondarily induces insulin resistance in other 
insulin target tissues and this might be caused by the chronic hyperinsulinaemia 
observed in these mice (Abel et al. 2001). 
1.6IRAP 
IRAP or vp165 is an aminopeptidase, which was first cloned from rat adipocytes (Keller 
et al. 1995), has been found to colocalise with GLUT4 in rat adipocytes (Mali de et al. 
1997), 3T3 L-l adipocytes (Ross et al. 1996) as well as rat skeletal muscle (Aledo et al. 
1997). Immunoadsorption of GLUT4 vesicles and subsequent analysis of the vesicles 
with IRAP antibody as well as immunoadsorption of IRAP vesicles and subsequent 
analysis of the vesicles with GLUT4 antibody have shown that these two proteins 
colocalise perfectly in the basal state in 3T3-Ll adipocytes' (Ross et al. 1996). 
Subcellular fractionations revealed that IRAP translocates to the plasma membrane to a 
similar extent then GLUT4 both in 3T3-Ll adipocytes (Ross et al. 1996) as well as rat 
adipocytes (Mali de et al. 1997). Subsequently biotinylation experiments showed the 
increase at the plasma membrane due to insulin to be about 8-fold (Ross et al. 1996). 
Confocal microscopy of rat adipocytes using double labelling with GLUf4 and IRAP 
suggested an about 85% overlap between the two proteins (Mali de et al. 1997). 
Similarly, using the more accurate electron microscopy method on GLUT4 or IRAP 
vesicles showed a 70 - 90% overlap depending on the cell type (Martin et al. 1997). 
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Ablation experiments showed that !RAP was ablated to a similar degree as GLUT4, 
suggesting that it is localised in two or more intracellular compartments very much like 
GLUT4 (Martin et al. 1997). Similar to GLUT4 !RAP recycles constantly between the 
plasma membrane and intracellular membranes and is endocytosed via clathrin coated 
pits (Garza & Birnbaum 2000). Several studies support the idea that GLUT4 and !RAP 
recycle through the endocytic pathway in a very similar manner (Malide et ai. 1997; 
Ross et ai. 1997; Garza & Birnbaum 2000). 
So far very little is known about the concrete function of !RAP and it is not quite clear 
yet whether !RAP has any role in GLUT4 trafficking. One study has suggested a role of 
IRAP in constitutive, but not insulin stimulated GLUT4 trafficking (Filippis et al. 1998). 
On the other hand, injection of !RAP (especially a 28 amino acid stretch of the 
cytoplasmic tail of the protein) into 3T3-Ll adipocytes causes GLUT4 translocation in 
the absence of insulin. This translocation to the plasma membrane could not be inhibited 
by wortmannin the PI3-kinase inhibitor. These results therefore suggest that the action of 
IRAP on GLUT4 is downstream of PI3-kinase activity. (Waters et ai. 1997) A 
hypothesis for these results is that retention proteins interact with the C-terminus of 
GLUT4 or/and the N-terminus of !RAP. Injecting !RAP peptides into cells causes 
competition of these peptides with intracellular !RAP for the retention proteins and 
"1-)'; 
thereby translocation of the GLUT4 vesicles to the plasma membrane (Waters et al. 
1997). This data was supported by the generation of a chimeric reporter molecule vpTR 
that contains the N-terminal cytoplasmic domain of !RAP and the transmembrane and 
extracellular domains of the transferrin receptor and behaves very much like !RAP. A 
mutation of the di-Ieucine motif in the cytoplasmic tail of vpTR showed that this motif 
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interacts with the machinery responsible for insulin-regulated intracellular retention 
(Johnson et al. 1998; Subtil et al. 2000). 
1.7 Other molecules in GLUT4 vesicle 
1.7.1 SCAMPs 
Secretory carrier membrane proteins (SCAMPs) are between 35 and 40kDa and are 
found in all secretory carrier membranes. They colocalise with GLUT4 in the LDM 
fraction both in the absence and presence of insulin, and indeed a 37kDa SCAMP is 
found on GLUT4 vesicles (Laurie et al. 1993). SCAMPs only show a slight 
translocation to the plasma membrane after insulin treatment and the authors propose 
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that SCAMPs are segregated from GLuT4 in the presence of insulin possibly due to a 
more rapid intemalisation (Laurie et al. 1993). A role of these proteins in GLUT4 
trafficking has not been shown. 
1.7.2 VAMP/Cellubrevin 
'"0 
Both vesicle-associated membrane protein 2 (V AMP2) and cellubrevinIV AMP3 have 
been found on GLUT4 vesicles (Cain et ai. 1992; Vo1chuk et al. 1995; Tamori et al. 
1996; Martin et al. 1996; Malide et al. 1997). These proteins are important for the 
SNARE-type mechanism of translocation of GLUT4 to the plasma membrane and will 
be discussed in detail below. Both VAMP2 and cellubrevin show insulin-stimulated 
translocation to the plasma membrane (Cain et al. 1992; Volchuk et al. 1995; Tamori et 
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al. 1996; Martin et al. 1996). It is now thought that VAMP2 is important in the 
translocation of the GSVs to the plasma membrane, while cellubrevin plays a role in the 
endosomal translocation of GLUT4 and other proteins (Vo1chuk et al. 1995; Cheatham 
et ai. 1996; Martin et ai. 1996; Martin et ai. 1998). 
1.7.3 PI4.kinase 
PI4-kinase is a lipid kinase which phosphorylates the inositol ring at the D-4 position 
thereby generating PI(4)P. GLUT4 vesicles isolated form rat adipocytes have been 
found to contain PI4 kinase (Del Vecchio & Pilch 1991) and indeed PI 4 kinase activity 
has been found on GLUT4 vesicles from rat skeletal muscle (Kristiansen et al. 1998). 
The kinase activity on GLUT4 vesicles from both adipocytes and muscle on the other 
hand is not regulated by insulin (Del Vecchio & Pilch 1991; Kristiansen et al. 1998) and 
this enzyme is probably not involved in GLUT4 trafficking. 
1.7.4 AktJPKB 
As discussed above protein kinase B~ (PKB~/Akt-2) has been implicated in insulin 
action (Hill et al 1999). This isoform of PKB is located in the cytosol as well as in all 
membrane fractions in a subcellular fractionation of adipocytes and this is in contrast to 
PKBa (Akt-l) which is exclusively cytosoIic (Calera et al 1998). Insulin has no effect 
on the cellular distribution of PKBa, but causes a very slight increase of PKB~ in the 
LDM fraction, probably deriving from the cytosol. Interestingly PKB~ was found on 
GLUT4 vesicles and the ratio PKB13/GLUT4 increased after insulin treatment consistent 
with an increase of PKBI3 and a decrease of GLUT4 in these vesicles (Calera et aI1998). 
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1.7.5 Sortilin 
Sortilin is a 110 kDa protein that was found originally by its presence on GLUT4 
vesicles of adipocytes (Morris et ai. 1998). Similar to GLUT4, sortilin is absent in 3T3-
Ll fibroblasts and its levels are maximal around day 8 after differentiation. Insulin 
causes a very small redistribution of sortilin from the WMs to the plasma membrane in 
3T3-Ll adipocytes and this is surprising due to its presence on GLUT4 vesicles. The 
authors of this study suggest that most of the sortilin may be in GLUT4 vesicles arising 
from endosomes and Golgi rather then from the GSVs (Morris et ai. 1998). So far a role 
of sortilin in GLUT4 trafficking has not been found. 
1.7.6 Pantophysin 
The synaptophysin homologue pantophysin has been cloned from both 3T3-Ll 
fibroblasts (Haass et ai. 1996) and adipocytes (Brooks et al. 2000). Pantophysin is an 
integral membrane protein of small cytoplasmic transport vesicles and it was found to be 
ubiquitously expressed (Haass et al. 1996). In 3T3-LI adipocytes pantophysin has been 
shown to be localised to GLUT4 vesicles and interact with the v-SNARE V AMP2 
.. 
(Brooks et al. 2000). Insulin caused a small increase of this protein at the plasma 
membrane, but incubation of permeabJised 3T3-LI adipocytes with a small C-terminal 
peptide of pantophysin had no effect on GLUT4 trafficking. Interestingly although 
insulin had no effect on the phosphorylation state of pantophysin, it stimulated the 
association of a 77 kDa protein with pantophysin (Brooks et ai. 2000). These data 
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suggest that insulin regulates pantophysin, but the function of this protein in vesicle 
trafficking is still unclear. 
1.8 The SNARE hypothesis 
The SNARE hypothesis originates from the research on synapses, where 
neurotransmitters in the presynapse are stored in vesicles ready to be released into the 
synaptic cleft. Calcium influx into the presynapse due to an action potential travelling 
down the axon causes rapid release of this neurotransmitter (as reviewed in SUdhof 
1995). The study of these synaptic vesicles and how they fuse with their target 
membrane has provided much infonnation about regulated secretion in cells in general 
and how this is controlled. 
The SNARE hypothesis provides a conceptual framework to explain the docking and 
fusion of synaptic vesicles with the plasma membrane. This model states that the vesicle 
that is supposed to fuse with the membrane contains a protein called vesicle-SNARE (v-
SNARE) and that the target membrane contains a target-SNARE (t-SNARE). 
Complementary v-SNARE and t-SNARE pairs are able to engage and this could initiate 
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the fusion event (SBllner et al. 1993a). Several other proteins are also thought to be 
involved in this process which will be discussed below. 
One of these proteins is NSF (N-ethylmaleimide-sensitive factor), a tetramer made of 
76kDaiton subunits (Block et al. 1988). NSF is an ATPase that can bind several other 
proteins in the ATP bound state (Wilson et ai. 1992) and NSF activity is necessary for 
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membrane fusion (Whiteheart et ai. 1994). In the initial experiments which led to the 
SNARE hypothesis Rothman and colleagues assembled the so-called 20S particle using 
NSF in the ATP bound state as bait. Five proteins were found to be part of the 20S 
complex: NSF, a-SNAP, synaptobrevinIV AMP (vesicle-associated membrane protein 
2), syntaxin and SNAP25 (Sonner et al. 1993a and b). VAMP, syntaxin and SNAP25 are 
called SNAREs (for soluble NSF attachment protein receptor) and interestingly these 
proteins can form a complex even in the absence of a-SNAP and NSF (Sonner et ai. 
1993b). When ATP was added to this complex it was hydrolysed by NSF and the 20S 
particle was disassembled. 
Many different isoforms of the SNAREs have subsequently been identified which has 
led to the suggestion that the formation of the SNARE complex is an obligatory step in 
all membrane fusion (Bock et ai. 1996; Advani et ai. 1998; Prekeris et ai. 1998; Tang et 
ai. 1998). V AMPs are located on the cytoplasmic surface of vesicles (hence the name v-
SNAREs) and are anchored in the membrane via their hydrophobic C-terminus which 
contains a membrane spanning domain (Trimble et ai. 1988). Syntaxin and SNAP25 
located in the target or plasma membrane (Sonner et al. 1993b) are hence called t-
SNAREs. 
.. 
The original hypothesis proposed that pairing of the v-SNARE with the t-SNAREs 
results in vesicle docking at the plasma membrane, and in order for fusion to occur this 
complex has to be broken up. Due to the fact that these three SNARE proteins can form 
a stable entity, an energy input is required for this to happen and this was thought to be 
the reason why ATP hydrolysis by NSF, with the help of a-SNAP, is needed. 
SUbsequent studies have suggested that this is an over simplified view and only correct 
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in parts. A more up to date model for SNARE complex function will be discussed in 
more detail below. 
1.8.1 Evidence for the function of SNARE proteins and their specificity 
Evidence in favour of the SNARE hypothesis includes experiments using the eight 
different botulinum and tetanus toxins. These are some of the most dangerous toxins 
because they inhibit synaptic vesicle exocytosis and therefore block nerve function. 
These toxins are proteases, five of which can cleave V AMP, two cleave SNAP-25 and 
one cleaves syntaxin (as reviewed in SUdhof 1995). Interestingly these proteins can only 
be cleaved before the assembly of the SNARE complex, but not in the complex itself 
(Hayashi et al. 1994), which suggests that the cleaving sites are not accessible to the 
toxins once the complex has formed. Cleavage of VAMP using these toxins resulted in 
inhibition of neurotransmitter release in the squid giant synapse, but increased the 
amount of docked synaptic vesicles suggesting that VAMP was not important in the 
docking of the vesicles at the active zone, but necessary for a post-docking event (Hunt 
et al. 1994). 
There has been considerable debate regarding the minimal machinery needed for 
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membrane fusion. One report showed that fusion can occur when only SNARE proteins 
are present in the membrane without NSF and a-SNAP, although this fusion was shown 
to be very slow (Weber et al. 1998). This has led to the concept of the so-called 
SNAREpin model of fusion, where the SNARE proteins represent the minimal 
machinery required for membrane fusion. Another study showed that NSF, with the help 
of a-SNAP as regulator, was sufficient for rapid membrane fusion and that there was no 
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need for SNARE proteins (Otter-Nilsson et al. 1999). This latter study may be an 
artefact of in vitro experiments, or may arise as a consequence of the unusual lipid 
mixture of the model membranes employed. Further studies will be required to resolve 
these discrepancies. Nonetheless, the SNAREpin model is now becoming widely 
accepted. 
The discovery that a SNARE type mechanism is present in all kinds of vesicle 
exocytosis and that there are many isoforms of the SNARE proteins prompted an 
analysis of the specificity of this process. In the original SNARE hypothesis it was 
suggested that the amount of VAMP and syntaxin isoforms present provided enough 
possibility for the formation of specific pairs and that this ensured the specificity of this 
mechanism (Sollner et al. 1993b). In the last years this idea has been challenged. In an in 
vitro study, SNAP-25 and two homologues, three syntaxin homologues and five VAMP 
isoforms were tested for the formation of a SNARE complex. Although the results 
demonstrated some variability, using thermostability as a measurement for complex 
formation, all VAMPs tested could bind a variety of t-SNARE combinations, generating 
stable structures (Yang et al. 1999). The authors of this study concluded that SNARE 
pairing is promiscuous and that the specificity is likely derived from other proteins that 
are able to regulate SNARE complex formation. Indeed, there are many proteins 
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involved in the regulation of membrane fusion (as reviewed in Lin & Scheller 2000) 
some of which will be discussed below. 
A recent study on the other hand showed that SNARE pairing in vivo is much more 
specific. In this study a vesicle-to-plasma membrane fusion assay was used, measuring 
the release of eH]norepinephrine. It is known that the SNAREs involved in this fusion 
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event are syntaxinl, SNAP-25 and VAMP2. Microinjection of the coiled-coil domain 
of both syntaxin 1 and 4, but not of any of the other syntaxin homologues could inhibit 
fusion of norepinephrine-containing PC12 cell granules with the plasma membrane 
(Scales et al. 2000). Similarily the coiled-coil domain of V AMP2 and to a lesser degree 
V AMP4 could inhibit fusion, but none of the other VAMP homologues. A modification 
of this assay was used to look for the ability of different SNAP-25 homologues to rescue 
neurotoxin cleaved SNAP-25. It was found that not only SNAP-25, but also SNAP-23 
could rescue this. SNAP-29 on the other hand was much less effective (Scales et al. 
2000). One important observation in this study, which might explain the different in 
vitro results mentioned above, is that measuring thermostability is not always a good 
indicator of specific SNARE interactions. The authors concluded that SNARE proteins 
play an important role in the fidelity of membrane trafficking and are likely to impart a 
good deal of the specificity of fusion (Scales et al. 2000), but that there are also other 
proteins which chaperone the formation of the core fusion complex. 
1.8.2 The structure of the SNARE complex 
Recently the crystal structure of the SNARE complex of syntaxin lA, synaptobrevin 2 
(V AMP2) and SNAP25 has been solved (Sutton et ai. 1998). Prior to this structure, it 
was already known that the SNARE proteins form coiled coils (Chapman et al. 1994) 
and that syntaxin and synaptobrevin lie parallel to each other in the complex (Hanson et 
al. 1997). This is in some ways surprising, because both syntaxin and 
synaptobrevinIV AMP are anchored in their respective membrane via their C-terminus. 
On the other hand this position of the SNARE proteins brings the two opposite 
membranes in close proximity and this might help to drive the fusion of the membranes 
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(also reviewed in Hughson 1999). The crystal structure revealed that the synaptic fusion 
complex is arranged as a cylinder consisting of one helix each of syntaxin and 
synaptobrevin and of two helices of SNAP25 (Figure 1.5). The helices lie such that the 
N-termini are at one end of the bundle and the C-termini at the other end. SNAP25, 
which is not an integral membrane protein, but bound to the membrane by palmitylation 
of cysteine residues present near the middle of the sequence (Chapman et al. 1994), 
therefore has a linker region between the two helices, which traverses the length of the 
cylinder. Interestingly, inside the coiled coil there is a hydrophilic layer made of an 
arginine residue from synaptobrevin and three glutamine residues, one from syntaxin 
and two from SNAP25 (one from each helix). These residues are thought to stabilise 
each other and are sealed away from the surrounding solvent by a hydrophobic layer. 
For this reason synaptobrevinIV AMP is sometimes called an R-SNARE and syntaxin 
and SNAP25 are called Q-SNAREs. Although it is not yet clear why these polar residues 
are in the middle of the complex, it was suggested that this could help disassembly of the 
complex, if the seal was punctured by a protein such as NSF or a-SNAP (Sutton et ai. 
1998). 
1.8.3 Syntaxin 
.,.i>" 
Syntaxin was originally discovered by its ability to bind to synaptotagminlp65 (Bennet 
et ai. 1992), a synaptic vesicle protein important in calcium sensing (as reviewed in 
SUdhof 1995). Syntaxin was cloned from rat brain and two isoforms were found, p35A 
and p35B (syntaxin lA and IB) both of which were found to be present largely at the 
plasma membrane at the site of neurotransmitter release (Bennet et al. 1992). Syntaxin is 
an integral membrane protein, with a short transmembrane region at the C-terminus of 
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the protein (Bennet et al. 1992; Kee et al. 1995). The cytoplasmic region of syntaxin 
contains at least three coiled-coil domains of which the one closed to the transmembrane 
region (ill) is most important for binding VAMP, a-SNAP and SNAP25 (Calakos et al. 
1994; Chapman et al. 1994; Kee et al. 1995; Hanson et al. 1995). Mutational studies of 
syntaxin have shown that the V AMP-syntaxin interaction is very specific and sensitive 
to mutations, the interaction of SNAP-25 with syntaxin on the other hand is much less 
specific (Kee et al. 1995). Both the H3 region (Wu et al. 1999) and the N-terminal 
helical region of syntaxin lA can bind synaptotagmin in a Ca2+ dependent manner and 
this is part of the calcium trigger in neurotransmitter release (Fernandez et al. 1998). 
Another protein, important in Ca2+ signalling in neuronal cells, that can bind syntaxin on 
the H3 domain is cysteine string protein (Wu et ai. 1999) and the authors propose that 
there is a region in neuronal syntaxin which is important in calcium mediated synaptic 
vesicle exocytosis. 
One protein that is implied to be important in SNARE complex regulation and can bind 
syntaxin is n-secllMunc-18 and will be discussed in more detail below. This protein 
requires both the amino-terminal domain of syntaxin as well as the H3 domain for 
binding and prevents binding of syntaxin to the other SNARE proteins (Pevsner et al. 
1994; Kee et ai. 1995; Fernandez et al. 1998). It was suggested that binding of n-sec1 to 
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syntaxin stabilises intramolecular protein-protein interactions and that this prevents the 
interaction of other proteins with the H3 region (Kee et ai. 1995). Interestingly this study 
also showed that the full cytoplasmic region of syntaxin is needed for dissociation of the 
20S complex and it thought that a-SNAP and V AMP with the help of NSF are displaced 
from the H3 region by the amino-terminal helical regions (HI and H2) (Kee et al. 1995; 
Ranson et ai. 1995). It is now thought that syntaxin can adopt at least three different 
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conformations, one in isolation, another in the SNARE complex and a third when 
bound to Munc-18 (Misura et al. 2000). 
As mentioned before, there are many non-neuronal isoforms of syntaxin and syntaxin is 
not only involved in vesicles fusing with the plasma membrane but also in trafficking 
between various membrane compartments, such as ER to Golgi and Golgi to endosomes 
(Bock et al. 1996; Advani et al. 1998; Prekeris et al. 1998; Tang et al. 1998). The non-
neuronal isoform syntaxin 4 is important in the translocation of GLUT4 and will be 
discussed in detail below. 
1.8.4 VAMP 
VAMPI was originally cloned from the brain of a cartilaginous fish and found to be 
predominately present on synaptic vesicles (Trimble et al. 1988). This protein has a 
molecular mass of 13kDalton and can be divided into three structural domains. The C-
terminus is hydrophobic and spans the vesicle membrane and the N-terminal domain, 
Which contains a proline rich sequence and a long hydrophilic stretch, is exposed to the 
cytoplasm (Trimble et al. 1988). There are many mammalian homologues of VAMP, 
they vary in length and not all of them have the proline rich N-terminus (Advani et al. 
1998). As described ab~~e, VAMP can bind both syntaxin and SNAP-25 (Sollner et al. 
1993b) via coiled-coil regions, but the individual interactions between both proteins are 
relatively weak and it was shown that SNAP-25-syntaxin heterodimers form a high 
affinity binding site for VAMP (Chapman et al. 1994; Hayashi et al. 1994). Unlike 
syntaxin, VAMP does not bind a-SNAP directly (McMahon & SUdhof 1995; Hanson et 
al. 1995) and this suggests a post-docking role of a-SNAP (McMahon & SUdhof 1995). 
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Synaptophysin is a very abundant vesicle membrane protein that forms a high 
molecular weight complex on the membrane, containing four synaptophysin subunits 
and one low molecular protein (McMahon et al. 1996). This protein has been identified 
as V AMP and indeed V AMP2 is able to bind synaptophysin via its amino-terminal 
domain (Washboume et al. 1995). Interestingly though, synaptophysin is not essential 
for synaptic function as determined by synaptophysin knockout mice (McMahon et al. 
1996) and its precise role and the importance of the synaptophysin-VAMP interaction 
remain to be determined. 
1.8.5 The regulation of the SNARE complex and Munc18/nsec1 
Clearly the regulation of the SNARE complex formation is crucial for the fusion of the 
Correct vesicles with the target membrane. Rab proteins are thought to play a role in 
regulating the specificity of vesicle trafficking events and the multitude of rab proteins 
present would make them ideal candidates for SNARE complex regulation (as reviewed 
in Lin & Scheller 2000). Although rab proteins are not part of the SNARE complex 
. 
(Sollner et al. 1993b), they are thought to playa role in SNARE complex assembly and 
were suggested to act as a catalyst (Sf,ljgaard et al. 1994). The rab5 effector EEAl can 
bind syntaxin13 transiently (McBride et al. 1999). This and other data has suggested that 
EEA1 is important in t~thering endosomal vesicles on the plasma membrane and the 
SUbsequent binding of EEA1 to syntaxin could then drive fusion of the membranes 
(Christoforidis et al. 1999; McBride et al. 1999; and reviewed in Clague 1998). 
Another important regulatory protein of SNARE complex formation is the above 
mentioned Munc-18. Munc-18/nSecl is the neuronal J1omologue of the yeast protein 
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seclp and it is known to be important in neurotransmitter release (as reviewed in Lin & 
Scheller 2000). Munc-I8 has been shown to bind syntaxin alone, but not to syntax in in 
the SNARE complex, and binding of Munc-I8 to syntaxin inhibits the formation of the 
syntaxin-VAMP-SNAP-25 complex (Pevsner et ai. 1994). Interestingly phosphorylation 
of Munc-I8 by PKC inhibits the interaction of Munc-I8 with syntaxin and this might 
facilitate the formation of the SNARE complex (Fujita et ai. 1996). There are several 
non-neuronal isoforms of Munc-I8 that have been found to bind many syntaxin isoforms 
and which may playa role in different types of exocytosis (Rata & SUdhof 1995). 
Recently the three-dimensional structure of nSec1lMunc-I8 with syntaxin IA has been 
solved (Misura et al. 2000). Interaction between these two proteins is complex, 
involving both the N- and C-terminal cytoplasmic domain of syntaxin and the whole of 
Munc-I8. Most interactions between the two proteins are between residues that are 
conserved in the sequence of the different protein isoforms, but there are also a smaller 
number of interactions between areas that are not conserved and these are thought to 
contribute to the specificity between isoforms. One such pair are Munc-I8c and 
syntaxin4 and the importance of Munc-I8c in GLUT4 translocation will be discussed 
below. 
DissOciation of the syntaxin-Munc-I8 complex is thought to be brought about by a 
conformational change in Munc-I8 and is probably mediated by another protein(s) such 
as rab or a rab effector. A conformational change in Munc-I8 would provide a 
favourable environment for the SNARE complex formation and it is now known that 
Munc-I8 has not only a negative, but also a positive role in SNARE complex formation, 
acting as a mediator for the association of these proteins (Misura et ai. 2000). 
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1.8.6 The docking and fusion of vesicles with the membrane 
The release of neurotransmitter into the presynaptic cleft and indeed many other 
processes involving the fusion of vesicles with the target membrane, starts with the 
translocation of those vesicles to the membrane (Figure 1.6). Attachment of the vesicles 
to the membrane can be divided into tethering and then docking (as reviewed in Foster 
& Klip 2000). Tethering of the vesicles on the membrane occurs by a so far little known 
process, probably involving rab proteins and their effectors. Many studies have shown 
that neither SNARE proteins nor NSF and a-SNAP are required for this step (Hunt et al. 
1994; DeBello et al. 1995; McMahon & SUdhof 1995; Nichols et al. 1997). The 
formation of the SNARE complex then docks the vesicles to the membrane and leads 
ultimately to fusion. Syntaxin starts in the closed conformation bound to Munc-18 as 
desCribed above. A conformational change in Munc-18, mediated by other proteins, 
causes the recognition of syntaxin by V AMP and SNAP-25 and subsequent SNARE 
complex formation. This brings the two membranes into close proximity and leads to 
fusion by a mechanism not clearly known yet. A recent study suggested that membrane 
fusion is an active event, and that the SNARE complex exerts force on the membrane 
anchors, which provides an essential driving force for fusion (McNew et al. 2000). 
Disassembly of the SNARE complex is known to involve NSF and a-SNAP (Hayashi et 
ai. 1995; Nagiec et al. 1995; Barnard et al. 1997; Rice & Brunger 1999), but in contrast 
to the initial model, NSF and a-SNAP are not required for fusion itself (Nichols et ai. 
1997). EXamining yeast vacuolar fusion has shown that NSF and a-SNAP are involved 
in a pre-docking stage (Mayer et al. 1996). This is surprising, but could be explained by 
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the suggestion that NSF and a.-SNAP are necessary for the disassembly of cis SNARE 
complexes that occur after membrane fusion. In order for a new cycle of vesicle fusion 
to happen, SNARE proteins have to be disassembled and recycled to their correct 
location (as reviewed in Lin & Scheller 2000). NSF on the other hand has been found in 
a complex with rab5 and EEAl and it was suggested that NSF could prime SNARE 
proteins before fusion (McBride et al. 1999). Clearly more research is needed to 
determine the full function of all the proteins involved in the translocation and fusion of 
the vesicles with their target membrane. 
1.9 SNARE proteins in GLUT4 translocation 
Although GLUT4 exocytosis is a much slower process than neurotransmitter release it 
resembles this process in many ways. In both mechanisms vesicles containing cargo are 
stored intracellularly until a signal triggers their translocation to the plasma membrane. 
For neurotransmitter release this signal is the entry of calcium into the cell, while for 
GLUT4 exocytosis it is the binding of insulin to its receptor and the subsequent 
Signalling cascade. Docking of vesicles at the plasma membrane then leads to fusion and 
release of cargo either into the synaptic cleft in neurotransmitter release or by insertion 
.. 
of GLUT4 into the plasma membrane. This similarity led to the search for a SNARE 
type mechanism in insulin sensitive tissue and resulted in a much more detailed 
understanding of GLUT4 translocation in these cells (for review see Foster & Klip 
2000). 
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Homologues of many SNARE proteins have been found in fat and muscle cells. 
V AMP2 and cellubrevin (a VAMP homologue) have been found in rat adipocytes (Cain 
et aI. 1992; Martin et al. 1996), 3T3-Ll adipocytes (Tamori et al. 1996; Martin et al. 
1996) and muscle cells (Vo1chuk et al. 1994; Kristiansen et ai. 1996). Functional data 
using Clostridial botulinum neurotoxins have shown that cleavage of cellubrevin and 
VAMP2 will inhibit insulin-mediated GLUT4 translocation (Cheatham et aI. 1996; 
Macaulay et al. 1997). Interestingly the cleavage of VAMP2 but not cellubrevin by an 
IgA protease, also blocked the majority of insulin-stimulated GLUT4 translocation 
(Cheatham et al. 1996). The introduction of GST -V AMP2 into permeabilised adipocytes 
also inhibited insulin-stimulated GLUT4 translocation (Cheatham et al. 1996; Martin et 
al. 1998; Millar et aI. 1999), whereas by contrast GST-cellubrevin was without effect on 
insulin-stimulated GLUT4 translocation (Martin et al. 1998). GLUT4 translocation was 
also inhibited by 40%-50% when 3T3-Ll adipocytes were treated with an N-terminal 
peptide of VAMP2 (Macaulay et al. 1997; Olson et al. 1997; Martin et al. 1998) and this 
same peptide did not have any effect on insulin-stimulated GLUTI translocation (Martin 
et al. 1998). On the other hand GST-cellubrevin inhibits insulin-stimulated GLUTI 
translocation partially (Millar et al. 1999). From this data it was proposed that 
cellubrevin is important in translocation of endosomal proteins such as GLUTI to the 
plasma membrane, while VAMP2 specifically regulates the docking of GSVs in 
response to insulin. 
Much research has focused on the exact intracellular location of V AMP2 and 
cellubrevin. Both proteins translocate from intracellular stores to the plasma membrane 
in response to insulin and are found in GLUT4 vesicles (Cain et al. 1992; Martin et al. 
1996; Tamori et al. 1996; Timmers et al. 1996). Endosome ablation showed that 
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cellubrevin was ablated to a similar degree as TfR, while V AMP2 was only ablated by 
about 10%. This data and vesicle adsorption together with ablation suggest that 
cellubrevin is enriched in the endosomal GLUT4 vesicles, while V AMP2 is present in 
the GSVs (Martin et al. 1996). 
Syntaxin4 is expressed in many tissues and high levels of it were found at the plasma 
membrane in adipocytes (Timmers et al. 1996; Tellam et al. 1997) and muscle (Volchuk 
et al. 1996). Low levels of syntaxin4 were found in intracellular membranes (Timmers et 
al. 1996; Tellam et al. 1997) and from there it appears to translocate to the plasma 
membrane in response to insulin in a similar manner as GLUT4 (Tellam et al. 1997), the 
fUnctional significance of this is not clear. 
Insulin stimulated glucose transport was shown to be inhibited by the injection of either 
antibodies to syntaxin4 (Tell am et al. 1997) or of a syntaxin4 peptide into adipocytes 
(Macaulay et al. 1997; Olson et al. 1997). Similarly the treatment of permeabilised 3T3-
Ll adipocytes with GST -syntaxin4 caused the inhibition of insulin-stimulated GLUT4 
translocation (Cheatham et al. 1996). Interestingly the introduction of a cytoplasmic 
syntaxin4 peptide into cells did not inhibit insulin-mediated GLUTI translocation 
(Olson et al. 1997). This set of data supports the specific role for syntaxin4 in GLUT4 
.. 
vesicle fusion at the plasma membrane. 
EVidence for the presence of SNAP25 in adipocytes is ambiguous (Jagadish et al. 1996; 
Wong et al. 1997), but two SNAP25 homologues called SNAP23 and syndet have been 
found to be expressed in fat and muscle tissue (Ravichandran et al. 1996; Wong et al. 
1997; Araki et al. 1997; Rea et al. 1998). Both proteins are as expected predominantly 
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located to the plasma membrane fraction (Araki et ai. 1997; Wong et ai. 1997; Rea et 
al. 1998). 
An antibody to syndet as well as a C-terminal peptide have been shown to inhibit insulin 
stimulated GLUT4 translocation by 40%, but did not inhibit GLUTI translocation (Rea 
et al. 1998). Binding studies using yeast two hybrid have revealed that SNAP23 can 
bind strongly to syntaxinl and 4 (Araki et al. 1997) as well as VAMPI and 2 
(Ravichandran et al. 1996). Similarly, surface plasmon resonance experiments have 
shown that syndet can bind syntaxin4 and V AMP2 individually and that this is disrupted 
by 0.5% SDS, while incubation of all three proteins together resulted in a 0.5% SDS 
resistant complex formation (Rea et ai. 1998). 
Screening of rat adipocytes for NSF and a-SNAP revealed that both proteins are 
intracellularly located and to a substantial extent are present on GLUT4 vesicles 
(Mastick et al. 1997). 
It is now thought that in insulin-sensitive tissues GLUT4 translocation occurs via a 
SNARE type mechanism similar to neuronal cells involving the formation of a complex 
made of syntaxin4, VAMP2, syndetlSNAP23 as well as NSF and a-SNAP. Indeed the 
formation of a 20S SNAiE complex in vitro has been confirmed and shown to be 
independent of insulin treatment (St-Denis et al. 1999). 
The importance of a SNARE-mechanism for GLUT4 translocation leads to the question 
of how this is regulated and how insulin effects this mechanism. As mentioned above, 
there are several proteins important for the regulation of the SNARE complex. One such 
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candidate is Munc-18 of which several isoforms exist (Tellam et al. 1995). Munc-18c is 
ubiquitously expressed and its subcellular location in adipocytes is almost identical to 
that of syntaxin4 with highest levels found in the plasma membrane fraction and lower 
levels in the LDM fraction (Tellam et aZ. 1997). In vitro binding studies showed that 
Munc-18c bound strongly to syntaxin4 (Tellam et al. 1997; Tamori et aZ. 1998) and that 
it was able to reduce the association of syntaxin4 and VAMP2 by 75%. Similarly Munc-
18c was also able to reduce the binding of cellubrevin to syntaxin4 by 60% (Tellam et 
al. 1997). Co-immunoprecipitation experiments showed that syntaxin4 can bind both 
SNAP23 and Munc-18c in vivo, but that Munc-18c decreases the affinity of syntaxin4 
for SNAP23 (Araki et al. 1997). Overexpression of Munc-18c in 3T3-Ll adipocytes 
inhibits insulin-stimulated GLUT4, but not GLUTI translocation (Tamori et aZ. 1998). 
Similarly a Munc-18c peptide can inhibit GLUT4 and IRAP integration into the plasma 
membrane (Thurmond et aZ. 2000). In these cells GLUT4 vesicles were found to be 
located just below the membrane unable to fuse with the plasma membrane, probably 
due to the peptide binding to all the available syntaxin4, thereby preventing the 
formation of the SNARE complex (Thurmond et aZ. 2000). 
Another SNARE complex regulator is synip (Min et aZ. 1999). Synip is a syntaxin4 
binding protein and its expression is restricted to adipocyte and muscle cells. 
Interestingly in the prese~~e of insulin the affinity of synip for syntaxin4 is reduced 
suggesting that this protein is an insulin-sensitive regulator for GLUT4 translocation. 
This is supported by the fact that a C-terminal peptide of synip can inhibit insulin-
mediated GLUT4 but not GLUTI translocation. It is thought that the N-terminus of 
synip Contains a regulatory domain, which causes the insulin-mediated decrease of 
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syntaxin4-synip interaction, thereby allowing SNARE complex formation and 
subsequent fusion of the GSVs with the plasma membrane (reviewed in Bennett 1999). 
The question of how insulin regulates the formation of the SNARE complex and 
ultimately fusion of the GLUT4 vesicles with the plasma membrane cannot be totally 
explained by synip. As above mentioned, there are other proteins such as the small 
GTPase rab which might control the SNARE complex formation. Indeed a direct 
interaction of syntaxin4 with rab4 has been shown recently and this interaction was 
regulated by the guanine nucleotide status of rab4 and therefore indirectly by insulin (Li 
et al. 2001). The significance of this interaction was not determined and so far there is 
little known about what function rab proteins have in insulin-stimulated glucose 
transport. 
Other proteins that have recently been identified to interact with SNARE proteins in 
insulin-sensitive cells are pantophysin and cysteine string protein (Brooks et al. 2000; 
Chamberlain et al. 2001). The cysteine-string protein Cspl interacts with syntaxin4 in 
3T3-Ll adipocytes and it was proposed that this protein might be a chaperone of 
syntaxin4, regulating the conformational status of this t-SNARE (Chamberlain et al. 
2001). Pantophysin is homologous to synaptophysin and can interact with VAMP2, but 
.. 
the significance of this is not yet known (Brooks et al. 2000). 
From these studies it is clear that the SNARE mechanism is absolutely vital for GLUT4 
exocytosis into the plasma membrane and subsequent glucose transport. Decreased 
inSUlin-stimulated glucose uptake due to a defect in GLUT4 translocation could 
therefore be explained by a fault in the SNARE mechanism. So far there are no studies 
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looking at SNARE proteins in insulin resistance and diabetes and in this thesis we 
therefore set out to examined SNARE levels and distributions in an insulin resistant 
model system (Chapter 4). 
1.10 Aims of this Study 
The objective of this thesis was to further characterise the GLUT4 trafficking pathways 
both under normal and insulin resistant conditions. Therefore proteins which are 
important in GLUT4 targeting and translocation were studied. 
In Chapter 3 we look at a new method using iodixanol as a gradient material to separate 
the two intracellular GLUT4 compartments and also investigate GSV formation during 
differentiation. 
Insulin resistance precedes the development of diabetes and in order to learn more about 
the cellular mechanism which causes this we studied insulin resistant 3T3-L1 adipocytes 
in Chapter 4. 
In Chapter 5 we tried to characterise the adaptor proteins in adipocytes and examined 
Whether there are any direct interactions between these proteins and GLUT4. 
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Figure 1.1 PI3·kinase is a central enzyme in insulin mediated glucose uptake 
The insulin receptor uses IRS proteins to activate PI3-kinase. Activated insulin receptor 
binds transiently to IRS, which becomes phosphorylated. Phosphorylated IRS binds the 
regulatory subunit (p85) of PI3-kinase and this will activate the catalytic subunit (plIO). 
The IRSIPI3-kinase complex translocates to internal membranes (LDM), which contaiJl 
the GLUT4 vesicle pool as well as microtubules. In response to insulin GLU14 
translocates to the plasma membrane (PM). 
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Figure 1.2 Glucose transporter structure 
A schematic model for the transmembrane organisation of a GLUT. Shown are the 12 
membrane spanning helices and the large loops between helices 1 and 2 and 6 and 7. 
Note that both N- and C-terminus are intracellular . 
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Figure 1.3 Membrane protein recycling models (Holman et al. 1994) 
A In the 2-pool model, the fully functional plasma membrane protein (T p) is in 
equilibrium with only one intracellular pool (Tee). B In the 3-pool model, two distinct 
intracellular pools are designated, the early endosomal pool (Tee). and the tubulo' 
vesicular compartment (Ttv). C and D In the 4-pool models, occluded forms are added to 
the plasma membrane occurring either before (Tpo, C) or after (Tpc, D) the fullY 
functional plasma membrane pool. E In the 5-pool model, two occluded plasmll 
membrane pools are included as well as two intracellular pools. 
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Figure 1.4 GLUT4 trafficking in cells 
Shown is a schematic representation of both GLUT4 and transferrin receptor trafficking· 
Both proteins are internalised from the plasma membrane (PM) into endosomes, from 
where they are trafficked into sorting endosomes. Most of the transferrin receptor, but a 
-
low percentage of GLUT4 then recycle back to the plasma membrane. GLUT4 is packed 
into specialised GLUT4 storage vesicles (GSVs); this step could arise directly from 
endosomes, or from the trans-Golgi network (TGN). Insulin causes the fusion of the 
GSVs with the plasma membrane and therefore the insertion of GLUT4 into the plasma 
membrane . 
. "r.i 
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Figure 1.S Hypothetical model of the synaptic fusion complex (Sutton et al. 1998) 
Four helices, one from syntaxin (red), one from VAMP (blue) and two from SNAP-25 
(green), form a coiled coil structure. The transmembrane domains of VAMP and 
syntaxin are included (yellow) as well as the linker region of SNAP-25 (brown). Note 
that the here illustrated helices represent only a part of each protein. 
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Figure 1.6 Simplified model for the docking and fusion of the vesicles with tbe 
membrane 
Vesicles filled with neurotransmitter translocate to the plasma membrane (PM). NSf 
and <x-SNAP may have a role in vesicle priming. Vesicles are then tethered to the target 
membrane via a little known process, possibly involving rab proteins and their effectors 
(see text for detail). After the release of syntaxin by Munc-18, the SNARE comple~ 
assembles and drives membrane fusion. Cis-SNARE complexes are then separated wiW 
the help of NSF and <x-SNAP. Note that the role of NSF in this event is still unclear· 
Before the next vesicles can fuse with the membrane, V AMP has to be recycled into itS 
correct intracellular compartment. 
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CHAPTER 2 . MATERIALS AND METHODS 
2.1 Materials 
All reagents used in the course of the project were of a high quality and were 
obtained from the following suppliers: 
2.1.1 General Reagents 
Amersham International Pic, Aylesbury, Buckinghamshire, UK 
Horseradish peroxidase (HRP)-conjugated donkey anti-rabbit IgG antibody 
Horseradish peroxidase (HRP)-conjugated sheep anti-mouse IgG antibody 
Horseradish peroxidase (HRP)-conjugated Protein A 
ECL Western blotting detection reagents 
ECL plus Western blotting detection reagents 
AnachemLtd., Luton, Bedfortshire, UK 
30% acrylamidelbisacrylamide 
Bio-Rad Laboratories Ltd, Hemel Hempstead, Hertfordshire, UK 
N, N, N', N'-tetramethylethylenediamine (TEMED) 
Boehringer Mannheim, Germany 
Chlorophenol red-(3-D-galactopyranoside (CPRG) 
Tris 
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Protease Inhibitor cocktail tablets, complete™ 
Protease Inhibitor cocktail tablets, completelM, Mini 
Difco Laboratories, Detroit, USA 
Yeast nitrogen base (without amino acids) 
Fisher Ltd., Loughborough, Leicestershire, UK 
Ammonium persulphate 
Ammonium sulfate 
Boric acid 
Calcium Chloride (CaCh) 
Diaminoethanetetra-acetic acid, Disodium salt (EDT A) 
Disodium hydrogen orthophosphate (Na2HP04) 
Glucose 
Glycerol 
Glycine 
N-2-hydroxyethylpiperazine-N'-2-ethanesulphonic acid (HEPES) 
Hydrochloric acid (HCI) 
Magnesium sulfate (MgS04) 
Methanol 
Potassium chloride (KCl) 
Potassium Dihydrogen orthophosphate (KH2P04) 
SOdium dodecyl sulphate (SDS) 
Sodium chloride (NaCl) 
Sodium dihydrogen orthophosphate dihydrate (NaH2P04) 
SOdium hydrogen carbonate (NaHC03) 
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Sucrose 
Trichloroacetic acid 
Tri-Sodium citrate (Na3C6Hs07) 
Kodak Ltd, Hemel Hempstead, Hertfordshire, UK 
X-Omat S film 
Merck Ltd (BDH), Lutterworth, Leicestershire, UK 
Ethanolamine 
Magnesium chloride (MgClz) 
Tween 20 
Zinccloride (ZnClz) 
NEN Dupont (UK) Ltd, Stevenage, Hertfordshire, UK 
[125I] transferrin 
New England Biolabs (UK) Ltd, Hitchin, Hertfordshire, UK 
Prestained protein marker, broad range (6-17SkDa) 
Novo Nordisk, Denmark 
Insulin (Porcine) 
Nycomed, Norway 
OptiPrepTM (Iodixanol) 
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Oxoid Ltd, Hampshire, UK 
Bacteriological agar 
YEPD 
Pierce, Rockford, Illinois, USA 
BCA TM Protein Assay Kit 
Premier Brands UK, Knighton Adbaston, Staffordshire, UK 
Marvel powdered milk 
Schleicher & Schuell, Dassel, Germany 
Nitrocellulose membrane (pore size:0.45IlM) 
Whatman International Ltd, Maidstone, UK 
Whatman No.1 filter paper 
Whatman No.3 filter paper 
Whatman 3mm filter paper 
2.1.2 Cell Culture Materials 
American Type Culture Collection, Rockville, USA 
3T3-Ll fibroblasts 
Gibco BRL, Paisley, Lanarkshire, UK 
Foetal bovine serum (PBS) 
New born calf serum (NCS) 
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Dulbecco's modified Eagle's medium (without sodium pyruvate, with 4500mg/L 
glucose) (DMEM) 
10000U/ml penicillin, 10000U/ml streptomycin 
TrypsinlEDT A solution 
AS Nunc, DK Roskilde, Denmark 
50 ml centrifuge tubes 
Costar 
6 cm cell culture plates 
75cm2 cell culture flasks 
Falcon 
10 cm cell culture plates 
6-well cell culture plates 
Bibby Sterilin Ltd, Stone, Staffordshire, UK 
Sterile pipettes 
13.5 ml centrifuge tubes 
Unless otherwise indicated, all remaining chemicals were supplied by Sigma 
Chemical Company Ltd, Poole, Dorset, UK. 
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2.1.3 Antibodies 
GLUT4 antibody was raised in rabbit and affinity purified 
Transferrin antibody was from Zymed Laboratories, Cambridge, UK 
AP2 antibody was from Sigma, Chemical Company Ltd, Poole, Dorset, UK. 
SyndetlSNAP-23 antibody was from Synaptic Systems, Gottingen, Germany 
The !RAP antibody was monoclonal and kindly provided by Morris Birnbaum, 
University of Pensylvania. 
Following antibodies were the kind gift of David James, Australia: VAMP2, 
syntaxin4 and cellubrevin. 
Following antibodies were kindly provided by Margret Robinson, Cambridge, UK: 
API (y), AP3 (0 and J.1) and AP4 (p and E). 
TGN 38 antibody was kindly provided by George Banting, Bristol, UK. 
Pacs-I antibody was kindly provided by Dr Yang, USA. 
AP3 (0) was a kind gift of Jim-Tong Horng, University of California, San Francisco 
USA. 
2.2. General Buffers 
2.2.1 Phosphate Buffered Saline (PBS) 
I36mM NaCI, lOmM NaH2P04, 2.SmM KCI, 1.8mM KH2P04, pH 7.4. 
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2.2.2 Krebs Ringer Phosphate (KRP) Buffer 
128mM NaCI, 4.7mM KCI, 5mM NaH2P04, 1.25mM MgS04, 1.25mM CaCh, pH 
7.4. 
2.2.3 HES Buffer 
255mM sucrose, 20mM HEPES, ImM EDTA, pH 7.4. 
2.2.4 Krebs Ringer MES (KRMES) Buffer 
136mM NaCI, 4.7mM KCI, 1.25mM CaCh, 1.25mM MgS04, 10mM MES, 25mM 
Glucose, pH 6. 
2.2.5 Kreps Ringer HEPES (KRHEPES) Buffer 
136mM NaCI, 4.7mM KCI, 1.25mM CaCh, 1.25mM MgS04• lOmM HEPES, pH 
7.4. 
2.2.6 Lysis/Immunoprecipitation Buffer 
50mM HEPES, ImM EDTA, lOmM MgCh, 150mM NaCI, ImM sodium 
orthovanadate, 10% Glycerol, 1 % Triton, pH 7.4 
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2.3 Cell Culture 
2.3.13T3-Ll Murine Fibroblasts 
3T3-LI fibroblasts were cultured in 75cm2 flasks containing DMEMlIO% (v/v) 
newborn calf serum and 1 % (v/v) penicillin and streptomycin. Cells were cultured at 
37°C in a humidified atmosphere of 10% C02 and the media was replaced every 48 
h. When subconfluent (showing 80% confluency) the cells were passaged into 6-well 
or IOcm culture plates and a 75cm2 carry over flask. Cells were cultured to 4 days 
post confluency and then differentiated into adipocytes. 
2.3.2 Trypsinisation and Passage of 3T3-Ll Fibroblasts 
Following aspiration of media from a 75cm2 flask, Iml of trypsinlEDTA solution 
was added to wash the remaining media from the monolayer of cells. In turn, this 
was aspirated and 3ml of trypsinlEDT A solution was added and the flask was 
incubated at 37°C in a humidified atmosphere of 10% C02 for 5 min. Careful 
agitation of the flask resulted in the cells being lifted from the surface of the flask. 
This cell suspension was then added to a maximum volume of 230ml DMEMlIO% 
(v/v) newborn calf serum and 1 % (v/v) penicillin and streptomycin. With occasional 
agitation the cells were split between 10cm culture plates and lor 6-well culture 
plates and 2 x 75cm2 flasks. 
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2.3.3 Differentiation of 3T3-Ll Fibroblasts 
Differentiation media of DMEMllO% (v/v) foetal bovine serum, 1 % (v/v) penicillin 
and streptomycin, 0.251lM dexamethasone, 0.5mM methyl isobutylxanthine and 
l~g/ml insulin was prepared as outlined below. 
A stock of 2.SmM dexamethasone (in ethanol) was diluted 1 :20 with DMEMI 10% 
(v/v) foetal bovine serum, 1 % (v/v) penicillin and streptomycin immediately prior to 
Use yielding a SOOX stock solution. A SOOX sterile solution of methyl 
isobutylxanthine (IDMX) was prepared by dissolving SS.6mg IDMX in Iml of 2M 
KOH and passing the solution through a 0.22 micron filter. Insulin (lmglml) was 
prepared in O.OIM HCL and filter sterilised using a 0.22 micron filter as before. 
Differentiation media was prepared by adding both the dexamethasone and IDMX 
solutions to a IX concentration in DMEMlIO% (v/v) foetal bovine serum, 1 % (v/v) 
penicillin and streptomycin and then adding insulin to a final concentration of 
1 Jlg/ml. 
3T3-Ll fibroblasts were cultured on 6-well or IOcm culture plates until 4 days post 
confluency. The growth media was aspirated and replaced with differentiation media. 
After 48 h, this media was replaced with DMEMlIO% (v/v) foetal bovine serum, 1% 
(v/v) penicillin and streptomycin and insulin at IJlglml. The cells were incubated in 
this media for a further 48 h. Following differentiation, the media was replaced with 
DMEM/IO% (v/v) foetal bovine serum, 1% (v/v) penicillin and streptomycin. The 
media was changed every 48 h and the cells were used 10-14 days post 
_ differentiation. 
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2.3.4 Freezing and Storage of Cells 
Fibroblasts were cultured to 80% confluency, the media was aspirated and Iml of 
trypsinlEDT A solution was added to wash the remaining media from the monolayer 
of cells. In tum, this was aspirated and 3ml of trypsinlEDT A solution was added and 
the flask was incubated at 37°C in a humidified atmosphere of 10% C02 for 5 min. 
Careful agitation resulted in the cells being lifted from the surface of the flask. 3ml 
of DMEMJI0% (v/v) newborn calf serum, 1 % (v/v) penicillin and streptomycin was 
added to the cell suspension and gently triturated over the surface of the flask. The 
cell suspension was then transferred to a sterile tube and centrifuged at 2000 x g for 4 
min. Following aspiration of the supernatant the pellet was 'flicked' gently and then 
resuspended in Iml of DMEMJIO% (v/v) newborn calf serum, 1% (v/v) penicillin 
and streptomycin and 10% (v/v) DMSO. The suspension was then transferred to a 
1.8ml polypropylene cryo-vial and placed at -80°C overnight to freeze slowly before 
being stored in a liquid nitrogen vat. 
2.3.5 Resurrection of Frozen Cell Stocks from Liquid Nitrogen 
A vial of cells was removed from from liquid nitrogen, transferred to a 37°C water 
bath and thawed. The cell suspension' was then pipetted into a 75cm2 culture flask 
containing DMEMlIO% (v/v) newborn calf serum, 1% (v/v) penicillin and 
streptomycin which had previously been equilibrated at 37°C in a humidified 
atmosphere of 10% C02. The media was replaced after 24 h and the cells were 
cultured as described before. 
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2.3.6 Collagen coating of Cell Culture Plastic Ware 
Collagen coated plates were often used for permeabilisation experiments and PM 
lawn assays to enhance adhesion of the cells to the plate surface upon differentiation. 
A solution of collagen in acetic acid was used to wash the plates leaving a thin film 
coating after aspiration. Plates were then dried in a sterile flow hood and irradiated 
with U.V light overnight. Prior to use, plates were washed with serum-free DMEM 
to remove any traces of acetic acid. 
2.4 Antibody Preparations 
The anti-GLUT4 antibody used was rabbit polyclonal antibody against a peptide 
comprising the C-terminall4 amino acid residues of the human isoform of GLUT4 
described in Brant et al. 1993. 
2.4.1 Purification of Anti·GLUT4 Antibody 
This procedure required the use of an affinity column consisting of Separose beads to 
Which the antigenic peptide (C-temilnal 14 amino acid residues) of the human 
GLUT4 isoform was covalently attached. 
Following equilibration of the column with approximately 20ml of PBS (see Section 
2.2.1) 300j..ll of lOX PBS was added to 2.7ml antisera (raised against the GLUT4 C-
, terminal peptide) and applied to the column. The column was incub~ted for 30 min 
at room temperature and then washed with PBS until all the brown coloured eluate 
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had been collected. The eluant was reapplied and again incubated in the column for 
30 min at room temperature. Following the final incubation, the column was washed 
with PBS, until the eluant gave an 00 reading at 280nm of zero. The GLUT4 
antibody was eluted with 2M glycine, pH 2, collected in Iml fractions and the 00 
reading at 280nm determined for each fraction. The fractions with the highest 00 
readings were pooled and 50111 1M Tris was added per Iml antibody in order to 
adjust the pH. This was dialysed overnight against PBS, at 4°C and finally, 
aliquoted, snap frozen and stored at -20°C. 
2.S Protein Assay 
Protein concentration was measured using the BCA assay with all samples being 
performed in duplicate. A standard curve, using 1OJ,t1 of prepared standards (0.2, 0.4, 
0.6, 0.8, 1, 1.5 and 2mglml BSA) was set up in a 96-well plate. In general 1OJ,t1 of 
samples were used for analysis. BCA buffers were mixed according to the 
manufacturer's instructions and 200J,t1 of this solution were added to each welL The 
96-well plate was covered with clingfilm and incubated at 37°C for 30 minutes. 
After this time absorbance was measured at 500nm in a plate reader (LKB Wallace, 
HelSinki, Finnland). A standard cu~e was plotted and the concentrations of the 
samples was determined. 
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2.6 SDS/Polyacrylamide Gel Electrophoresis 
SOS/polyacrylamide gel electrophoresis was carried out using Bio-Rad mini-
PROTEAN IT or Hoefer large gel apparatus. The percentage of acrylamide in each 
gel ranged between 7.5% - 15%, according to the molecular weight of the protein of 
interest. All reagents were of electrophoresis grade. 
On assembly of either Bio-Rad mini-PROTEAN IT or Hoefer large gel apparatus, the 
seperating gel was prepared using 30% acrylamide/bisacrylamide, 1.5M Tris-HCL 
(pH 8.8) (to a final concentration of 375mM), 10% (w/v) SOS (to a final 
concentration of 0.1 %), polymerised with 10% (w/v) ammonium persulphate (to a 
final concentration of 0.1 %) and TEMEO (to a final concentration of 0.019%). The 
stacking gel was prepared using 30% acryl ami de/bi sacryl ami de, 1M Tris-HCL (pH 
6.8) (to a final concentration of 125mM), 10% (w/v) SOS (to a final concentration of 
0.1 %), polymerised with 10% (w/v) ammonium persulphate (to a final concentration 
of 0.1 %) and TEMEO (to a final concentration of 0.05%). 
Protein samples were resuspended in IX SDS PAGE sample buffer (93mM Tris-CI 
pH6.8, 20mM dithiothreitol [added immediately before use], 1mM sodium EOTA, 
10% (w/v) glycerol, 2% (w/v) SOS,"0.002% (w/v) bromophenol blue) and loaded 
onto the wells in the stacking gel. Broad-range pre-stained molecular weight markers 
[Mr 6-175 kDa (Biolabs)] were used routinely. Gels were electrophoresed in 
electrode buffer (25mM Tris, 190mM glycine and 0.1 % (w/v) SOS) at a constant 
voltage to ensure good separation of the molecular weight markers. 
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2.7 SDS/Polyacrylamide Gel Staining 
2.7.1 Coomassie blue staining of protein gel 
Following SDSlPolyacrylamide Gel Electrophoresis a 0.25% Coomassie blue stain 
solution was prepared. For this lOml of glacial acetic acid was mixed with 90ml of a 
methanol:IIzO (1:1 v/v) mixture and 0.25g of Brilliant Blue R were added. This stain 
was then filtered through a Whatman number! filter paper. The gel was submerged 
in the stain for about 2h and destained with the same acetic acid, methanol:IIzO 
mixture (without the dye) as described above. Destaining was for at least 3h or OIN, 
depending on the resolution wanted. To record the results the gel was photographed. 
2.7.2 Silver Staining 
FOllowing SDSlPolyacrylamide Gel Electrophoresis, the gel was submerged in 50% 
methanol and left in this to fix for at least 2h. Just before the staining 800mg of silver 
nitrate (AgN03) were dissolved in 4ml of ~O. Then, in a separate beaker, 2.1ml of 
NH3 (14.1M) were added to 21ml of 0.36% NaOH and to this mixture the silver 
nitrate solution was added dropwise. This was then filled up to 100ml with lIzO. The 
fiXed gel was then submerged in this'· solution and gently rocked for 5min. The gel 
Was then washed several times in lIzO over a time-period of 15min. In order to 
develop the stain 250J!1 of 1 % citric acid and 250J!1 of 38% formaldehyde were added 
to 500ml of lIzO and the gel was submerged in this and again gently rocked. The gel 
Was observed all the time and the solution was taken off and replaced with water 
. once the protein bands appeard (about 2min). The gel was then againwashed several 
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times with ~O and stored in SO% methanol. In order to record the results the gel 
was photographed. 
2.8 Western blotting of Proteins 
Proteins were separated by SDS/polyacrylamide gel electrophoresis as previously 
described. A sponge pad, two sheets of Whatman 3mm filter paper and a sheet of 
nitrocellulose membrane (pore size O.4SmM), cut to size and previously soaked with 
transfer buffer (2SmM NaH2P04, pH 6.S) were placed on the black plate of the gel 
cassette holder. The gel was then placed on top of the nitrocellulose membrane and 
any air bubbles were gently removed. The "sandwich" was completed with two more 
sheets of filter paper and a sponge pad as before. Transfer was carried out using a 
Bio-Rad mini or Bio-Rad trans-blot electrophoretic cell containing transfer buffer at 
a constant current of 2S0mA for 3 h or overnight at 40mA. The efficiency of transfer 
was determined by staining the nitrocellulose with Ponceau S solution prior to 
blocking. 
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2.9 Immunodetection of Proteins 
2.9.1 Incubation with antibodies 
Following transfer, non-specific binding sites on the nitrocellulose membrane were 
blocked by shaking for at least 1 h in 5% (w/v) dried skimmed milk (see section 
2.1.1) in TBST-l buffer (20mM Tris, 150mM NaCI, 0.02% Tween-20, pH 7.4). 
The nitrocellose membrane was then transferred to a plastic pocket containing 
primary antibody in 1% (w/v) dried skimmed milk in TBST-l buffer at the 
appropriate dilution and shaken for at least 2 h at room temperature. Following five 
washes with TBST-l buffer over a period of 1 h, the membrane was incubated in 1 % 
(w/v) dried skimmed milk in TBST-l buffer with the appropriate secondary 
antibody, (HRP-linked IgG) at a 1:1000 dilution for 1 h at room temperature. The 
membrane was then washed a further five times over a period of 1 h. 
2.9.2 Using the EeL Detection System 
Following incubation with the appropriate HRP-linked IgG and subsequent washing, 
the membrane was washed in distilled H20. The signal was detected using either 
EeL or EeL plus. For EeL, equal volumes of Amersham "detection reagent 1" and 
"detection reagent 2" were mixed and the membrane was immersed and shaken in 
this mixture for 60 s. For ECL plus, Amersham detection reagent A and B were 
mixed at a 40: 1 ratio. The membrane was dried slightly and lied flat on a piece of 
. Cling film. The mixed solution was pipetted onto the membrane and .incubated for 5 
minutes. After either ECL detection system, the membrane was then blotted' dry, 
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placed in a plastic pocket in a light tight casset and exposed to Kodak film. The film 
was developed using an X-OMAT processor. 
2.9.3 Quantification of signals 
In order to determine the intensity of the signal the developed film was scanned into 
a computer, taking care to use an exposure which is in the linear range of the signal. 
Intensity of the bands were measured using the Molecular Analyst software 
(BioRad). For this boxes of equal size were drawn around each band of interest and 
the intensity of the area inside the box was measured. A background reading was 
taken and subtracted from the obtained value. Unless otherwise stated the mean and 
standard error of at least three such quantifications were calculated. 
2.10 Endosome Ablation 
2.10.1 Preparation of Tf-HRP Conjugate 
Preparation of Tf-HRP protein conjugate was carried out as described by Livingstone 
et al. 1996. 
BUffer 1 (O.1M NaClIlOmM NaP04, pH 7.2) was prepared by adding acid 
(NaClINaH2P04) to alkali (NaClINa2HP04) to pH 7.2. 150mg of horseradish 
peroxidase (HRP) was dissolved in 7.5ml of buffer I, transferred to dialysis tubing 
_ (previously boiled in 2%NaHC03, 10mM EDTA and stored in 50?o ethanol:50% 
H20) and dialysed at 4°C overnight against 2-4 litres of the same buffer. Following 
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dialysis, 3g of succinate (disodium salt) was added to the protein solution at room 
temperature. At O°C, 1.0Sg of crushed succinic anhydride was added and the mixture 
was stirred for 30 min at O°C and then for a further 30 min at room temperature. 
Meanwhile, four 20ml o-SO sephadex columns were prepared. Buffer 2 (O.IM 
NaClllmM NaP04) was prepared by adding acid (NaCIlNaH2P04) to alkali 
(NaClINa2HP04) to pH 7.2. 9g of O-SO sephadex was slowly added to 100mI of 
buffer 2 and four 20ml syringes, plugged with glass wool, were packed with this 
sephadex and equilibrated with the same buffer. 
The mixture was then resolved using 3 of the columns (the remaining column being 
stored at 4°C to be used later) and eluted with buffer 2. The elutant was then 
concentrated using Centriprep 3 columns (Amicon Ltd, UK) by centrifugation at 
2000 x g, at 4°C to a final volume of l.S-3ml. At O°C, 37Smg of N-hydroxy 
succinimide and 600mg of N-ethyl-N-(3-dimethylaminopropyl) carbodiimide 
hydrochloride (BDAC) were added and the mixture was stirred at O°C for 3 h. The 
resultant solution was then resolved using the remaining 0-50 sephadex column as 
before. 
At this stage the 'active' HRP was ready to be coupled to transferrin. This was carried 
Out immediately to prevent hydrolysis of the active NHS esters. 6ml of 2Smglml apo-
transferrin (in buffer 2) and 106-107 cpm 125I-transferrin were added to the elutant 
and stirred at 2°C for 48 h. The solution was then quenched with glycine and either 
stored at 2°C with the addition of azide or snap frozen and stored at -80°C. 
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Meanwhile, a Sephacryl S-300 column (lm in length) was equilibrated overnight 
with buffer 2 at lOmlIh. The conjugate was concentrated to 2-3ml as before and 
applied to the column. When the brown band of conjugate reached approximately 
half way down the column, O.Sml fractions were collected. The fractions were then 
counted using a v-counter and a graph of cpm versus fraction number was plotted. 
The fractions representing the first two peaks were pooled (the first two being the 
smallest of three peaks, with the third peak corresponding to unconjugated 1251_ 
transferrin) and concentrated to 3-4ml as before. The conjugate was reapplied to the 
column and fractions were collected and counted as before. On plotting a graph, the 
fractions representing the largest peak were pooled and concentrated to 3-4ml as 
before. The protein concentration was determined by a BCA assay (see Section 2.5) 
before the conjugate was iron loaded by adding 37SJ.ll of a SOmM FeS04 stock and 
112.SJ.lI of a 2S0mM KHC03 stock. The conjugate was then filtered through 
Whatman No.1 paper, aliquoted, snap frozen and stored at -80°C. 
2.10.2 Use of Tf·HRP 
Ablation of the recycling endosomal system was carried out as described by 
livingstone et al. 1996. 
DUring a 2 h incubation in serum-free DMEM, 3T3-Ll adipocytes were incubated 
with Tf-HRP conjugate (20J.lg/ml final concentration) for 60 min at 37°C. The cells 
Were then placed on ice, washed gently three times over a period of 10 min with ice-
cold isotonic citrate buffer (1S0mM NaCl, 20mM Tri-sodium citrate, pH S.O) and 
once with ice-cold PBS (see Section 2.2.1). Chilling the cells prevel!ted any further 
Vesicle trafficking during the DAB cytochemistry while acid washing with citrate 
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buffer removed any cell-surface-attached Tf-HRP. 3,3'-diaminobenzidine (DAB) 
(2mglml stock prepared freshly in PBS, vortexed thoroughly and filtered through a 
0.22 J.lm-pore-size-filter) was added at 100 J.lglml to all cells and H202 (final 
concentration 0.02% v/v) was added to experimental plates only. After a 60 min 
incubation at 4°C in the dark the reaction was stopped by washing the cells with ice-
cold PBS. 
2.11 Fractionation of cells 
2.11.1 Subcellular Fractionation of 3T3·Ll Adipocytes 
Subcellular fractions (PM, HDM, lDM and SP) were obtained as described for the 
fractionation of rat adipocytes by Piper et at. 1991, modified by Martin et at. 1994 
Cells cultured on IOcm plates were either treated as stated below or incubated at 
37°C in serum-free DMEM for 2 h. Following the transfer of plates onto ice the cells 
Were washed 3 times with ice-cold RES buffer (see Section 2.2.3). On addition of 
2ml RES buffer containing protease inhibitors (protease inhibitor cocktail tablet 
from Boehringer Mannheim) the cells"were scraped and then homogenised with 20 
hand strokes in a Dounce homogeniser. Homogenates were transferred to pre-chilled 
Oakridge Beckman centrifuge tubes and centrifuged at 19,000 x g for 20 min at 4°C. 
The resulting pellet was resuspended in Iml ice-cold HES buffer and layered onto 
. Iml of 1. 12M sucrose in HES buffer in a Beckman tube and centrifuged at 100,000 x 
g for 60 min at 4°C in a swing out rotor. The upper layer was carefully taken off to 
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leave a brown band at the interface (plasma membrane) and a brown pellet 
(mitochondria/nuclei fraction). The plasma membrane fraction was transferred to an 
Oakridge centrifuge tube, resuspended in 15ml RES buffer and pelleted at 40,000 x g 
for 20 min at 4°C. 
Meanwhile, the supernatant from the initial spin was centrifuged at 41,000 x g for 20 
min at 4°C, yielding a pellet designated as the high density microsomal fraction 
(HOM). The resulting supernatant was centrifuged at 180,000 x g for 60 min at 4°C 
yielding a pellet designated the low density microsomal fraction (LDM). The 
supernatant of this spin contained the soluble proteins. All membrane fractions were 
resuspended in RES buffer and together with the soluble proteins snap frozen in 
liquid nitrogen and stored at -80°C prior to analysis. 
2.11.2 Total Membrane Preparation 
Cells cultured on 10cm plates were either experimentally treated or incubated at 
37°C in serum-free DMEM for 2 h. Following the transfer of plates onto ice the cells 
Were washed 3 times with ice-cold RES buffer (see Section 2.2.3). On addition of 
2ml RES buffer containing protease inhibitors (protease inhibitor cocktail tablet 
from Boehringer Mannheim) the cells' were scraped and then homogenised with 20 
hand strokes in a Dounce homogeniser. 
The homogenate was centrifuged at 180,000 x g for 60 min at 4°C. The pellet from 
this spin was dissolved in RES Buffer (200jll per plate starting material) and re-
, homogenised in a small Dounce homogeniser with 10 hand strokes in order to limit 
protein aggregation. The supernatant of this spin containing the soluble proteins was 
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also kept. The fractions were snap frozen in liquid nitrogen and stored at -80°C prior 
to analysis. 
2.12 Immunoadsorption of GLUT4 Vesicles 
3T3-L1 adipocytes were fractionated as above with minor modifications. For 
preparation of intracellular (LDM) membranes for immunoadsorption, cells cultured 
on IOcm plates were incubated at 37°C in serum-free DMEM for 2 h at 37°C. The 
plates were transferred onto ice and washed 3 times with ice-cold RES buffer (see 
Section 2.2.3). On addition of 1ml of the same buffer containing protease inhibitors, 
the cells were scraped and then homogenised in a Dounce homogeniser as before. 
Homogenates were transferred to pre-chilled Oakridge centrifuge tubes and 
centrifuged at 41,000 x g for 20 min at 4°C to remove plasma membranes, 
mitochondria, nuclei and high-density microsomes. The reSUlting supernatant was 
centrifuged at 180,000 x g for 60 min at 4°C to yield a pellet containing the low 
density microsomal (LDM) membranes, which was resuspended in RES buffer 
(200~1 RES per plate of cells) containing NaCI (lOOmM final). The resuspended 
pellet was homogenised in a small Dounce homogeniser with about 10 hand strokes 
and represents the starting material. ". 
Protein A-Sepharose was made up by weighing out 100mg of solid into an eppendorf 
tube and adding RES buffer in order to rehydrate the Sepharose. The beads were then 
sPUn down at full speed for about 30 seconds and the supernatant removed, the beads 
Were washed three times in RES buffer containing 1 % bovine serum albumin (BSA). 
In order to make a 50% slurry RES containing 1 %BSA was added to the swollen 
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protein A Sepharose. The beads were now blocked by adding about SOOJ.LI of RES 
containing 2% BSA to the beads and rotating them for 2hours at 4°C. After this time 
the blocked beads were spun down the supernatant was removed and the beads were 
then loaded with either affinity purified polyclonal anti-GLUT4 (see Section 2.4.1) 
or non-specific IgG, as a control, by shaking for 2 h on a miramax at 4°C. 
In order to preclear the LDM's, 400J.LI of sample was added to an eppendorf tube 
together with 100J.LI of unloaded beads (washed once in RES) as well as 300J.LI RES 
containing 100mM NaCl. This was rotated on a wheel at 4°C for the same time as 
the beads were precoupled. 
After this time the coupled beads were washed 3 times with RES containing 1 % 
BSA. The tubes containing the LDM samples were spun down, the supernatant 
containing precleared LDM were added onto the coupled beads and the pellet was 
discarded. More HESlNaCI was added to the tubes and these were rotated slowly 
end-over-end for 3hours at 4°C. 
After this time samples were centrifuged for S min at 2000 x g to pellet the 
irnmunadsorbent. The supernatant from this spin was centrifuged at 2000 x g for 10 
,. 
min to remove any remaining cells. The resulting supernatant was added to Sml 
Beekman Ultra-clear tubes and centrifuged at 180,000 x g for 60 min at 4°C. The 
resulting pellet containing LDM after adsorption was resuspended in 100JlI RES (see 
Section 2.6) . 
. The immunoadsorbent pellet was washed three times in Iml HESlNaCl. The pellet 
Was then resuspended in 90JlI of 1% Triton X-IOO in PBS, vortexed briefly and the 
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vesicle proteins were solubilised by incubation with occasional agitation for 30 min 
at room temperature. The beads were pelleted by centrifugation at 10,000 x g for 30 s 
using a microfuge. The supernatant containing the adsorbed vesicles was collected to 
a fresh tube and again centrifuged for 30 s before carefully removing the supernatant. 
All fractions were snap frozen in liquid nitrogen and stored at -80aC prior to 
analysis. 
2.13 Indirect Immunofluorescence Microscopy 
2.13.1 Plasma Membrane Lawn Assay 
The plasma membrane lawn assay was carried out as described (Robinson et al 
1992) to generate highly purified plasma membrane (PM) fragments in order to 
determine the relative levels of different proteins at the cell surface. 
3T3-Ll adipocytes cultured on collagen-coated coverslips on 6-well plates were 
treated as described in individual experiments. At the conclusion of the experiment, 
cells were rapidly washed once with Ice-cold buffer A (SOmM HEPES (pH7.2) and 
lOmM NaCl) and then twice with ice-cold buffer B (20mM HEPES (pH7.2), 100mM 
KCI, 2mM CaCI2, ImM MgCh, pepstatin A (lJlg/ml), Trypsin inhibitor (2Jlg/ml) 
and O.SmM Benzamide). While immersed in buffer B, the cells were sonicated using 
a 0.8mm tapered Dawa Ultrasonics probe at SO watts for 3 s to generate a lawn of 
. PM fragments attached to the coverslip. 
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Lawns were washed three times with PBS (see Section 2.2.1) and then fixed to the 
coverslips for 15 min by incubating in freshly prepared 2% parafonnaldehyde in 
PBS. Cells were then washed three times with PBS and the reaction was quenched 
with 3 washes of 50mM N1I4CIIPBS over a period of 10 min. Cells were washed a 
further three times with PBS. Cells were then washed with PBSIO.2% gelatin (PBS, 
0.2% fish-skin gelatin and 0.1 % goat serum, to block non-specific binding sites) and 
again three times with PBS over a 5 min period. 
An aliquot of primary antibody was centifuged in a micofuge, diluted to the required 
concentration in PBSIO.2% gelatin and stored on ice prior to use. Following the 
addition of lOOJlI of antibody solution to a sheet of parafilm, the coverslips were 
placed cells-down on the solution and incubated at room temperature for 1-2 h. PM 
lawns were washed three times sequentially with PBSIO.2% gelatin and PBS over a 5 
min period. 
Due to fluorescent dyes on the secondary antibodies the preparation of PM lawns 
from this point on was continued in as dark a room as possible. Secondary antibody, 
fluorescein isothiocyanate (FITC)-conjugated goat anti-rabbit IgG was prepared as 
for primary antibody and staining was carried out as described above. Coverslips 
were covered with aluminium foil dunng the 1-2 h incubation to avoid bleaching of 
dyes. As before, the PM lawns were washed three times sequentially with PBSIO.2% 
gelatin and PBS over a 5 min period. Coverslips were then mounted onto slides by 
plaCing them lawn down onto a 15JlI drop of movio!. Again, to prevent bleaching the 
slides were covered with aluminium foil and allowed to dry overnight. The slides 
Were stored in the dark prior to analysis. 
88 
Coverslips were viewed using x 40 or x 63/1.4 Zeiss oil immersion objectives on a 
Zeiss Axiovert fluorescence microscope (Carl Zeiss, Germany) equipped with a 
Zeiss LSM4 laser confocal imaging system. For each coverslip about 8 different 
lawn areas were scanned into the computer and the intensity of the signal was 
determined using Metamorph software (Universal Imaging, Inc.,West Chester, PA) . 
Means and standard error of those values were calculated. 
2.13.2 Whole cell Indirect Immunofluorescence Microscopy 
3T3-Ll adipocytes cultured on coverslips on 6-well plates were either treated as 
stated below or incubated in serum-free DMEM for 2 h at 37°C. Cells were then 
transferred onto ice and washed three times in cold PBS (see Section 2.2.1) and then 
fixed using ice cold acetone for 15 min. Subsequently the cells were again washed 
three times with PBS, followed by three washes in PBS/5% goat serum over a time 
period of 30 min. The cells were then incubated with primary antibody diluted in 
PBS/I % goat serum for 1 hour as described above. After this time cells were washed 
three times with PBS/~. I % (w/v) BSA and incubated with FITC-conjugated 
secondary antibodies diluted in PBS/2.5% goat serum as described above. Cells were 
again washed three times with PBS and mounted on glass slides as described above. 
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2.14 Chronic Insulin treatment 
Treatment with insulin for a prolonged time was as described by Kozka et.al1991. 
3T3-Ll adipocytes were cultured either on 6-well plates or lOcm dishes. Cells were 
then incubated with or without 500nM insulin for 24 h. After this time the plates 
were transferred onto a 37°C hotplate and washed 4 times over the course of about 1 
h 20 min with KRMES Buffer pH6 (see section 2.2.4) (warmed up to 37°C) in order 
to remove all insulin from the receptors. After this time cells were quickly washed 
with warm PBS, serum free media was added and cells were transferred back into an 
incubator at 37°C (humidified atmosphere of 10% C02) for 2 h. The plates were then 
again placed on a 37°C hot plate, washed 3 times over half an hour with KRHEPES 
buffer (see section 2.2.5) and then stimulated in this buffer with or without IlJM 
insulin for 30 minutes. After this time subcellular fractionations, total membrane 
preparation, plasma membrane lawn assays or whole cell immunofluorescence were 
done as described above. 
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2.15 Iodixanol Gradients 
OptiPrep is a sterile solution of Iodixanol (5,5' [(2-hydroxy-1-3propanediyl)-
bis(acetylamino) ]bis[N ,N' -bis(2,3dihydroxypropyl-2,4,6-triiodo-1 ,3-benzenecarbox-
amide]. 
Gradients were prepared as described by Hashiramoto et al 2000 with slight changes. 
Low density microsomal (LDM) membranes were prepared as described before and 
mixed with iodixanol to a final concentration of 14%. Volumes were made up to 
3.9ml using RES Buffer (see Section 2.2.3) and the mixture was sealed in quick-seal 
Beckman polyallomer tubes. Tubes were inverted several times to ensure sufficient 
mixing and then spun at 295 000 x g in a near vertical rotor (Beckman, TLNlOO) for 
1 h at 4°C. Acceleration from 0 - 5000 rpm was set to be 5 min and decceleration 
Was without breaks in order not to disturb the forming gradient. 300J.LI fractions were 
Collected by piercing first a hole in the top of the tube to let air in and then piercing 
the bottom of the tube. 
All fractions were snap frozen in liquid nitrogen and stored at -80°C prior to 
analysis. 
~j>. 
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2.16 ImmuDoprecipitatioDs 
Cells were grown on lOcm plates and treated as described in the results chapters. 
After the experiment, plates were transferred onto ice, washed once with cold PBS 
(see Section 2.2.1) and then 2ml of lysis/Immunoprecipitation buffer (see section 
2.2.6) were pi petted onto the plate. The buffer was left on the plates for about 5 min 
and then cells were washed off the plates by pi petting the buffer up and down. The 
cell suspension was tranferred to chilled Beckman tubes and spun at 50 000 x g for 1 
h at 4°C. 
The pellet from this spin was discarded and the supernatant was used for 
immunoprecipitation. This supernatant was transferred to eppendorf tubes and 
incubated with the respective antibody (usually about lOJ..lg of antibody per 
immunoprecipitation) by rotating on a rotating wheel at 4°C for 2 to 4 h. Protein A-
Sepharose or protein G-Sepharose was made up by weighing out lOOmg of solid into 
an eppendorf tube and adding Immunoprecipitation (IP) buffer in order to rehydrate 
the Sepharose. The beads were then spun down at full speed for 30 seconds and the 
supernatant removed. Now the beads were washed three times in IP buffer. In order 
to make a 50% slurry the same amount of IP buffer was added to the beads as there 
.. 
Was pure beads. About 50J..lI of 50% slurry was added to each immunoprecipitation 
and the tubes were rotated for at least another 2 h at 4°C. After this time the 
inunuoprecipitations were spun at 5000 x g for 2 minutes at 4°C and the supernatant 
Was transferred to a fresh tube and snap frozen. The sepharose beads were washed 
once in IP buffer and once in IP buffer containing only 0.1 % Triton. After removing 
all the liquid of the beads 100J..lI of 1.3 x sample buffer (120.9mM Tris-CI pH 6.8, 
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1.3mM sodium EDTA, 13% (w/v) glycerol, 2.6% (w/v) SDS, 0.0026% (w/v) 
bromophenol blue, 6M Urea, 26mM dithiothreitol) were added to the beads and 
incubated at room temperature for 30 min. After this time the beads were spun down 
and discarded and the supernatant containing any immunoprecipitated proteins was 
snap frozen and stored at -80°C prior to analysis. 
2.17 Yeast two hybrid 
2.17.1 Transformation 
Saccharomyces cerevisiae strain UO (MATa his3D200 trpl-901 leu2-3, 112 ade2 
LYS2::(lexAop)4-IDS3 URA3::(lexAop)s-lacZ gal4 gal80) was co-transformed with 
plasmids to express either the C- or N tail of GLUT4 as LexA fusions (pBTMlI6) 
and J,.tl, J,12, J,.t3A, J,.t3B or J,.t4 as VP16 fusions. As a negative control cells were also 
transformed with pLexA-GLUT4 N- or C terminus and pVPI6. 
For this lOml of YEPD were inoculated with several colonies of UO and grown over 
night at 30°C. 5mls of this overnight culture were then added to 50 mls of YEPD 
" 
Containing 2% glucose and grown for a further 2-4 h.The cells were then pelleted by 
spinning at 3500 x g for 5 min. The cells were washed once in TE (lOmM Tris P H 
7.5, ImM EDTA) and pelleted as before. The cells were now resuspended in 2ml of 
a 100mM Lithium acetate/0.5 x TE mix (200J,.t1 of 1M LiAc pH 7.5, 100J,.t1 10 x TE, 
1.7ml dH20) and incubated in this for 10 min at room temperature. Meanwhile a 
, DNA mixture was made in 1.5ml eppendorf tubes; for this IJ,.tg of each plasmid 
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DNA (GLUT4 constructs and J..I. constructs) was mixed with 100J..l.g of denatured 
salmon sperm DNA (denatured by boiling for 5 min immediately before use). After 
the 10 min incubation 100J..l.I of yeast suspension was added to the DNA and mixed 
well. To this 700J..l.I of a 100mMLiAc/40% PEG-3350/1 x TE mix (1.4ml 1M LiAc, 
1.4mI 10 x TE, 11.2mI 50% PEG-3350) was added and mixed by vortexing .. This 
was now incubated for 30 min at 30°C. After this time 88J..1.1 of DMSO were added, 
mixed and incubated for 7 min at 42°C. The tubes were then microfuged at full speed 
for 1 minute, the supernatant was aspirated and the pellet was resuspended in 1ml 
TE. The tubes were again microfuged at full speed for 10 s and the supernatant 
aspirated. The cell pellet was now resuspended in 100J..l.I of TE and plated on 
selective media. 
In order to make Yc plates 1.2g yeast nitrogen base (lacking amino acids) 5g 
ammonium sulfate and 109 succinic acid were mixed in 900ml of water and pH'd to 
5, then 2g of agar were added to each 90 ml of media and this was autoclaved. When 
the mixture had cooled down to slightly hotter then handwarm, glucose to a final 
concentration of 2% and amino acids to 0.0005% or 0.001 % were added and plates 
Were poured. For the selection, plates lacked uracil and the amino acids lysine in 
order to maintain the L40 strain, the amino acid tryptophan in order to select for the 
LexA-GLUT4 fusions and leucine in order to select for the VP16-J..I. fusions. Plates 
Were grown for 3 days at 30°C. 
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2.17.2 p-Galactosidase Filter Assay 
Overnight cultures of the transfonnations were grown in Y c media containing 2% 
glucose and all amino acids except Trp, Leu, Lys and uracil. One loop of these OIN 
cultures were streaked onto selective media lacking Trp, Leu, Lys and Ura and grown 
until visible colonies had fonned. The colonies were then lifted onto whatman 1 
filter paper by slowly lowereing the filter onto the plate and letting the yeast adsorb 
into the paper. The filter was then lifted off snap frozen in liquid nitrogen and then 
thawed at room temperature. This freeze/thaw cycle was repeated three times in 
order to break the cells open. 5-lOml of Z Buffer (60mM Na2HP04, 40mM 
NaH2P04, lOmM KCI, ImM MgS04, pH 7) containing O.4mglml X-gal and 0.28% 
Mercaptoethanol were added to a new square plate and two fresh Whatman 1 filters 
Were lowered onto the plate avoiding air-bubbles. Excess buffer was then drained 
and the thawed filter containing the yeast was laid on top of the two filter again 
aVoiding air-bubbles. This was now incubated at 30°C overnight. 
The development of blue colour was an indication of beta-galactosidase activity and 
therefore an interaction of the two fusion proteins. 
2.17.3 -His plates 
Overnight cultures of the transfonnations were grown in Y c media containing 2% 
glucose and all amino acids except Trp, Leu, Lys and uracil. One loop of these 
Overnight cultures were streaked onto selective media lacking Trp, Leu, Lys, Ura and 
- His (in order to select for positive interactants) and grown until colonies on the 
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positive controls appeared. Growth on media lacking histidine suggests an 
interaction of the fusion proteins. 
2.17.4 -His liquid cultures 
Overnight cultures of the transformations were grown in Y c media containing 2% 
glucose and all amino acids except Trp, Leu, Lys and uracil. Liquid -His cultures 
were then set up using 5 ml of YC media containing 2% glucose and all amino acids 
except Trp, Leu, Lys, His and uracil and adding 5J,l1 of the overnight cultures. These 
cultures were grown in the shaking incubator at 30°C for up to 72 h. OD600 readings 
were taken at different time points in order to determine growth of the cultures. 
Growth in media lacking histidine suggests an interaction of the fusion proteins. 
2.17.5 Liquid f3-Galactosidase Assay 
Overnight cultures of the transformations were grown in Y c media containing 2% 
glucose and all amino acids except Trp, Leu, Lys and uracil. Iml of this overnight 
Cuture was then added to 4ml of YPD media and grown until the cells were mid log 
phase (OD600 0.5-0.8). 1.5 ml of the culture were then transferred into eppendorf 
tUbes, centrifuged at 16000 x g for 30 s to pellet the cells and the supernatant was 
aspirated. The cells were then resuspended in Iml of Buffer 1 (lOOmM HEPES, 
150mM NaCl, 5mM aspartic acid, lOmglml BSA, 0.05% Tween, pH 7.3), 
Centrifuged again and the supernatant taken off. The pellet was then resuspended in 
300J,l1 of Buffer 1 and 100J,lI were transferred to a new tube. Cells were then broken 
open by repeated freeze thaw cycles (frozen in liquid nitrogen and then thawed at 
37°C for ca 1 min, repeated three times) then 0.7 ml of Buffer 2 (20mI Buffer! with 
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27.1 mg of Chlorophenol red-j3-D-galactopyranoside (CPRG» were added to each 
sample and mixed by vortexing. The time when buffer 2 was added was recorded 
and used as starting time for the colour to develop. Samples were then incubated at 
30°C for several hours checking the development of colour regulary. The reaction 
was stopped by adding 0.5 ml 3mM ZnCh to the sample and the tubes were then 
centrifuged at 16000 x g for 1 min in order to get rid of cell debris. The ODS78 of 1 
ml sample was then measured and the j3-galactosidase units were calculated: 
j3-galactosidase units = 1000 XODS78/(t x V x OD600) 
where: t = elapsed time (in min) of incubation 
V = 0.1 x concentration factor (concentration factor = 5) 
OD600 = A600 of 1 ml starting culture 
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CHAPTER 3 • IODIXANOL GRADIENT ANALYSIS OF INTRACELLULAR 
GLUT4 STORES AND THE FORMATION OF THE GLUT4 
COMPARTMENT DURING DIFFERENTIATION 
3.1 Aims 
1. To further characterise the use of iodixanol equilibrium centrifugation for 
resolving GLUT4 compartments in 3T3-Ll adipocytes 
2. To examine the formation of the insulin responsive compartment during 
differentiation of 3T3-Ll fibroblasts into adipocytes 
3.2 Introduction 
Insulin stimulates the uptake of glucose into fat and muscle cells. This effect is 
mainly due to the translocation of GLUT4 from intracellular membranes to the cell 
sUrface in the presence of insulin (see Chapter 1.5). In the absence of insulin GLUT4 
is found both in endosomes (-40~) and in specialised GLUT4 storage vesicles 
(GSV) (-60%) (Martin et al. 1997; Livingstone et al. 1996). The GSVs are highly 
insulin sensitive and explain why GLUT4 exhibits a much larger extent of 
translocation to the plasma membrane (about IS-fold) than other endosomal proteins 
such as the transferrin receptor (TtR) and GLUTI (about 2-fold) (Tanner & Lienhard 
1987; Piper et al. 1991). 
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The nature and formation of the GLUT4 containing compartment has been the 
subject of a great deal of research (for Review see Rea & James 1997). 
The differentiation of 3T3-Ll fibroblasts into adipocytes involves morphological 
changes as well as changes in gene expression. The cells begin to round up and 
accumulate lipid droplets (Blok et at. 1988; EI-Jack et at. 1999) and proteins 
necessary for the insulin-stimulated uptake of glucose are synthesised (Frost & Lane 
1988). These proteins include insulin signalling proteins such as the insulin receptor 
and insulin receptor substrates (IRS) (Kohanski et al. 1986; Frost & Lane 1988) as 
well as GLUT4. GLUT4 protein can first be detected around day 4 of differentiation 
and its levels increase dramatically thereafter and plateau around day 10 (Birnbaum 
1989; Kaestner et at. 1989). Other proteins such as the TfR and GLUTI are present 
in fibroblasts and adipocytes (EI-Jack et at. 1999). 
The aminopeptidase IRAP (also called vp165) is present in fibroblasts, as well as 
adipocytes. Its level increases 8 - 10-fold during differentiation and it has been found 
to co-localise up to 90% with GLUT4 in adipocytes (Chapter 1.6). IRAP is ablated 
Using Tf-HRP to a similar amount as GLUT4 and is known to translocate to the 
plasma membrane in response to insulin in a similar manner as GLUT4 (Ross et at. 
1996; Martin et ai. 1997). The body of evidence now available strongly suggests that 
'" ,... ~ 
in adipocytes and cardiac myocytes, GLUT4 and IRAP exhibit almost complete co-
localisation. 
One of the main problems in studying GLUT4 has been the difficulty of segregating 
GSVs from recycling endosomes. Endosome ablation has been used to determine the 
amount of GLUT4 present in the endosomes or the GSV compartment (Livingstone 
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et al. 1996) but this approach does not resolve the compartments for purification 
purposes. A recent study has described a new approach to separate these two vesicle 
populations using iodixanol gradient centrifugation (Hashiramoto & James 2000). 
Iodixanol is an iodinated density gradient compound which can form self-generated 
gradients. It can be added directly to the biological sample and is an ideal medium 
for the resolution of, for example, membrane vesicles (Billington et al. 1998). In 
3T3-Ll adipocytes iodixanol gradient centrifugation has been used to separate 
intracellular GLUT4-containing membranes into two peaks, one being enriched in 
endosomallTGN markers (peak 2) and the other containing the GSVs (peak 1) 
(Hashiramoto & James 2000). 
In these studies we have characterised iodixanol gradient centrifugation in 3T3-Ll 
adipocytes with respect to GLUT4 and other proteins that partly co-localise with 
GLUT4. We have confirmed here that this is a powerful means to resolve distinct 
intracellular GLUT4 pools. 
We have also used endosome ablation to study the formation of the GSV 
compartment during differentiation using !RAP as a marker protein due to its 
presence throughout differentiation. This data suggests that the GLUT4 storage 
compartment only forms during differentiation and only once GLUT4 is expressed . 
.. 
100 
3.3 Results 
3.3.1 Characterisation of the iodixanol gradients 
In order to visualise the two pools of GLUT4 (endosomal and GSV) we have used 
the method of Hashiramoto and James using iodixanol equilibrium sedimentation 
analysis (Hashiramoto & James 2000). 
Due to the use of a near vertical rotor in this study instead of the vertical rotor used 
by Hashiramoto we found it necessary to change this method slightly and use a 
higher g-force but a shorter spin-time (Materials and Methods, section 2.15). Using 
this approach intracellular GLUT4 vesicle fractions from 3T3-Ll adipocytes were 
segregated into two peaks as can be seen in Figure 3.1A. Peak 1 contains 40 ± 5% of 
the total GLUT4 present within the LDM fraction and peak 2 contains 45 ± 8% of 
the GLUT4 present within the LDM fraction (mean ± S.D. of three experiments). In 
agreement with Hashiramoto and James, we found that insulin induced a greater loss 
of GLUT4 from peak 1 (51 ± 3.5% reduction) then from peak 2 (Figure 3.1B) 
consistent with the suggestion that peak 1 contains the GLUT4 storage vesicles: Peak 
2 in contrast is thought to contain the recycling endosomes, and in response to 
insulin, GLUT4 levels in this peak decrease by 23 ± 2.6%, consistent with the idea 
.. ' 
that the endosomes are less insulin responsive than GSVs. 
We also show here that !RAP behaves in a very similar manner to GLUT4. In the 
absence of insulin IRAP is present in both peaks, but in the presence of insulin there 
is a greater reduction of IRAP from peak 1 (61 ± 6.3% reduction) then peak 2 (30 ± 
4% reduction) (Figure 3.1A and 3.1B). 
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In order to further characterise the nature of these two compartments, we examined 
the distribution of the v-SNAREs V AMP2 and cellubrevin in iodixanol gradient 
fractions. (Figure 3.1C) VAMP2 was found to co-segregate with the GSV peak and 
cellubrevin co-segregated with the endosomal peak (Figure 3.1C). This is somewhat 
different to the data of Hashiramoto, who found both proteins equally present in 
peaks 1 and 2, but supports the idea that VAMP2 is the v-SNARE for the GSVs, 
while cellubrevin is the v-SNARE for the endosomes (Martin et al. 1996; Martin et 
al. 1998). The transferrin receptor is found in both peaks and again insulin causes a 
greater loss of this protein from peak 1 (Figure 3.1 C). 
In order to determine the robustness of the separation of the two peaks, we 
centrifuged some of the fractions through a second iodixanol gradient. For this either 
fractions 2 and 3 or fractions 9 and 10 were pooled, subjected to iodixanol gradient 
centrifugation, and recovered fractions probed for GLUT4 content. As can be seen in 
Figure 3.2A GLUT4 in fractions 2 and 3 ended as predicted in the denser peak 
fOllowing re-centrifugation. On the other hand, GLUT4 in fractions 9 and 10, which 
originated from peak 2, distributed throughout the whole of the second gradient, and 
formed again two peaks. This may relate to the suggestion that peak 2 consists of two 
peaks, peak 2a being enriched in sortilin (Morris et al. 1998; Gould unpublished; ,. 
Hashiramoto & James 2000) and the lighter peak 2b containing the TfR, rab4 and 
rabU (Hashiramoto & James 2000). We did not confirm this in this study. 
Alternatively, it may imply that the difference in vesicle size and density between the 
two pools is very small and that a longer spin-time would accumulate more recycling 
endosomes in the bottom fraction. 
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Previously it has been found that fraction 1 (bottom of the gradient) contained the 
majority of protein loaded onto the gradient. It was suggested that this fraction 
comprises cytoskeletal protein complexes (Hashiramoto & James 2000). We 
confirmed that most of the protein content of the gradient was present in the dense 
fraction 1 (Figure 3.2B). Analysis of protein content of the fractions using BCA (see 
section 2.5) gave a similar result with most protein in fraction 1 (data not shown). 
Other studies from this laboratory have confirmed that this fraction contains 
cytoskeletal proteins (L.Chamberlain, S.Kane and G.W.Gould unpublished). 
3.3.2 Formation of the GSVs upon differentiation of 3T3·Ll fibroblasts 
Endosome ablation is a technique that has been used extensively to distinguish 
between the endosomal and the GLUT4 storage compartment (Livingstone et ai. 
1996 and Introduction section 1.5.3). We wished to use this approach to examine the 
biogenesis of the GSVs during the differentiation of adipocytes. Because a previous 
study (Hashiramoto & James 2000) had shown that the concentration of DAB could 
be a crucial determinant of the effectiveness of the reaction, we performed an 
experiment in which we tested different lengths of incubation with Tf-HRP conjugate 
(1 and 3 hours) and different DAB concentrations (lOOIlg/ml and Img/ml). Ablation 
of the TfR did not change significantly after longer exposure to the conjugate or after 
.l>-
increased DAB concentrations (Figure 3.3). For this reason we used a 1 hour 
exposure to Tf-HRP and 1001lg/ml DAB for further experiments. These conditions 
Were the same as those used previously in all studies from this lab. 
In order to determine at what time after differentiation the GLUT4 storage 
compartment forms, we performed endosome ablation using the Tf-HRP conjugate. 
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Due to the fact that expression of GLUT4 becomes evident around day 4 following 
the initiation of differentiation, we used IRAP as a marker for GSV formation prior 
to day 4. In Figure 3.4 it can be seen that IRAP is highly sensitive to endosome 
ablation at days 1 and 3, implying that the majority of IRAP is localised to TtR-
positive endosomes at these times. At day 5 of differentiation on the other hand most 
of IRAP is resistant to endosome ablation, consistent with the protein being localised 
in a distinct set of intracellular vesicles, presumably GSVs. 
Other people in the lab have confirmed this idea by separating the intracellular 
membranes from 3T3-L1 adipocytes at different stages of differentiation on 
iodixanol gradient (P.A.Baker, S.GoodfeIlow and G.W.Gould). For completion this 
Figure is included in this study (Figure 3.5) and shows that at day 1 and 4 most IRAP 
is found in the endosomal pool, while at day 8 most of it is found in the GSV peak 
suggesting again an absence of the GSVs before day 5. 
3.4 Discussion 
In these studies we have confirmed and extended the use of iodixanol gradient 
centrifugation as a powerful method to separate the endosomal and the GLUT4 
j,~, ' 
storage compartments. In response to insulin GLUT4 and proteins that are known to 
Co-localise with GLUT4, such as IRAP and V AMP2, translocate from peak 1 of the 
gradient to a much higher degree than from peak 2. This supports the argument that 
peak 1 contains the GSVs, while peak 2 contains the recycling endosomes and also 
probably some elements of the TGN (Hashiramoto & James 2000). 
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Our studies further suggest that the formation of the GSVs during differentiation 
happens at around day 4 - 5. Before this time IRAP is found in endosomes together 
with the transferrin receptor. This is supported by the fact that IRAP is ablated to a 
much greater extent on day 1 and 3 post differentiation than is the case at day 5 or 
day 8 - 12 (Martin et al. 1997). Detectable expression of GLUT4 is first observed at 
around day 4 -5, and we therefore propose that either the GLUT4 storage 
compartment only forms once GLUT4 is expressed, or that at a stage concomitant 
with expression of GLUT4, IRAP is able to enter pre-formed GSVs from which it 
was until then excluded. 
Studies from other workers in the laboratory using iodixanol gradients support this 
data (Figure 3.5). IRAP and the TfR are found in the endosomal peak at day 1 and 
day 4 post differentiation, but at day 8 IRAP as well as GLUT4 are found both in the 
endosomaI as well as in the GSV peak, suggesting either the absence of GSVs prior 
to day 4, or an inability of GLUT4 and IRAP to enter these vesicles before this time. 
These data are illustrated in Figure 3.5 and was performed by an undergraduate 
student (Paul A. Baker). 
The absence of an insulin-sensitive GLUT4 storage compartment before day 4 is also 
supported by a study examining the levels of IRAP at the plasma membrane in 
,.' 
fibroblasts and adipocytes (Ross et al. 1998). It was found that IRAP in fibroblasts 
increases 1.8-fold at the plasma membrane in response to insulin, much less than the 
8-fold increase observed in differentiated adipocytes. TtR levels on the plasma 
membrane on the other hand stay nearly identical during differentiation. This shows 
that differentiation leads to enhanced intracellular sequestration of IRAP and 
suggests that the formation of the insulin responsive compartment occurs at some 
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time during differentiation (Ross et ai. 1998). From our data we would conclude that 
this time-point during differentiation coincides with the expression of GLUT4, and 
that at this time the GSVs are formed and IRAP is sequestered into these vesicles. 
It is important to note that one possible explanation of the data in Figure 3.4 is that 
this may be a consequence of the levels of expression of IRAP relative to TfR. As 
levels of IRAP increase substantially during differentiation but levels of TfR remain 
relatively constant, it is possible that the inability to observe significant ablation of 
!RAP after day 3 is a function of an increased ratio of IRAP:TfR. However, we do 
not believe this is the case. The cross-linking (ablating) efficiency of this system is a 
function of the enzyme HRP, and is thus catalytic and not stoichiometric. Also, we 
have shown that these conditions are capable of ablating all of the GLUTI expressed 
in these cells (Livingstone et ai. 1996); GLUTI is expressed at a level in 
considerable excess compared to TfR. Hence, we believe that the data presented in 
Figure 4.3 is a function of altered localisation of IRAP and not altered stoichiometry 
of expression. 
Studies using the transfection of GLUT4 into fibroblasts (Haney et ai. 1991; Hudson 
et al. 1992) have shown that ectopically expressed GLUT4 does not translocate to 
the plasma membrane in response to insulin. Confocal staining and EM studies of 
"'f~, 
those cells showed GLUT4 to be in structures which seemed identical to the GLUT4 
compartments of adipocytes. Interestingly though the transfected GLUT4 co-
localised totally with the TfR (Hudson et at. 1992). This suggests that the transfected 
GLUT4 is localised in endosomes, and the absence of GSVs in fibroblasts. 
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Other studies have proposed that the formation of the insulin responsive 
compartment occurs before the expression of GLUT4, at around day 3 of 
differentiation (EI-Jack et ai. 1999). Their conclusion is based on the narrowing of 
intracellular GLUTI and TfR distributions in sucrose gradients from day 0 to day 3 
of differentiation. IRAP is also found in the same peak on the gradient at day 3 and 
so is GLUT4 at day 9. Their conclusion is that this newly formed compartment is the 
GSV s, but the problem with sucrose gradient fractionations is that one cannot 
distinguish between endosomes and GSVs. Hence, in the study of EI-Jack et ai., it is 
not possible to precisely determine where the GLUT4 is localised relative to TfR in 
any of the experiments. In 3T3-Ll adipocytes the amount of GLUT4 and TfR co-
localisation is known to be about 30 - 40 % (Livingstone et al. 1996; Kandror & 
Pilch 1998). 
Many studies now appear to support the notion that the majority of GLUT4 does not 
co-localise with the TfR in adipocytes or muscle, and evidence is accumulating to 
suggest that GLUT4, TfR and other plasma membrane proteins may recycle via 
multiple distinct pathways. The key issue is that the recycling of GLUT4 is largely 
distinct from these pathways and is profoundly insulin-sensitive (Tanner & Lienhard 
1987; Holman et ai. 1994; Kandror & Pilch 1998). This is discussed further below. 
Malide & Cushman have used wortmannin in rat adipocytes in order to follow 
GLUT4 recycling in these cells. The PI3 kinase inhibitor wortmannin is known to 
block the translocation of GLUT4 to the plasma membrane in response to insulin 
(Chapter 1.3.3) and also causes the formation of phase-lucent vacuoles in rat 
adipocytes (Mali de & Cushman 1997). In this study it was shown by 
immunofluorescence microscopy that when insulin was added together with 
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wortmannin GLUT4 stayed in vesicles identical to those in basal cells. On the other 
hand if insulin was given first followed by wortmannin several minutes later, GLUT4 
accumulated in the wortmannin-induced vacuoles. The rational behind this was 
suggested to be that GLUT4 translocates to the plasma membrane and is then 
endocytosed, but due to the presence of wortmannin cannot be recycled further. The 
morphologically altered compartment is though to represent the endosomes, and 
GLUT4 was under these conditions found to co-localise with the TfR and rab4, both 
usually found in early endosomes. The conclusion of this study was that under 
normal conditions GLUT4 is sorted out of the TfR compartment into a separate 
vesicle population from which it can then translocate to the plasma membrane in 
response to insulin (Mali de & Cushman 1997). 
A recent study in rat adipocytes using cell surface biotinylation together with 
GLUT4 vesicle adsorption found that the TfR and IRAP present in GLUT4 vesicles 
behaved in very different ways in response to insulin. The TfR rapidly recycled 
between the plasma membrane and the GLUT4 vesicles and after only 5 minutes 
50% of TfR was biotinylated corresponding with its appearance at the plasma 
membrane. In 30 minutes all the TfR found in the vesicles had been at the plasma 
membrane. IRAP on the other hand stayed on the plasma membrane for at least 30 
minutes after insulin administration (Kandror 1999). This data suggests that, as 
.. 
shown before (Livingstone et ai. 1996) GLUT4 is present in endosomes as well as 
GSVs, and that the difference in recycling rates between IRAP and TfR is due to 
their localisation in two different compartments. 
These experiments all support the presence of GLUT4 in two different 
compartments, one being endosomes and the other a highly insulin sensitive 
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compartment, which we propose to be formed only once GLUT4 is expressed. Some 
of the data could also be interpreted that the GSVs are already present in fibroblasts, 
but only after the expression of GLUT4 do IRAP and GLUT4 get sequestered into 
this compartment. This seems rather unlikely though as we can find no role of this 
compartment in fibroblasts and also because there is clearly some kind of 
compartment formation at day 3 post differentiation (EI-Jack et al. 1999). 
It seems likely from these experiments that there are many steps which lead to the 
formation of the GSVs. During differentiation some kind of rearrangement of the cell 
occurs which leads to the formation of a different kind of endosomal recycling 
vesicle than present in fibroblasts. Expression of GLUT4 could then lead to the 
formation of the GSVs and sequestration of proteins such as IRAP away from the 
recycling endosomes. Clearly further work is required to elucidate this problem. 
In conclusion we have confirmed the use of iodixanol gradient centrifugation as an 
important tool to study GLUT4 trafficking. We also present preliminary results to 
suggest that the formation of the GLUT4 storage compartment during differentiation 
happens only once GLUT4 is expressed. 
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Figure 3.1A Iodixanol gradient sedimentation analysis of GLUT4 and IRAP in 
3T3·Ll adipocytes. 
3T3-Ll adipocytes were treated with (I) or without (B) IJ.tM insulin for 30 minutes. 
LDM fractions were prepared and subjected to iodixanol density gradient analysis as 
described in Materials and Methods (section 2.15). Fractions were collected from the 
bottom of the gradient and ca. 1110 of each fraction was separated by SDS-PAO]3· 
Shown are typical immunoblots for the proteins indicated in basal and insulin treated 
cells. Peak 1 corresponds to the OLUT4 storage vesicles COSV) and peak 2 
corresponds to endosomeslTON. 
",r.;( 
110 
Figure 3.1A 
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Figure 3.1H Quantification of GLUT4 and IRAP on iodixanol gradients 
3T3-Ll adipocytes were treated with (I) or without (B) IJ.A.M insulin for 30 minutes. 
LDM fractions were prepared and subjected to iodixanol density gradient analysis as 
described in Materials and Methods (section 2.15). Samples were analysed as 
described in figure lA and shown is the quantification of three independent 
experiments of this type in which the % change in GLUT4 and IRAP in each of the 
two peaks was quantified. The greater magnitude of reduction in peak 1 compared to 
peak 2 was significant for both proteins (p<0.05). 
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Figure 3.te Iodixanol gradient sedimentation analysis of cellubrevin, VAMPZ 
and the transferrin receptor in 3T3·Lt adipocytes. 
3T3-Ll adipocytes were treated with (I) or without (B) IJ.lM insulin for 30 minuteS. 
LDM fractions were prepared and subjected to iodixanol density gradient analysis as 
described in Materials and Methods (section 2.15). Fractions were collected fro11l the 
bottom of the gradient and ca. 1110 of each fraction was separated by SDS-PAO]3· 
Shown are typical immunoblots for the proteins indicated in basal and insulin treated 
cells. ·.~k 
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Figure 3.2A GLUT4 stays in the bottom but not top fractions whell 
recentrifuged on a second iodixanol gradient 
2 fractions of an iodixanol gradient (either fractions 2 and 3 or fractions 9 and 10) 
were pooled and recentrifuged on a second iodixanol gradient, as described ill 
Materials and Methods (section 2.15). The collected fractions were separated bY 
SDS-PAGE and probed for GLUT4. Shown is a representative imrnunoblot (n=2). 
( ~·i 
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Figure 3.2A 
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Figure 3.2B Protein profile of Iodixanol gradient fractions 
Internal membranes (LDM's) from 3T3-Ll adipocytes were prepared and separated 
on an iodixanol gradient as described in Materials and Methods (section 2.11.1 and 
2.15). The collected fractions were separated by SDS-PAGE and the gel was stained 
using coomassie blue. Shown is a representative gel. Protein estimation via BCA 
assay (Materials and Methods section 2.5) gave a similar result, with most protein iJl 
fraction 1. 
118 
Figure 3.2B 
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Figure 3.3 Prolonged incubation with Tf·HRP conjugate or higher DAB 
concentrations does not change the amount of endosome ablation in 3T3 .. Ll 
adipocytes 
3T3-Ll adipocytes were incubated for either 1 hour (lh) or 3 hours (3h) with 'ff-
HRP conjugate and ablation was continued as described in Materials and Methods 
(section 2.10.2), with the exception that DAB concentrations were varied. "+" 
indicates °lmg/ml DAB while for the other samples lOOJ.tg/ml DAB was used. 
Intracellular membranes (LDM's) were prepared from each sample and 20~g of 
protein was separated by SDS-PAGE, followed by immunoblotting with GLU'f4 or 
TfR antibodies (TfR = transferrin receptor). Controls were incubated either with 
1001lg/ml (B) or Img/ml (B+) DAB. Shown is a typical experiment. 
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Figure 3.4 Ablation of lRAP, TfR and GLUT4 at different times after 
differentiation 
Duplicate plates of 3T3-L~ adipocytes at 1, 3, and 5 days post-differentiation were 
loaded with Tf-HRP for 1 hour. Thereafter, cells were either ablated (+ H202) or not 
(-H202) as described in Materials and Methods (section 2.10.2). LDM's were 
prepared and for each condition 20J..Lg of protein was separated by SDS-PAGE and 
irnrnunoblotted incubated with the antibodies indicated. A similar result was obtained 
in a previous experiment using only cells at day 3 and day 5 after ablation. 
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Figure 3.5 Iodixanol gradients of 3T3·Ll adipocytes at day 1, day 4 and day 8 
after differentiation 
Low density membranes. of 3T3-Ll adipocytes were prepared as described ill 
Materials and Methods (section 2.11.1) at either day 1, day 4 or day 8 after 
differentiation of the cells. Iodixanol gradients of the LDM's were run as described ill 
Materials and Methods (section 2.15) and about 1I1Oth of the collected fractiolls 
were separated by SDS-PAGE and immunoblotted with the indicated antibOdies. 
(This Figure is from an experiment done by Paul A. Baker and Sarah Goodfellow) 
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CHAPTER 4 • GLUT4 TRAFFICKING IN THE INSULIN RESISTANT 
STATE 
4.1 Aims 
Insulin-stimulated GLUT4 translocation is known to be reduced in 3T3-LI 
adipocytes after chronic insulin treatment. The aim of this chapter is to determine the 
molecular basis of this. 
4.2 Introduction 
Type 2 diabetes is one of the major health problems in the Western world (Chapter 
1.2). In recent years it has been shown to be a very heterogeneous disease with no 
clear genotype leading to the phenotype of hyperinsulinaemia and hyperglycaemia. In 
the cascade of events, from insulin distribution in the blood to the effect it has on 
muscle and fat cells and to the final uptake of glucose into the cells, there are many 
possible sites of defect which could lead to an insulin resistant phenotype. The major 
downstream event which seems to be defective in all insulin resistant patients is the 
translocation of the insulin responsive glucose transporter GLUT4 from an 
intracellular store to the plasma membrane (as reviewed in Hunter & Garvey 1998). 
Many studies have therefore concentrated on understanding this translocation 
mechanism and on characterising the GLUT4 compartment. 
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In the absence of insulin 95% of GLUT4 is intracellular (Slot et al. 1991a; Slot et al. 
1991b) and it is now known that it occupies at least two different intracellular 
compartments (Holman et al. 1994). One of these is thought to be the endosomes and 
the other is a highly insulin sensitive compartment sometimes named GLUT4 storage 
vesicles (GSVs) (Chapter 1.5.3). The presence of GLUT4 in these specialised 
vesicles enables the rapid translocation of GLUT4 to the plasma membrane in 
response to insulin and distinguishes this protein from endosomal proteins such as 
the transferrin receptor (TfR) and GLUTI (Tanner & Lienhard 1987; Calderhead et 
al. 1990; Piper et al. 1991). 
Some other proteins co-localise with GLUT4 in this specialised compartment, such 
as the insulin responsive aminopeptidase !RAP (sometimes called vpI65). !RAP 
shows about a 8-fold translocation to the plasma membrane in response to insulin in 
3T3-Ll adipocytes (Ross et al. 1996), and 90% of it has been shown to co-localise 
with GLUT4 within intracellular membranes of adipocytes and cardiac myocytes 
(Ross et al. 1997; Martin et al. 1998). 
Another protein that co-localises with GLUT4 and !RAP in the GLUT4 storage 
vesicles is V AMP2. GLUT4 has been shown to translocate to the plasma membrane 
via a SNARE type mechanism (Cheatham et al. 1996; Rea et al. 1998) (Chapter 1.9). 
V AMP2 has been suggested to be the v-SNARE responsible for GLUT4 
translocation from the GSVs, while cellubrevin is thought to be the v-SNARE 
involved in translocation of GLUT4 and other proteins from the endosomes to the 
plasma membrane (Martin et al. 1996; Martin et al. 1998; Miller et al. 1999). The 
corresponding t-SNAREs are syntaxin4 and SNAP23/syndet (Rea et al. 1998) and 
these are found mostly on the plasma membrane. 
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In this chapter we sought to determine why GLUT4 does not translocate to the 
plasma membrane in insulin resistant cells. Kozka et ai. have shown that 3T3-Ll 
adipocytes treated for a prolonged time with insulin had 50% lower GLUT4 levels at 
the plasma membrane than control cells. These cells were also found to be resistant 
to acute insulin challenge and no further GLUT4 could be recruited to the plasma 
membrane (Kozka et al. 1991). 
We confirm here that 3T3-L1 adipocytes can be made unresponsive to further insulin 
challenge when treated for a prolonged period of time with high levels of insulin. We 
further show that this chronic insulin treatment can cause changes in both the levels 
and subcellular distribution of many proteins involved in GLUT4 trafficking, and that 
GLUT4 becomes selectively depleted from the GSVs in insulin resistant cells. 
4.3 Results 
It has been shown that treatment of 3T3-Ll adipocytes with 500nM insulin for 24h 
followed by a reversal using low pH washes, renders these cells insulin resistant in 
terms of insulin-stimulated GLUT4 translocation (Kozka et al. 1991) (Materials and 
Methods, section 2.14.1). We first set out to recapitulate this data using the following 
basic protocol. Cells were incubated with 500nM insulin for 24h, and following this 
were washed with KRMES buffer (pH 6) for about 80 minutes to remove all insulin 
from its receptor. Cells were then incubated in serum free media for 2h and either 
treated or not with IJ.lM insulin in KRHEPES buffer (pH 7.4). 
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4.3.1 Effect of chronic insulin on GLUT4 
To confirm previous published data regarding the effects of chronic insulin treatment 
on GLUT4 trafficking, we perfonned subcellular fractionations of control cells and 
chronically insulin treated cells and analysed these by SDS-PAGE and 
immunoblotting. It can be seen in Figure 4.1A that as expected in control cells 
GLUT4 translocates from the LDM fraction to the PM in response to an acute insulin 
treatment. On the other hand in cells which have been treated with insulin for 24h, 
the extent of GLUT4 translocation is greatly reduced and the levels of GLUT4 at the 
PM are less then those observed in acutely stimulated control cells. 
When a subcellular fractionation of control and chronically insulin stimulated cells 
was separated by SDS-PAGE followed by silver staining, we could see that treatment 
of these cells with 500nM insulin for 24 hours did not significantly change the 
general protein composition of these cells (Figure 4.1B). 
Similar results as mentioned above were obtained using the plasma membrane lawn 
assay of GLUT4 translocation (Figure 4.2A) which also showed a reduction in 
insulin-stimulated GLUT4 translocation in chronically insulin treated cells. The 
amount of GLUT4 at the plasma membrane was measured and it can be seen in the 
quantification in Figure 4.2B that while in control cells the fold increase at the PM 
due to acute insulin is about 6-fold, this is reduced to only 1.5-fold in chronically 
stimulated cells. Whole cell immunoflurescence gave very similar results (Figure 
4.2C). Insulin clearly causes an increase of GLUT4 at the plasma membrane, but in 
chronic insulin treated cells there is less GLUT4 found at the plasma membrane and 
this was not significantly increased by an acute insulin challenge. 
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In order to determine whether the reduction in translocation of GLUT4 could be due 
to a decrease in total GLUT4 levels, total membranes from control and chronically 
treated cells were compared by quantitative immunoblotting. It can be seen from 
Figures 4.3A and B that GLUT4 levels are indeed down by about 50% in the chronic 
insulin treated cells. 
Chronic insulin treatment therefore causes both a downregulation of GLUT4 protein 
and a decreased extent of insulin-stimulated translocation. This data is in agreement 
with published studies (Kozka et al. 1991; Kozka & Holman 1993; Sargeant et al. 
1993; Flores-Riveros et al. 1993) 
4.3.2 IRAP behaves differently to GLUT4 upon chronic insulin treatment 
IRAP has been found to co-localise with GLUT4 and translocate in a similar manner 
as GLUT4 to the PM in response to insulin (Chapter 1.6). In contrast to GLUT4 
however, cellular levels of IRAP were not depleted by chronic insulin treatment 
(Figure 4.3). Despite this, like GLUT4, IRAP exhibited decreased translocation from 
the LDM to the PM after chronic insulin treatment, as can be seen in Figure 4.1A. 
Furthermore, levels of IRAP at the PM in the absence of acute insulin are higher in 
chronic insulin cells compared to control cells (Figure 4.2B). Interestingly, IRAP 
levels in the HDM's also increased due to this treatment and this is in contrast to 
GLUT4 which is found to have a decrease in its levels in the HDM (Figure 4.1A). 
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4.3.3 Chronic insulin has an up regulatory effect on SNARE proteins 
Although the decreased GLUT4 levels could explain the reduced levels of GLUT4 at 
the PM, they cannot explain the decreased fold translocation of GLUT4. This led us 
to propose that in insulin resistant 3T3-L1 adipocytes, GLUT4 is either mis-targeted 
and is not localised to the GSVs, or that there is a defect in the translocation of the 
GSVs to the plasma membrane. 
The latter hypothesis led us to investigate proteins which have been implicated in 
GLUT4 trafficking. SNARE proteins are thought to be important for the docking and 
subsequent fusion of the GSVs with the plasma membrane (Introduction 1.9). We 
therefore examined different SNARE proteins both for their total cellular content and 
for their subcellular distribution. 
The v-SNARE V AMP2, thought to be involved in the fusion of the GSV with the 
PM, is one such candidate. In Figure 4.3 it can be seen that V AMP2 levels are 
upregulated due to chronic insulin treatment (l.S-fold, p < 0.02). Analysis of 
subcellular fractionations showed that in chronic insulin treated cells V AMP2 levels 
at the PM do not change upon acute insulin exposure, and are higher than the 
corresponding fractions from control cells (Figure 4.4). Note that the fractionation 
experiment also demonstrates that V AMP2 levels are increased in all fractions in 
chronic insulin samples (Figure 4.4). By contrast, chronic insulin treatment did not 
result in a significant increase in cellubrevin content (Figure 4.3) or change its 
distribution (Figure 4.4). 
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Syntaxin4 the corresponding t-SNARE is found mostly at the plasma membrane and 
its levels due to chronic insulin are upregulated by 1.3-fold (p < 0.05) (Figure 4.3A 
and B). SNAP23/syndet another t-SNARE recently shown to be involved in GLUT4 
trafficking (Rea et al.1998) was upregulated upon chronic insulin treatment by 50% 
(p < 0.04) (Figure 4.3A and B). Figure 4.3A and B also show, that levels of the 
transferrin receptor (TfR) and TGN38 do not change in response to chronic insulin 
treatment. The subcellular distribution of syntaxin4 and syndet were not greatly 
altered by chronic insulin. 
4.3.4 Effect of chronic insulin on other proteins involved in GLUT4 trafficking 
Targeting of cellular proteins to the right compartment is crucial for a cell and we 
therefore examined whether prolonged insulin treatment affected the distribution of 
proteins known to regulate membrane protein trafficking. 
AP2, the adaptor known to be important for clathrin mediated endocytosis (as 
reviewed in Robinson 1994) is found mainly at the PM, as can be seen in Figure 4.5. ' 
Chronic insulin treatment does not change this distribution. API has been found to 
localise to the TGN ( as reviewed in Robinson 1994) and in Figure 4.5 it can be seen 
that this protein is found as expected in the LDM fraction. API localisation does not 
seem to change due to chronic nor acute insulin. 
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4.3.5 Ablation analysis of endosomal GLUT4 content in control and chronic 
insulin treated cells 
In order to test the hypothesis that GLUT4 is mis-targeted in insulin resistant cells, 
we investigated whether the distribution of GLUT4 between the GSVs and the 
endosomes changes in chronic insulin treated cells using endosome ablation (see 
Materials and Methods section 2.10.2). 
Ablation of the endosomal recycling compartment using a Tf-HRP conjugate has 
been shown to eliminate most of the vesicles containing the transferrin receptor as 
well as endosomal markers such as cellubrevin and rab5 (Livingstone et al. 1996). 
Only about 40% of GLUT4 is ablated by this means, due to the fact that the majority 
of GLUT4 is localised in a specialised transferrin receptor negative compartment 
termed GSVs. We used ablation in order to determine whether under chronic insulin 
conditions more GLUT4 is localised in the endosomal recycling system than before, 
as this could account for decreased insulin-stimulated GLUT4 translocation, as the 
endosomes are inherently less insulin sensitive than GSVs (Millar et al. 1999). The 
results show no clear difference in the extent of ablation of GLUT4 in control or 
chronically insulin stimulated cells (Figure 4.6). When the same samples were 
probed for the transferrin receptor and IRAP, ablation of these proteins was shown to 
be increased in the chronically insulin stimulated cells, compared with control cells. 
Loading of cells with transfenin-HRP conjugate for one hour only ablates about 70% 
of the transferrin receptor (Livingstone et al. 1996). The increased ablation of the 
TfR after prolonged insulin treatment probably reflects the fact that there is an 
increase in endosomal recycling under these conditions and the conjugate is 
accessible to a larger fraction of the transferrin receptor. 
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These results would suggest little difference in the localisation of GLUT4 between 
chronically insulin stimulated cells and control cells, but that there is an increase of 
IRAP in the endosomes. This will be discussed further below. 
4.3.6 Comparison of GLUT4 vesicles in control and chronic insulin stimulated 
cells 
Another method to determine whether GLUT4 is mis-targeted in insulin resistant 
cells is to examine the composition of GLUT4 vesicles in control and chronic insulin 
treated cells. Such vesicles can be isolated by immunoadsorption approaches (see 
Materials and Methods section 2.12) 
In Figure 4.7 the results of GLUT4 vesicle adsorption's are presented. In this method 
protein A-coated sepharose beads were loaded with GLUT4 antibody and then 
incubated with the IDM fraction of either control or chronically insulin treated cells. 
GLUT4 vesicles are separated from the IDM fraction by this means and it can be 
seen that nearly all the GLUT4 has disappeared from the IDM's after adsorption 
(lane 5 versus 6 and 7 versus 8), indicating that this method results in quantitative 
adsorption of GLUT4 from the LDM fractions. The use of a random IgG shows that 
there is no non-specific binding of GLUT4 vesicles to the sepharose beads. 
The amount of !RAP found in GLUT4 vesicles did not change due to chronic insulin 
treatment (Figure 4.7A). Interestingly, more TfR seems to be present in the GLUT4 
vesicles from chronic insulin treated cells. This would therefore suggest an increased 
co-localisation of GLUT4 and IRAP with the TfR. 
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We have silver-stained the GLUT4 vesicles after SDS-PAGE in an effort to observe 
any changes in the vesicle protein composition, but we were unable to identify any 
specific changes in the protein profile by this means (Figure 4.7B). 
From this data we would suggest that more GLUT4 and IRAP reside in transferrin 
receptor positive endosomes in prolonged insulin treated cells than in control cells. 
4.3.7 GLUT4 is selectively lost from the GSVs in chronic insulin treated cells 
As described in chapter 3, iodixanol gradient centrifugation enables us to separate the 
recycling endosomes from the GLUT4 storage vesicles and it is a powerful method to 
look at GLUT410calisation (Hashiramoto & James 2000). 
We have used this method to determine whether long term insulin treatment results 
in an alteration in the pattern of GLUT4 localisation between the two pools. In Figure 
4.8 it can be seen that under basal conditions both GLUT4 and IRAP are, as 
predicted, found in both the GSV and endosomalffGN peaks. In chronic insulin 
treated cells on the other hand there is a depletion of both proteins from the GSV 
peak. In Figure 4.9 the amount of GLUT4 and IRAP present in either peak are 
expressed as a percentage of the content in control (untreated) cells. The selective 
loss due to chronic insulin treatment from peak 1 is 67 ± 7% reduction for GLUT4 
and 62 ± 6% reduction for IRAP. For peak 2 on the other hand there is a smaller 
depletion of GLUT4 (19 ± 4.5%), while there is an increase in the amount of IRAP 
by38 ±6%. 
135 
In order to be certain that the effect of long term insulin treatment on GLUT4 and 
IRAP localisation was selective, we examined the distribution of several other 
membrane proteins. V AMP2, cellubrevin and API (y-adaptin) did not show any 
significant change in their distribution between the GSV and the endosomal peak due 
to chronic insulin treatment (Figure 4.10). This suggests that this treatment does not 
cause a general alteration to membrane trafficking, but that the effects on GLUT4 
and IRAP are specific. 
4.4 Discussion 
Previous studies have shown that insulin resistance occurs before the onset of 
diabetes and that the body, in order to overcome this resistance, produces more and 
more insulin (hyperinsulinaemia) which eventually can lead to the breakdown of 
insulin secretion and finally to diabetes (as reviewed in Kahn 1994) (Chapter 1.2). 
Kozka et al. have shown that treatment of 3T3-Ll adipocytes with 500nM insulin for 
24 hours, mimicking a hyperinsulinaemic state, decreased the insulin responsiveness 
of GLUT4 by at least 50% (Kozka et ai. 1991). In our studies we aimed to determine 
why insulin ceases to be able to recruit GLUT4 to the plasma membrane under such 
conditions. 
We have confirmed the reduced ability of insulin to mobilise GLUT4 in chronic 
insulin treated cells using subcellular fractionations, plasma membrane lawn assays 
and whole cell immunofluorescence. By all these different methods, an acute insulin 
stimulation could only cause a - 1.5-fold stimulation of GLUT4 translocation in 
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chronic insulin treated cells. We also found that total cellular GLUT4 protein levels 
decrease due to this treatment, which is in contrast to the study by Kozka et al., but 
has since been confirmed in many studies, some of which are described below. 
The downregulation of GLUT4 in adipocytes by prolonged insulin has been shown to 
be at the mRNA level (Flores-Riveros et al. 1993; MacDougold et al. 1995; Hemati 
et al. 1998) as well as at the protein level (Flores-Riveros et al. 1993; Sargeant et al. 
1993), with the half life of GLUT4 decreasing from 50 hours to about 15 hours 
(Sargeant et al. 1993). The decrease of GLUT4 mRNA levels is thought to be due to 
a dephosphorylation of the transcription factor CIEBPa, which will inactivate the 
transcription factor and cause a reduction in GLUT4 gene transcription (Hemati et al. 
1998). It is likely that decreased GLUT4 levels and decreased half life of GLUT4 
may also arise as a consequence of GLUT4 being targeted for degradation. 
Adipocytes from insulin resistant patients have been shown to have a decrease in 
GLUT4 levels (Garvey et ai. 1991). Our data therefore is in strong accordance with 
cells in diabetic patients and supports the use of these cells as a model system. 
Many studies have implied that the downregulation of GLUT4 in adipocytes from 
diabetic patients is the main reason why those cells are insulin resistant. On the other 
hand, overexpression of GLUT4 h(adipocytes using transgenic mice has shown to 
result in enhanced whole-body insulin sensitivity in both normal as well as diabetic 
mice (as reviewed in Kahn 1996). This effect was mainly due to increased basal 
glucose transport explained by an increase of GLUT4 at the plasma membrane. These 
studies would suggest a more important role of adipose tissue in whole body insulin 
sensitivity then previously recognised, although adipocytes account for only 5 - 20% 
of post-prandial glucose disposal (reviewed in Hunter & Garvey 1998). Treatments 
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that cause upregulation of OLUT4 could therefore greatly increase the insulin 
sensitivity of diabetic patients. Metformin, an antihyperglycemic agent, has been 
shown to block the hyperinsulinaemic downregulation of plasma membrane OLUT4 
in rat adipocytes (Kozka & Holman 1993) and it is used clinically to alleviate insulin 
resistance by improving glucose tolerance in type2 diabetic patients (Davidson et al. 
1997). 
If the insulin resistance observed in our study was explained only by a general 
decrease in OLUT4 levels, we would expect the OLUT4 left in these cells still to be 
targeted to its special (OSV) compartment and therefore should still show an at least 
4-fold translocation to the plasma membrane, although levels in each location 
compared to control cells should be reduced. Our results do not confirm this 
hypothesis (Figures 4.1 and 4.2) and we therefore suggest that the OLUT4 left in 
chronic insulin treated cells is either mis-targeted or that proteins necessary for 
OLUT4 trafficking are malfunctioning. 
To study the second possibility, proteins involved in OLUT4 trafficking were 
examined. 
Interestingly IRAP, which has so far always been thought to behave in a similar 
manner to OLUT4 (Ross et al. 1996; Martin et ai. 1997), is not down-regulated due 
to chronic insulin treatment, and its subcellular distribution is also quite different to 
OLUT4 under these conditions. We found that a larger fraction of IRAP was present 
in the high density membranes; similar data was observed using other models of 
insulin resistance, such as high glucose or high glucosamine treatment (Fillipis et al. 
1998). The authors of this study suggest that this implies a role of IRAP in the 
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constitutive, but not insulin stimulated GLUT4 translocation (Fillipis et al. 1998). 
Further studies have to be made to confirm a role for IRAP in GLUT4 trafficking. 
The difference in trafficking between GLUT4 and IRAP found here are thought to be 
due to different targeting signals in the cytoplasmic domains of those proteins, but so 
far little is known regarding which sequences may be regulating these events. 
Chronic insulin treatment did not change the levels or distribution of the adaptors 1 
and 2, and this is of interest as API has been found to co-localise with GLUT4 
(Marsh et al. 1998) and is even found on GLUT4 vesicles (Gillingham et ai. 1999). 
On the other hand, we found that the SNARE proteins V AMP2, syntaxin4 and syndet 
were upregulated by chronic insulin treatment, and that increased levels of V AMP2 
and cellubrevin were now present at the plasma membrane. 
Increased SNARE protein levels also occur in muscle of some of the rodent models 
for insulin resistance (Maier et al. 2000). An upregulation of those proteins is in one 
sense surprising as the reduced OLUT4 translocation observed in these insulin 
. resistant rats would be expected to be accompanied by a decrease in SNARE protein 
expression. Other studies have reported changes in SNARE protein expression 
accompanying insulin resistance in pancreatic beta-cells. Thus, in falfa as well as in 
the OK rats (both rodent models for type n diabetes), insulin secretion due to high 
glucose is impaired and in both studies a down-regulation of some SNARE proteins 
was found (Chan et al. 1999; Nagamatsu et al. 1999). Restoration of the SNARE 
protein levels in OK rats improved glucose-stimulated insulin secretion. However, 
and interestingly from the perspective of the data described here, overexpression of 
the SNARE proteins in normal rat islets decreased glucose-stimulated insulin release 
139 
(Nagamatsu et ai. 1999), suggesting that over-expression of SNARE proteins can 
profoundly alter membrane trafficking events. 
Upregulation of key proteins for GLUT4 trafficking could be a means of 
compensating for the reduced glucose uptake. Although it is not clear whether the 
changes in SNARE protein expression are causal or adaptive, we suggest that normal 
levels of SNARE proteins are important for their correct function in the cell. So far 
no one to our knowledge has looked at SNARE proteins involved in GLUT4 
trafficking in insulin resistance and we show here for the first time that the insulin 
resistant state causes alterations in key trafficking proteins. 
In order to study the possibility that GLUT4 is mis-targeted in chronic insulin treated 
cells several different methods have been applied to examine the cellular localisation 
of GLUT4 in those cells. 
The method of transferrin receptor ablation has been commonly used in order to 
distinguish between the GLUT4 in the recycling endosomal system and GLUT4 in 
the GSVs (Livingstone et al. 1996). The increase in transferrin receptor ablation due 
to chronic insulin treatment could mean that the TfR is now more susceptible for Tf-
HRP binding due to its increased" recycling in the constant presence of insulin. 
Similarly, the increased ablation of IRAP suggests a higher proportion of this protein 
is in a TfR positive compartment. Ablation results do not show an increase of 
GLUT4 in the ablatable pool with the amount of ablation being similar to control 
cells, but this is in contrast to the results using vesicle adsorption where there seems 
to be an increased co-localisation of GLUT4 with the TfR. Even in control cells we 
can not detect the 40% ablation of GLUT4 reported (Livingstone et ai. 1996) and this 
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might be the reason why there is no difference in the treated cells. However, it is 
important to recognise that the vesicle adsorption approach cannot distinguish 
between vesicles containing different ratio's of TfR to GLUT4. Hence, vesicles 
containing an average of 1 molecule of GLUT4 and 10 molecules of TfR (such as 
control cells) and vesicles containing 1 molecule of GLUT4 and 30 molecules of TfR 
(such as chronic insulin treated cells) are equally bound by the protein A-anti-GLUT4 
conjugate. The apparent increase in TfR content of GLUT4 vesicles therefore does 
not necessarily mean that more GLUT4 is localised to TfR-positive endosomes, but 
may simply reflect more TfR present in endosomes under chronic insulin treated 
conditions. This is confirmed by the fact that more TfR is ablated in chronic insulin 
treated cells than control cells and suggests that more TfR moves to the endosomes 
from deeper less accessible compartments in the cell. The crucial result here is the 
increased IRAP ablation observed in chronic insulin treated conditions, which 
implies that the extent of overlap of IRAP and TfR has increased and that therefore 
more IRAP is localised to endosomes than in control cells. 
To further clarify this we used iodixanol gradient centrifugation, as this method has 
greatly helped to study the different GLUT4 compartments. We have found here that 
in chronic insulin treated cells the cellular depletion of GLUT4 is selectively from 
the GSVs and that no more GLUT4gets sorted into the GSVs. The results for IRAP 
on the gradient look similar to GLUT4 but, as mentioned earlier, total cellular IRAP 
levels do not change due to chronic insulin treatment and is therefore a redistribution 
of IRAP from the GSVs to the plasma membrane (Figure 4.1) and to the endosomes 
in these cells (Figure 4.8). 
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GLUT4 on the other hand is downregulated by about 40% due to prolonged insulin 
treatment (Figure 4.3.B) and very little GLUT4 is present at the plasma membrane 
(Figure 4.1A). This data therefore shows that in these cells there is a selective loss of 
GLUT4 from the GSVs and the majority of the GLUT4 still present is now localised 
to the endosomes. 
Together these results support the hypothesis that GLUT4 is mis-targeted in chronic 
insulin treated cells (Figure 4.11). We propose that prolonged insulin causes the 
translocation of nearly all GLUT4 and IRAP to the plasma membrane. From there 
these proteins are endocytosed and are taken into the recycling endosomes. At this 
stage there seems to be a block in the sorting to the GSVs, supported by the low 
levels of both IRAP and GLUT4 in the GSV peak (Figure 4.8), and GLUT4 is 
presumably taken to a large part into lysosomes for degradation, confirmed by the 
downregulation of GLUT4 (Figure 4.3B). IRAP on the other hand stays in the 
endosomes (Figure 4.9) and this is supported by an increased co-localisation of the 
TfR with IRAP (Figures 4.6 and 4.7). In addition, IRAP translocation to the plasma 
membrane due to insulin is now about 1.5 - 2-fold (Figure 4.2B), which corresponds 
to the insulin sensitivity of the endosomes. 
In the cascade of events from insulin distribution in the blood to the effect it has on 
muscle and fat cells and to the final uptake of glucose into the cells there are many 
possible sites of defect which all could lead to a insulin resistant phenotype. The 
effects of long term insulin treatment have also been looked at from a signalling 
perspective. It is known that chronic insulin will also cause changes in many 
signalling proteins such as the insulin receptor and IRS-l (Knutson et al. 1995; 
Ricort et ai. 1995; Pryor et ai. 2000). Chronic insulin causes downregulation of IRS-
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1 and IRS-2 in 3T3-Ll adipocytes (Clark et al. 2000). A study in cultured rat 
adipocytes showed that chronic insulin treatment causes a decreased tyrosine 
phosphorylation of the insulin receptor p-subunit as well as several other changes in 
the signalling cascade, but this did not lead to a change of the exocytosis rate of 
GLUT4 (Pryor et ai. 2000). Similar changes in signalling proteins have also been 
found in diabetic patients. Some patients were found to have abnormalities in insulin 
receptors, however a defect for example in the intrinsic tyrosine kinase activity of the 
receptor can be reversed through weight loss and euglycemic therapy. (Freidenberg et 
al. 1988; Freidenberg et al. 1991). This illustrates that defects like this might be 
secondary rather then the cause of insulin resistance. It is now known that the major 
downstream event which seems to be defective in all insulin resistant patients is the 
translocation of GLUT4 from an intracellular store to the plasma membrane (as 
reviewed in Hunter & Garvey 1998). From our results this would therefore suggest 
that mis-targeting of GLUT4 is the main reason for insulin resistance. Interestingly 
mis-targeting of GLUT4 has also been suggested in muscle from type 2 diabetic 
patients (Chapter 1.5.5), but due to the difficulties in fractionating muscle it is not 
clear from this study (Garvey et al. 1998) where GLUT4 is found and whether this 
accounts for the decrease in glucose transport. 
In order to examine whether GLUT4 is selectively lost from the GSV compartment in 
insulin resistant patients it would be of great interest to look at the distribution of 
GLUT4 in muscle and fat. We have established that GLUT4, using human fat tissue, 
can be separated into two pools using iodixanol gradient centrifugation (data not 
shown). but due to the small amount of material obtainable and the small number of 
samples, we have not yet been able to see any differences in GLUT4 distribution in 
healthy versus diabetic patients. Further studies to look at this are under way. 
143 
In conclusion we have shown here that prolonged insulin treatment of 3T3-Ll 
adipocytes renders these cells insulin resistant. This is accompanied by a 
downregulation of GLUT4 and an upregulation of different SNARE proteins. The 
loss of GLUT4 from these cells is selective from the GSV compartment and this can 
explain the diminished GLUT4 fold translocation due to insulin in these cells. Finally 
these data illustrate that, under our experimental conditions, the trafficking of IRAP 
and GLUT4 are distinct. 
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Figure 4.1A Subcellular fractionation of 3T3·Ll adipocytes and the effect of 
chronic insulin treatment on GLUT4 and lRAP distribution 
3T3-Ll adipocytes were treated with or without insulin at 500nM for 24 hours. After 
washing as outlined in Materials and Methods (section 2.14), cells were acutely 
insulin-stimulated with I~M insulin for 30 minutes. Subcellular fractions were 
prepared as described in Materials and Methods (section 2.11.1). 20J.1g of protein was 
separated by SDS-PAGE and immunoblotted with the antibodies indicated. The 
resulting membrane fractions were plasma membrane (PM), low density membranes 
(LDM) and high density membranes (HDM). Shown is a representative immunob}ot 
and similar results were obtained from at least three experiments . 
. <:w 
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Figure 4.18 Subcellular fractionation of 3T3·L1 adipocytes and the effect of 
chronic insulin treatment on the protein distribution 
3T3-Ll adipocytes were treated with (CI) or without (B) insulin at SOOnM for 24 
hours and washed as outiined in Materials and Methods (section 2.14). Subcellular 
fractions were prepared as described in Materials and Methods (section 2.11.1) and 
analysed by SDS-PAGE. The resulting membrane fractions were plasma membrane 
(PM), low density membranes (LDM), high density membranes (HDM), and soluble 
proteins (SP). Shown is a silver nitrate stained gel of such an experiment. 
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Figure 4.2A Plasma Membrane Lawn assay of insulin-stimulated GLUT4 
translocation 
3T3-Ll adipocytes grown on glass cover-slips were treated with or without insulin at 
500nM for 24 hours. After washing as outlined in Materials and Methods (section 
2.14), cells were acutely insulin-stimulated with IJlM insulin for 30 minutes and 
plasma membrane lawns were prepared as described in Materials and Methods 
(section 2.13.1) and stained with GLUT4 antibody. Shown are the results of a typical 
experiment (n=3) in which representative fields are shown. 
, ' '~J:: 
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Figure 4.2B Insulin-stimulated GLUT4 and IRAP translocation differs in 
chronically insulin treated 3T3-Ll adipocytes 
3T3-L1 adipocytes grown on glass cover-slips were treated with or without insulin at 
500nM for 24 hours. After washing as outlined in Materials and Methods (section 
2.14), cells were acutely insulin-stimulated with IJ.lM insulin for 30 minutes and the 
extent of GLUT4 and IRAP translocation determined using the plasma membrane 
lawn technique Materials and Methods (section 2.13.1). Shown is the fold 
translocation over basal from two (IRAP) and four (GLUT4) experiments. For each 
condition at least 4 different areas of the coverslip were scanned and quantified. The 
mean of those was used to calculate the fold increase at the plasma membrane. B ::: 
basal cells, B+I = control cells acutely stimulated with insulin. CI = chronic insulin 
treated cells, and CI+I = chronic insulin treated cells acutely challenged with 
insulin. * indicates a siWtificant difference increase in cell surface levels of !RAP 
compared to basal cells (B), p=0.02. ** indicates a significant reduction in insulin" 
stimulated GLUT4 translocation compared to B+I, p<O.Ol, and t indicates a 
significant reduction in insulin-stimulated IRAP translocation compared to B+1, 
p<O.05. 
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Figure 4.2C Whole cell Immunofluorescence of GLUT4 distribution in 3T3-Ll 
adipocytes 
3T3-Ll adipocytes grown on glass cover-slips were treated with or without insulin at 
500nM for 24 hours. After washing as outlined in Materials and Methods (section 
2.14), cells were acutely insulin-stimulated or not with 111M insulin for 30 minutes 
and cells were stained with GLUT4 antibody as described in Materials and Methods 
(section 2.13.2). Shown are representative images from one experiment. 
... ,;t 
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Figure 4.3A Analysis of protein expression levels in chronically insulin treated 
3T3-Ll adipocytes 
Total membranes from control and chronically insulin treated 3T3-Ll adipocytes 
were prepared as outlined in Materials and Methods (section 2.11.2). Shown are 
representative immunoblots of the indicated amounts of membrane protein probed 
using the antibodies indicated. 
. .i-};,~ 
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Figure 4.3B Quantification of protein expression levels in chronically insulill 
treated 3T3-Ll adipocytes 
Total membranes from control and chronically insulin treated 3T3-Ll adipocytes 
were prepared as outlined in Materials and Methods (section 2.11.2). Samples were 
separated by SDS-PAGE and immunoblotted with respective antibodies. ShoWIl is 
the quantification of this data (mean ± s.e.m. from three independent preparations of 
membranes). In this analysis, protein levels in control cells are ascribed a value of 
100% and the effect of chronic insulin treatment on protein levels is expressed as a 0/0 
change from this value. Significant differences from control cells not exposed to 
chronic insulin treatment are indicated by *p<0.05, **p=0.02, ***not significant, 
****p=0.04 and t p<0.05. 
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Figure 4.4 Subcellular fractionation of 3T3-Ll adipocytes and the effect of 
chronic insulin treatment on the SNARE proteins 
3T3-Ll adipocytes were treated with or without insulin at 500nM for 24 hours. After 
washing as outlined in Materials and Methods (section 2.14), cells were acutely 
insulin-stimulated with I~M insulin for 30 minutes. Subcellular fractions were 
prepared as described in Materials and Methods (section 2.11.1) 20J..tg of protein was 
separated by SDS-PAGE and immunoblotted with the antibodies indicated. The 
resulting membrane fractions were plasma membrane (PM), low density membranes 
(LDM) and high density membranes (HDM). Shown is a representative immunoblot 
and similar results were obtained from three experiments . 
. '.f<;(" 
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Figure 4.5 Chronic insulin treatment causes no change in API and AP2 adaptor 
distribution 
3T3-Ll adipocytes were treated with or without insulin at 500nM for 24 hours. After 
washing as outlined in Materials and Methods (section 2.14), cells were acutely 
insulin-stimulated with IJlM insulin for 30 minutes. Subcellular fractions were 
prepared as described in Materials and Methods (section 2.11.1). 20J,.1g of protein was 
separated by SOS-PAGE and immunoblotted with the antibodies indicated. The 
resulting membrane fractions were plasma membrane (PM), low density membranes 
(LDM), high density membranes (HOM) and soluble proteins (SP). Shown is a 
representative immunoblot, similar results were obtained from two experiments. 
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Figure 4.6 Ablation of chronically insulin stimulated 3T3·Ll adipocytes 
3T3-Ll adipocytes were treated with or without insulin at 500nM for 24 hours. Aftef 
washing as outlined in Materials and Methods (section 2.14), cells were incubated 
with TfR-HRP for 1 hour and ablation was performed as described in Materials and 
Methods (section 2.10.2). LDM's were prepared and 20J.lg of protein separated bY 
SDS-PAGE. Shown are typical immunoblots for the antibodies indicated (n=3 fof 
GLUT4, n=2 for Transferrin Receptor and IRAP). H20 2 indicates ablation. 
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Figure 4.7A The effect of chronic insulin treatment on GLUT4 vesicle 
adsorption 
3T3-LI adipocytes were treated with or without insulin at 500nM for 24 hours. After 
washing as outlined in Materials and Methods (section 2.14) LDM's were prepared 
and used for immunoadsorption of vesicles, with either GLUT4 antibody or a randoIll 
IgG as control (IP AB), as described in Materials and Methods (section 2.12). one 
fifth of the vesicle and LDM fractions were then separated by SDS-P AGE and 
immunoblotted with the antibodies indicated (IB AB). Shown are immunoblots froIll 
a single experiment. 
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Figure 4.7B The effect of chronic insulin treatment on GLUT4 vesicle proteill 
profiles 
3T3-L1 adipocytes were treated with or without insulin at 500nM for 24 hours'. After 
washing as outlined in Materials and Methods (section 2.14) LDM's were prepared 
and used for immunoadsorption of vesicles, with either GLUT4 antibody or a randortl 
IgG as control, as described in Materials and Methods (section 2.12). One fifth of the 
vesicle and 1I20th of LDM fractions were then analysed by SDS-PAGE and the gel 
was stained with silver nitrate. Shown is a gel from a representative experiment. 
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Figure 4.8 Iodixanol gradient sedimentation analysis of GLUT4 and IRAP ill 
3T3·Ll adipocytes and the effect of chronic insulin treatment 
3T3-Ll adipocytes were treated with (CI) or without (B) insulin at 500nM fof 24 
hours. After washing as outlined in Materials and Methods (section 2.14) LlJM 
fractions were prepared and subjected to iodixanol density gradient analysiS 
Materials and Methods (section 2.15). Fractions were collected from the bottOJIl of 
the gradient and ca. 1110 of each fraction was separated by SDS-PAGE. A typical 
immunoblot for GLUT4 and IRAP is shown. 
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Figure 4.9 Quantitation of Iodixanol gradient sedimentation analysis of GLVf4 
and lRAP in 3T3·Ll adipocytes and the effect of chronic insulin treatment 
3T3-L1 adipocytes were treated with (CI) or without (B) insulin at 500nM for 24 
hours. After washing as outlined in Materials and Methods (section 2.14) LDM 
fractions were prepared and subjected to iodixanol density gradient analysis. 
Collected fractions were separated by SOS-PAGE and immunoblots from fouf 
different experiments were quantified. Shown is the % change in GLUT4 and !RAP 
in each of the two peaks. The reduction in GLUT4 and IRAP content of peak 1 were 
both statistically significant (*p<O.02 in both cases). The elevated level of IRAP ill 
peak 2 in chronic insulin cells was statistically significant compared to basal ceIls 
(tp=O.04). 
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Figure 4.10 Iodixanol gradient sedimentation analysis of VAMP2, cellubrevill 
and APt in 3T3-L1 adipocytes and the effect of chronic insulin treatment 
3T3-Ll adipocytes were treated with (CI) or without (B) insulin at 500nM for 24 
hours. After washing as'outlined in Materials and Methods (section 2.14) LDM 
fractions were prepared and subjected to iodixanol density gradient analysis as 
described earlier. Fractions were collected from the bottom of the gradient and ca. 
1110 of each fraction was separated by SDS-PAGE, and immunoblotted with the 
antibodies indicated. 
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Figure 4.11 Model for the distribution of several membrane proteins in chronic 
insulin treated cells 
A In control cells in the absence of insulin about 60% of GLUT4 are localised in the 
GSV compartment which is highly insulin sensitive. 40% of GLUT4 are found in the 
endosomes together with the Transferrin Receptor. IRAP shows a very similar 
distribution to GLUT4. Both proteins are virtually absent from the plasma membrane 
in the absence of insulin. 
B In cells that were treated for a prolonged period of time with insulin GLUT4 
cellular levels are downregulated probably by targeting GLUT4 to the lysosomes. 
There is a block in the targeting of proteins into the GSV s and proteins accumulate ill 
the endosomes. IRAP and TfR co-localise to a higher degree under these conditions. 
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CHAPTER 5 - CHARACTERISATION OF CLATHRIN ADAPTORS IN 3T3·Ll 
ADIPOCYTES AND THEIR INTERACTION WITH GLUT4 AND IRAP 
5.1 Aims 
1. To determine the cellular distribution of clathrin adaptors in 3T3-L1 adipocytes 
2. To examine whether there is an interaction between these adaptors and either 
GLUT4 or IRAP 
5.2 Introduction 
GLUT4, the insulin responsive glucose transporter, is intracellularly localised in the 
absence of insulin and is thought to be distributed -40% in the endosomes and -60% in 
a specialised insulin sensitive compartment called GLUT4 storage vesicles (GSVs) 
(Livingstone et al. 1996; Kandror 1999 and reviewed in Rea & James 1997). GLUT1, 
which has a much wider tissue distribution then GLUT4 (reviewed in Gould & Holman 
1993), co-localises in part with GLUT4 in adipocytes, but is found partly at the cell 
surface (Calderhead et al. 1990). GLUT1 is also insulin sensitive, but to a lesser degree 
then GLUT4. It is now thought that GLUT1 co-localises with GLUT4 in the endosomes 
and recycles constantly between this compartment and the plasma membrane, while 
GLUT4 is sequestered into GSVs (as reviewed in Rea & James 1997). These differences 
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in targeting of the two transporters have led many investigators to examine the amino 
acid sequences of the cytosolic domains of the transporters, as differences in the 
sequences of these regions might explain why GLUT1 and GLUT4 behave differently. It 
has been found, as described below, that the N- and C terminal tails of GLUT4 are 
especially important for its localisation. 
The N-terminus of GLUT4 contains a motif (F5QQI8) which resembles the tyrosine-
based internalisation motifs found in other membrane proteins such as the transferrin 
receptor, TON38 and the mannose 6-phosphate receptors (as reviewed in Bonifacino & 
Dell'Angelica 1999). This motif is thought to be important for the internalisation of the 
membrane protein as well as for targeting from endosomes to lysosomes and other 
compartments (reviewed in Marks et al. 1997~ Bonifacino & Dell'Angelica 1999). In 
GLUT4, mutation of the phenylalanine 5 to alanine results in increased levels of the 
transporter at the plasma membrane and endosomes, indicating the importance of this 
motif for internalisation (Piper et al. 1993) and possible targeting of GLUT4 to the 
GSVs or TON (Melvin et al. 1999). 
The GLUT4 C-terminus has been implied to be important in intracellular retention of 
GLUT4 (Lee et al. 1997). The C-terminus of GLUT4 contains a di-Ieucine motif and 
such motifs have also been found to be important for endocytosis in other membrane 
proteins (Marks et al. 1997). In 3T3-Ll adipocytes mutational studies of the di-leucine 
motif in GLUT4 have highlighted the importance of this motif in internalisation (Verhey 
et al. 1995) as well as a possible role in the trafficking of GLUT4 from the TGN to the 
endosomes (Melvin et al. 1999). Additionally, other residues within the C-terminus of 
GLUT4 (distinct from the di-Ieucine motif) are also known to be important in targeting 
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GLUT4 (Verhey et al. 1995; Sandoval et al. 2000). The acidic cluster at the extreme C-
terminus of GLUT4 (Shewan et al. 2000) as well as two glutamate residues adjacent to 
the di-Ieucine motif (Cope et al. 2000) have been shown to be crucial for targeting 
GLUT4 to the GSVs. 
Endocytosis and intracellular targeting of membrane proteins is known to occur via the 
recruitment of proteins such as clathrin and the clathrin adaptors to the membrane. These 
adaptors mediate association of clathrin with the membrane by recognising and binding 
to the different motifs in the membrane protein. This is best understood for clathrin-
mediated endocytosis, where the adaptor AP2 binds the membrane protein to be 
internalised, resulting in the recruitment of clathrin to the membrane (as reviewed in 
Robinson 1994; Bonifacino & Dell'Angelica 1999). Clathrin is a scaffold protein and 
often called a triskelion due to its three legged structure. It is made of three large 
190kDa subunits and three small subunits around 25kDa in size. The crystal structure of 
the N-terminus of the large subunit has greatly helped in studying the assembly of 
clathrin and its function in the recruitment of cargo (ter Haar et al. 1998). Adaptors can 
bind clathrin and stimulate the formation of clathrin cages. Thereby adaptors link the 
coat formation to cargo incorporation and prepare the membranes for endocytosis. 
Clathrin forming a lattice causes the invagination of the membrane and with the help of 
.. 
dynamin and many other proteins the forming vesicle buds off from the plasma 
membrane (as reviewed in Pishvaee & Payne 1998). 
So far four different but closely related adaptors have been identified. They are all 
heterotetrameric and have 2 large subunits and 2 smaller ones. The two large subunits of 
API are called y and ~1 and are around 100kDa, the medium subunit is called ~1 and the 
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small subunit a1 and they are 47 and 19kDa in size respectively. API was found to 
recruit clathrin to the TGN and is therefore important in budding from this compartment 
(as reviewed in Robinson 1994). 
AP2 consist of an Cf. and a P2 subunit which are again around 100kDa and the Jl2 and a2 
subunits are 50 and 17kDa respectively. As mentioned above AP2 is important in 
recruiting clathrin to the plasma membrane for endocytosis (as reviewed in Robinson 
1994). 
AP3 consists of a () subunit, which is 160kDa, and a p3 subunit of 120kDa. The ~3 and 
a3 subunits are 47kDa and 22kDa respectively (Dell' Angelica et ai. 1997). There is 
some dispute as to whether AP3 can bind clathrin, but it is thought to be important in 
transporting membrane proteins from the TON to lysosomes (as reviewed in Odorizzi et 
ai. 1998). 
AP4 has been discovered recently and it is mainly found around the TGN. It consists of 
two large subunits E (127kDa) and P4 (83kDa) and two smaller subunits Jl4 and 04, 
which are 50kDa and 17kDa respectively (Hirst et al. 1999). So far, little is known about 
its functional role. 
Quite a different kind of adaptor protein is PACS-l (phosphofurin acidic cluster sorting 
protein), which belongs to the family of the cytosolic connector proteins (Wan et al. 
1998). This protein is probably a different kind of coat protein and connects membrane 
protein to the clathrin! API sorting machinery at the TGN/endosomes. PACS-l consists 
.. of a single subunit of about 120kDa (Wan et al. 1998). 
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GLUT4 is known to be endocytosed via clathrin coated pits (Slot et ai. 1991a; Robinson 
et al. 1992) and co-localises with API in intracellular vesicles near the TGN (Marsh et 
ai. 1998). Indeed API and AP3 have also been found on GLUT4 vesicles in rat 
adipocytes (Gillingham et al. 1999). 
In this Chapter we set out to identify the adaptors present in 3T3-L1 adipocytes and 
determine whether GLUT4 is bound by any of these proteins under different conditions. 
We found that insulin had no effect on the distribution of the adaptors. Yeast two hybrid 
studies did not show any association between GLUT4 and the ).l chain of the adaptors, 
but immunoprecipitation suggested a complex formation between GLUT4 and API and 
AP3. 
5.3 Results 
5.3.1 Subcellular distribution of clathrin adaptors in 3T3·Ll adipocytes 
In order to characterise the subcellular distribution of adaptors in 3T3-Ll adipocytes in 
.. 
the absence or presence of insulin, we probed a subcellular fractionation for the five 
different adaptors. In Figure 5.1 it can be seen that insulin does not have an effect on the 
distribution of any of the adaptors examined. AP 1 has been reported to be found 
intracellularly associated with the TGN (as reviewed in Robinson 1994). In subcellular 
fractionations the TGN is found in the low density microsomes (WM) (Piper et at. 
1991; Martin et al. 1994) and as predicted we found the highest levels of API in the 
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LDM fraction with lower levels also present in ROM and soluble protein fraction. AP2 
on the other hand was found at the plasma membrane and this is as expected, as it is the 
adaptor important in c1athrin coated endocytosis from the plasma membrane (as 
reviewed in Robinson 1994). Interestingly AP2 is the only adaptor examined here which 
is not found in the soluble protein fraction. Two different antibodies were used to look at 
the distribution of AP3. AP3 is found mostly in the LDM and soluble protein fractions 
with lesser amounts in the ROMs and a small amount in the PM fraction. This is as 
expected as AP3 has been shown by immunofluorescence to be in the perinuclear region 
probably located in the TON and the endosomes (as reviewed in Odorizzi et ai. 1998). 
Interestingly when using the J..t chain antibody for AP3 we could detect a second band in 
the plasma membrane fraction and to a lesser degree in the ROMs, but not in any of the 
other fractions. The significance of this could not be determined. AP4, which has been 
identified recently (Dell'Angelica et al. 1999; Hirst et al. 1999) is found mostly in the 
LDM and the soluble protein fraction in 3T3-L1 adipocytes. AP4 has been shown by 
immunogold electron microscopy to be associated with nonclathrin-coated vesicles in 
the region of the TON (Hirst et ai. 1999) and the presence of AP4 in the LDM fraction 
supports this data. PACS-l which is known to be present mainly in endosomes and the 
TON (Wan et ai. 1998) is found in the LDM fraction in 3T3-L1 adipocytes. 
5.3.2 The intracellular adaptors are found in the GSV fraction on iodixanol 
gradients 
In order to determine whether OLUT4 and the adaptors that were found in intracellular 
fractions are present in the same vesicle population, iodixanol gradient centrifugation 
Was used. Figure 5.2 shows the distribution of API and AP3 in LDM loaded from basal 
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and insulin treated cells. Both proteins were predominantly found in peak: 1, particularly 
in the first fraction. This is surprising as Hashiramoto & James described peak 2 to 
contain the TGN (Hashiramoto & James 2000) and we would therefore have expected 
the adaptors in these fractions. The significance of this is discussed below. The results 
for AP4 and PACS-I were virtually identical (results not shown). These data suggest a 
possible co-localisation of the intracellular adaptors and GLUT4. 
5.3.3 Yeast 2 hybrid analysis of GLUT4:adaptor interactions 
Adaptors are known to bind membrane proteins directly and this is important for the 
targeting of these proteins (Ohno et aT. 1995; Sorkin et ai. 1995). In order to detennine 
whether the GLUT4 N- or C-tennini could bind the J..l chain of API-4, we used the yeast 
2 hybrid system as described previously (Stephens et ai. 1997; Stephens & Banting 
1998). The yeast strain L40 was transformed with either the C-terminal or the N-
tenninal tail of GLUT4 fused to LexA, a DNA binding domain (vector pBTMl16). The 
yeast was at the same time also transformed with the J..l chains of the adaptors fused to 
VP16, a activation domain (vector pVP16) (Table 5.1). As positive controls, the 
previously described cytosolic domain sequences of TGN38 (transformant 26) and 
19p120 (a lysosome-associated membrane protein, transformants 27 and 28) fused to the 
.'" 
LexA gene were used as described in Table 5.1 (strength of interaction described by +) 
(Stephens & Banting 1998). Negative controls were the empty plasmid pVP16 against 
the two GLUT4 constructs (transformants 1,7.13 and 19) and against the TGN38 
construct (transformant 25). Several screens were performed to look for interactions 
between the fusion proteins. 
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In the event of an interaction between the two proteins there is an activation of the two 
reporter genes and this can be measured either by ~-galactosidase activity or by growth 
of the yeast on media lacking histidine. The l3-galactosidase filter assays did not show 
any activation of transcription suggesting no interaction between either GLUT4 
constructs and the ).t chains of the adaptors (Figure 5.3). Similar results were obtained on 
plates lacking histidine and a photo of this plate is shown in Figure 5.4. Although 
transformant 20 seems to grow on the plate lacking histidine, which would suggest an 
interaction between the C-terminal tail of GLUT4 and J,.tl, this result could not be 
confirmed in a repeat of this experiment or in any of the other assays performed. 
A more sensitive assay is the use of liquid cultures to determine whether there is any 
activity of the reporter genes. In Table 5.2 the results of the transformed yeast grown in 
liquid media lacking histidine are summarised. OD600 readings to determine yeast 
growth were taken after 42 and 68 hours. The positive controls (26 and 27) showed 
growth after this time as did transformant 15 which was confirmed in a repeat of this 
experiment. This would suggest an interaction of the C-terminal tail of GLUT4 with J,.t2. 
/3-galactosidase activity can also be measured in a liquid culture assay using CPRG 
(chlorophenol red-~-D-galactopyranoside) as a substrate. ~-Galactosidase can cleave 
CPRG and this causes a colour change from yellow to orange/red, which can be detected 
-" 
by measuring the ODS7S. The results of such an assay can be seen in Table 5.3 and here 
the ODs78 readings after different times are shown. The positive control 27 showed as 
expected a very strong interaction seen by the strong colour development after only 2 
minutes. After 22 hours none of the GLUT4-construct transformants showed a clear 
colour development. Transformant 15 did not show any l3-galactosidase activity over the 
background activity. 
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In order to test some of the transformants again, which had in different repeats of the 
assays given any indication of an interaction, triplicate sets of 10 transformants were 
used for the CPRG assay. The results with calculated f3-galactosidase activity can be 
seen in Table 5.4. A positive interaction would be expected to have a value around 3 or 
more and this can only be seen in the positive controls. Importantly an interaction is only 
thought to be real if both reporter genes are activated. Transformant 15 is therefore 
unlikely to present a real interaction between GLUT4 and AP2. 
Thus, by yeast two-hybrid assay we could not find any interaction between the cytosolic 
tails of GLUT4 and the J..I. chains of the adaptors. 
5.3.4 Immunoprecipitations 
Adaptors are thought to be recruited to the membrane receptors from the cytosol under 
certain circumstances. In order to mimic such an event we treated 3T3-Ll adipocytes 
with insulin and then "reversed" this effect either by washing the cells with a low pH 
buffer for different times or by adding wortmannin as described in the Figure legends. 
Insulin will cause a translocation of GLUT4 to the plasma membrane and both the 
i<"iJ-
reversal and the wortmannin treatment cause the endocytosis of GLUT4, wortmannin by 
increasing the rate of endocytosis (Spiro et al. 1996) and low pH buffer washes by 
removing insulin from its receptor thus prompting GLUT4 re-intemalisation. 
Wortmannin has been shown to cause the accumulation of GLUT4 in intracellular 
vesicles distinct from GSVs (Malide & Cushman 1997; Chapter 3). The reversals using 
low pH buffer on the other hand should lead to the recruitment of GLUT4 to the GSV 
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compartment. These different treatments will lead to re-internalisation of GLUT4 and 
under these circumstances an interaction of the adaptors with GLUT4 is most likely. 
In order to look for an in vivo interaction between the adaptor complex and GLUT4 we 
immunoprecipitated (IP) GLUT4 from cells treated as described above and probed these 
for API, AP2 and AP3. Due to the fact that an adaptor could bind GLUT4 either on the 
C-terminus or on the N-terminus, we used GLUT4 antibodies raised against the N-
terminus or the C-terminus of GLUT4. It is important to note here that the N-terminal 
GLUT4 antibody used was whole serum, while the C-terminal GLUT4 antibody was 
affinity purified. In Figure 5.5 an immunoprecipitation using the C-terminal GLUT4 
antibody is shown. The upper panel shows that GLUT4 was successfully precipitated, 
but none of the adaptors seem to interact with GLUT4. The strong band in the lower 
panel IP is probably due to the antibody in the preparation crossreacting with the 
secondary antibody used for signal-detection. Figure 5.6 shows a nearly identical 
experiment, but in this case the N-terminal GLUT4 antibody was used for the 
immunoprecipitation. Again immunoprecipitation of GLUT4 was successful seen by the 
absence of GLUT4 in the supernatant and by the strong band in the IP lanes. The lower 
part of the band in the IP fractions is thought to represent OLUT4, while the upper part 
again is the antibody (IgO heavy chain) present in the immunoprecipitation, which will 
,$. 
run at about 50kDa. In this immuoprecipitation it can be seen that there is some API as 
well as AP3 present in the IP. The presence of AP3 is confirmed by both the antibody to 
the large c chain as well as to the small J..l chain of the adaptor complex, although the 
latter is difficult to distinguish due to the crossreacting contaminating antibody. The 
important result in the bottom panel of Figure 5.6 is the disappearance of the lower band 
in the supernatant fractions and the strength of the signal in the IP fractions. This is in 
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strong contrast to both Figure 5.5 as well as to the negative control seen in Figure 5.7 
and suggests an in vivo interaction of GLUT4 with API and AP3. 
In order to test whether IRAP, the aminopeptidase known to co-localise with GLUT4 
(Ross et ai. 1996; Martin et ai. 1997), can also interact with the adaptors, a similar 
experiment was performed using an IRAP antibody for immunoprecipitation. These 
results are shown in Figure 5.8 and they would suggest an interaction between IRAP and 
AP3, but not API. 
In conclusion this set of data suggests an in vivo interaction between the C-terminus of 
GLUT4 and API and AP3 as well as an interaction between IRAP and AP3. 
5.4 Discussion 
GLUT4, the insulin responsive glucose transporter, has been found to be localised in 
clathrin lattices at the plasma membrane (Robinson et al. 1992) and co-localises with 
AP 1 near the TGN (Marsh et ai. 1998). This evidence suggests a role of the c1athrin coat 
adaptors in the intracellular targeting of GLUT4. In this Chapter we therefore set out to 
d,' 
characterise clathrin adaptors in the insulin sensitive 3T3-Ll adipocyte cell line. We 
found here that insulin did not have any effect on the subcellular distribution of the 
adaptors. On the one hand, this may not be surprising, as these cells were treated for 
30min with IJ.1M insulin and this might be a too long timescale for determining the 
adaptor recruitment to the membrane as this might occur very quickly. Also plausible 
however, is that the subcellular fractionation method employed here is too crude to 
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detect relatively minor changes in subcellular distributions. It is of course also possible 
that insulin has no effect on the distribution of the adaptors. This is unlikely though as 
electron microscopy pictures of the plasma membrane have revealed that GLUT4 is 
found mainly in clathrin lattices in the absence of insulin, but in the presence of insulin 
GLUT4 was found both within and without clathrin lattices (Robinson et ai. 1992). This 
clearly demonstrates that insulin does have an effect on the association of GLUT4 with 
the clathrin coat (and therefore presumably with AP2). 
Adaptors are thought to be recruited to the membrane from the cytosol (as reviewed in 
Kirchhausen et ai. 1997). Surprisingly our results did not show any AP2 in the cytosolic 
fraction, which could of course be due to the fact that samples were only taken at two 
different conditions (Basal and Insulin) and a presence of AP2 in the cytoplasm could 
therefore have been missed. However, little is known about the requirements. for 
recruitment of AP2 to the plasma membrane and to our knowledge in vivo recruitment of 
AP2 from the cytosol to the membrane has not been shown. Binding of both API and 
AP3 to the target membrane on the other hand is found to be regulated by the small 
GTPase ARFI (as reviewed in Le Borgne & Hoflack 1998). 
All of the adaptors that were found intracellularly were mainly localised to the LDM 
.. 
fraction. Due to the fact that this fraction contains TGN and endosomes, as well as 
GSVs, we tried to determine where the adaptors in this fraction were localised. Iodixanol 
gradients revealed all of the adaptors in the first peak corresponding to the GSV 
compartment. The distribution of GLUT4 and the adaptors in this peak however was 
quite different. While GLUT4 is usually found in fractions 2-4, the adaptors were mainly 
found in fraction 1 (Figure 5.2 compare with Figure 3.1A). Another observation is that 
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Hashiramoto & James reported peak 2 to contain the TGN (Hashiramoto & James 
2000), but in our study very little of the adaptor proteins were found in this peak. One 
explanation for this could be that the TGN is not entirely found in peak 2 and that some 
is also present in the first peak. More likely though it is due to the complex formation of 
the adaptor proteins. Only LDM fractions are loaded on the gradient and the adaptors 
present in this fraction are therefore membrane associated. The presence of the adaptors 
in this first fraction suggests a complex formation with cytoskeletal elements as this 
fraction is thought to contain cytoskeleton. This method is therefore probably not 
accurate for determine the distribution of such proteins in the LDM fraction. 
Some of the adaptors on the other hand could well be present in the GSV compartment. 
Gillingham et al. have probed GLUT4 vesicles for API and AP3 and found significant 
amounts of both proteins on GLUT4 vesicles. Interestingly more API was recruited onto 
the GLUT4 vesicles in the presence of GTPyS and this was partially blocked by 
brefeldin A suggesting an involvement of ARF in this coating process (Gillingham et ai. 
2000). 
The fact that adaptors co-localise with GLUT4 in different regions of the cell led us to 
investigate whether there are any direct interactions between these proteins. The yeast 
.I; $.., 
two hybrid experiments did not show any interaction of GLUT4 with the adaptor 
medium chains. The absence of an interaction could be due to different methodical 
problems, probably in the GLUT4 constructs, as the yeast two hybrid screen using these 
medium chain constructs has been shown to work well with other proteins (Stephens et 
ai. 1997). One such example could be the distance between the reporter gene and 
GLUT4 as this has been shown to be important for J..I.l and J..I.2 binding to the tail of 
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TGN38 (Ohno et al. 1996). The lack of an interaction in our system could of course be 
due to the fact that these proteins do not interact in vivo, but this seems unlikely as the ~ 
chains of the adaptors have been shown to recognise both Tyrosine based signals (Ohno 
et al. 1995) as well as di-Ieucine motifs (Rodionov & Bakke 1998) of other membrane 
proteins. On the other hand, although the phenylalanine at position 5 in GLUT4 is 
known to be important for intemalisation (Piper et al. 1993) and is thought to be similar 
to a tyrosine-based motif, studies have shown that the tyrosine residue in this motif is 
absolutely essential for binding to ~2 and could not be substituted by a phenylalanine 
residue (as reviewed in Bonifacino & Dell'Angelica 1999). It is therefore not certain that 
this motif is involved in AP2 binding to GLUT4 and this could explain the lack of an 
interaction seen in the yeast 2 hybrid system. 
An in vivo interaction between a membrane protein and an adaptor has been shown for 
AP2 and the epidermal growth factor receptor (Sorkin et al. 1996). In order to look for 
such an interaction between GLUT4 and the adaptors we performed 
immunoprecipitations of GLUT4. Our data showed an interaction of the GLUT4 C-
terminus with API and AP3 and an interaction of IRAP with AP3. The C-terminus of 
GLUT4 contains, as described earlier, a di-leucine motif as well as an acidic cluster and 
other sequences important for GLUT4 targeting. Rapoport et al. showed by using an 
UV-induced cross-linking reaction that the \3-chain of API is able to bind to the di-
leucine motif of GLUT4 (Rapoport et al. 1998). It is therefore likely that the interaction 
we observe between GLUT4 and API is due to \31 binding the di-Ieucine motif in the C-
terminus of GLUT4. 
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AP3 has also been found to be able to bind to di-Ieucine motifs (Honing et al. 1998), but 
it is not known whether this interaction occurs also via the [) subunit of AP3. API is 
thought to be important in intracellular transport of membrane proteins to the 
endosomes, while AP3 is probably responsible for intracellular transport to lysosomes. If 
indeed both adaptors recognise the di-Ieucine motif in GLUT4 the question of specificity 
arises. For recognition of the Tyrosine-motif in membrane proteins by different adaptors, 
it is known that the residues surrounding the motif are important. It has been found that 
while mutation of one of the residues around the tyrosine-motif might reduce the binding 
to J.tl this has no effect on J.t2 binding and vice versa (Ohno et ai. 1996). This could be 
similar for the di-Ieucine motif and the surrounding sequences such as the acidic cluster 
might have a role in directing specificity. The di-Ieucine motif of GLUT4 is known to be 
important in targeting GLUT4 from the TGN/GSVs to the endosomes (Melvin et ai. 
1999) and the interaction between GLUT4 and API observed here is therefore supported 
by the knowledge of a role of API in this trafficking step. 
IRAP contains two di-Ieucine motifs in its cytosolic tail (Keller et ai. 1995), one of 
which has been implicated in intracellular retention of IRAP (Subtil et al. 2000) and the 
binding of AP3 found in this study could occur via these motifs. Clearly much more 
research has to be done to map the sites of these interactions. 
In this study we could not determine an interaction between AP2 and GLUT4. This is 
surprising, as GLUT4 is known to be endocytosed via clathrin coated pits (Robinson et 
al. 1992) and this is thought to mediated by AP2. It could of course be possible that 
there is no such interaction in vivo. One idea to explain this could be that during 
endocytosis several different membrane proteins are internalised together. GLUT4 could 
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be recruited to a site of endocytosis in which other membrane proteins are localised and 
AP2 might recognise a motif in some of the proteins other than GLUT4 and endocytosis 
occurs taking GLUT4 along. This model would though suggest that GLUT4 could 
recognise the site of endocytosis, presumably by the presence of a specialised membrane 
receptor for GLUT4. This would reduce the specificity of targeting of GLUT4, as there 
is the need for another protein that intemalises together under same conditions with 
GLUT4. 
The results found here could also be explained due to problems in immunoprecipitating 
such a large complex. There have been studies to determine whether AP2 will first bind 
clathrin and then bind the membrane protein or whether it binds first to the motif of the 
membrane protein and then recruits clathrin to the site of endocytosis (Rapoport et al. 
1997). If AP2 binds first to the membrane protein, an immunoprecipitation of this 
protein is more likely to co-precipitate AP2. If AP2 on the other hand binds clathrin first 
this will lead to the formation of a very big complex that might be difficult to 
immunoprecipitate. The lack of an immunoprecipitation of both GLUT4 and AP2 would 
support the formation of a complex between AP2 and clathrin first and this is supported 
by the fact that when clathrin and AP2 co-assemble there is an increase in affinity of the 
J.!2 chain for the receptor tail (Rapoport et al. 1997). Such hypotheses could explain why 
" 
other groups have failed to co-immunoprecipitate adaptor proteins with other membrane 
proteins (with the notable exception of the EGF receptor, Sorkin et al. 1996). 
One other observation from our results is that the interaction between the adaptors and 
GLUT4 is increased in the samples treated with wortmannin and in the reversed 
samples. This is consistent with the role of the adaptors API and AP3 in intracellular 
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targeting, as there should be under these conditions an increased trafficking of GLUT4 
through internal membranes, dictating a need for careful sorting of cargo. 
Although our immunoprecipitation results suggested an interaction between some of the 
adaptors and GLUT4 these results could not be consistently repeated. Due to the 
negative results from the yeast two hybrid studies and due to similar negative results 
found in other laboratories using a range of approaches (David E. James and Gwyn W. 
Gould personal correspondence) we did not pursue this data further. 
In conclusion we found that under our experimental conditions insulin has no effect on 
the distribution of c1athrin adaptors in 3T3-L1 adipocytes. We could not detennine any 
interaction between the medium chains of the adaptors with the cytosolic tails of 
GLUT4, but in vivo GLUT4 seems able to bind both API and AP3. 
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Figure 5.1 Insulin has no effect on the subcellular localisation of clathrin adaptors 
3T3-LI adipocytes were treated with or without IIlM Insulin for 30 minutes. subcellular 
frationations were prepared as described in Materials and Methods (section 2.11.1) at1d 
the resulting membrane fractions (PM: plasma membrane, LDM: low densitY 
membrane, HDM: high density membrane and SP: soluble proteins) were separated bY 
SDS-PAGE. 20llg of protein was loaded on each lane. Antibodies used were raised to 
different subunits of the adaptor complex, for API against the y subunit, for AP2 agaitlst 
the a subunit, for AP3 against either the 8 or the Il subunit and for AP4 against the e 
subunit. The position of the molecular markers are indicated on the left of the figure. 
Shown is a representative experiment, repeated twice with the same results. 
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Figure 5.2 Iodixanol gradient analysis of APt and AP3 distribution in LVl\1 
fractions. 
3T3-LI adipocytes were treated with (I) or without (B) Ij.tM Insulin for 30 minutes. 
LDM fractions were prepared and run on an iodixanol gradient as described in MaterialS 
and Methods (section 2.11.1 and 2.15). 25j.t1 of each fraction was separated by SDS~ 
PAGE and immunoblotted for API or AP3 (8). Shown is a representative immunobiot 
and the experiment was repeated with similar results. 
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Figure 5.2 
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Table 5.1 28 Transformants of the yeast strain L40 
N-terminal GLUT 4 construct (2 different constructs): 
G4NTT contains the first 23 amino acids of the human GLUT4 cDNA. The numbers 22 
and 25 represent two different constructs made exactly the same way. 
Vector containing DNA Vector containing activation 
binding domain (pBTM116) domain (pVP16) fused to 
fused to GLUT4 adaptor J.t chain 
1 G4NTT22 empty 
2 G4NTT22 Jl1 
3 G4NTT22 Jl2 
4 G4NTT22 Jl3A 
5 G4NTT22 Jl3B 
6 G4NTT22 Jl4 
7 G4NTT25 empty 
8 G4NTT25 Jl1 
9 G4NTT25 1J.2 
10 G4NTT25 f.A.3A 
11 G4NTT25 1J.3B 
12 G4NTT25 f.A.4 
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C-terminal GLUT 4 construct (2 different constructs): 
G4CTT encodes 42 amino acids from the region predicted to be the end of helix 12 and 
start of the cytosolic region onwards. The protein product of G4Tx2 is expected to be 
identical to G4CTT, but it also contains about 60bp of 3' untranslated region from the 
original GLUT4 eDNA. 
Vector containing DNA 
binding domain (pBTM116) 
fused to GLUT4/Controi 
13 G4CTT 
14 G4CTT 
15 G4CTT 
16 G4CTT 
17 G4CTT 
18 G4CTT 
19 G4Tx2 
20 G4Tx2 
21 G4Tx2 
22 G4Tx2 
23 G4Tx2 
24 G4Tx2 
Controls 
25 TGN38-SDY 
26 TGN38-SDY 
27 Igp120-AGYQRL 
28 IgpI20-AGYQRL 
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Vector containing activation 
domain (pVPI6) fused to 
adaptor J..I. chain 
empty 
J.Ll 
J.L2 
J.L3A 
J.L3B 
J.L4 
empty 
J.Ll 
J.L2 
J.L3A 
J.L3B 
J.t4 
Strength of interaction 
empty 
J.L2 + 
J.L2 +++ 
J.t3A ++ 
Figure 5.3 p-galactosidase filter assay to test for interaction of the fusion proteins 
IAO yeast strain was transformed Materials & Methods (section 2.17.1) and the 
transformants were streaked onto selection media plates and grown until colonies had 
appeared. The p-galactosidase filter assay was performed as described in Materials & 
Methods (section 2.17.2). A schematic layout of the transformants on the filter is shown 
below. Development of blue colour indicates an interaction between the expressed 
fusion proteins. Shown is a picture of the filter. A similar result was obtained in a second 
experiment. 
Order of the transformations on sqaure plates for the p-galactosidase filter assaY: 
1 2 3 4 5 6 
7 8 9 10 11 12 
13 14 15 16 17 18 
19 20 21 22 23 24 
25 26 27 28 
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Figure 5.4 Analysis of growth of transformed yeast on media lacking histidine 
IAO yeast strain was transfonned as described in Materials & Methods (section 2.17.1) 
and the transfonnants were streaked onto selection media plates lacking histidine 
(section 2.16.3). A schematic layout of the transfonnants is shown below. Growth on 
media lacking histidine suggests an interaction of the expressed fusion proteins. Shown 
is a scan of the culture plate. A similar result was obtained in a second experiment 
Order of the transformants for the minus Histidine plates 
6 5 4 3 
12 11 10 9 
2 
8 
1 
7 
18 17 16 15 14 13 
24 23 22 21 20 19 
28 27 26 25 
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Table 5.2 
Transformants 42 hours 68 hours Transformants 42 hours 68 hours 
OD600 OD600 OD600 OD6oo 
1 0.015 0.003 15 0.052 1.804 
2 0.015 0.002 16 0.034 0.163 
3 0.014 0.001 17 0.02 0.017 
4 0.016 0.001 18 0.073 0.021 
5 0.009 0.023 19 0.023 0.036 
6 0.012 0.01 20 0.029 0.023 
7 0.014 0.015 21 0.014 0.017 
8 0.003 0.013 22 0.023 0.06 
9 0.013 0.012 23 0.02 0.033 
10 0.003 0.021 24 0.012 0.005 
11 0.005 0.01 25 0.013 0.011 
12 0.013 0.015 26 0.043 1.7 
13 0.016 0.006 27 1.02 1.8 
14 0.012 0.005 
.. 
Table 5.2 Growth of transformants in Liquid minus histidine culture 
Transformed yeast were grown in selection media as described in Materials and 
Methods (section 2.17.4) and OD600 readings were taken at indicated timepoints in order 
to determine growth of the yeast. Similar results were obtained in a second experiment. 
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Table 5.3 
Transfonnants ODS78 Stopped Transfonnants ODS78 Stopped 
hlmin hlmin 
1 0.256 22h 15 0.37 22h 
2 0.273 22h 16 0.534 22h 
3 0.223 22h 17 0.459 22h 
4 0.205 22h 18 0.357 22h 
5 0.338 22h 19 0.336 22h 
6 0.236 22h 20 0.342 22h 
7 0.256 22h 21 0.285 22h 
8 0.272 22h 22 0.517 22h 
9 0.231 22h 23 0.333 22h 
10 0.295 22h 24 0.553 22h 
11 0.276 22h 25 0.218 22h 
12 0.213 22h 26 0.448 37min 
13 0.411 22h 27 , 1.558 2min 
14 0.231 22h 
,.." 
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Table 5.3 Liquid J3-galactosidase assay using CPRG as substrate 
Cultures were i'nitially grown for 4 hours without measuring the OD6oo and the assay 
was performed as described in Materials and Methods (section 2.17.5). Colour 
development was stopped at the indicated times and an ODs78 reading was taken. Due to 
the lack of an OD6oo measurement at the beginning, J3-galactosidase units could not be 
calculated. 
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Table 5.4 
Transformants ~-galactosidase units 
13 0.87 
15 0.94 
16 0.97 
18 0.96 
19 0.99 
22 0.9 
24 0.91 
25 0.77 
26 18.11 
28 10.5 
Table 5.4 ~.galactosidase units for some lransformanls in liquid culture assay using 
CPRG as substrate 
Some of the transformants were chosen for a detailed ~-galactosidase assay and three 
cultures were set up for each. The assay was performed exactly as described in Materials 
and Methods and ~-galactosidase units were calculated as described (section 2.17.5). 
The ~-galactosidase units are the mean of the three separate cultures. 
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Figure 5.5 Immunoprecipitation of GLUT4 using an antibody against the C· 
terminus ofGLUT4 
3T3-Ll adipocytes were either left untreated (B), treated for 30 minutes with 1~ 
insulin (I), treated for 30 minutes with IJ..tM insulin, then washed for 5 minutes with 
KRMES Buffer pH 6 (section 2.2.4) (R5), treated for 30 minutes with IJ..tM insulin, then 
washed for 15 minutes with KRMES Buffer pH 6 (RI5) or treated for 30 minutes with 
IJ..tM insulin, then for 15 minutes with 50nM Wortmann in (W). ImmunoprecipitatiOns 
were performed as described in Materials and Methods (section 2.16), separated bY 
SDS-PAGE and analysed by immunoblotting. For the supernatant about 1I1Oth of Ii 
10cm plate was loaded on the gel, for the immunoprecipitate about 1I3rd of a 10em plate 
was loaded on the gel. The positive control is 20J..tg of total membrane of untreated 3"[3" 
Ll adipocytes (no positive controls are shown for GLUT4 and AP2). 
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Figure 5.6 Immunoprecipitation of GLUT4 using an antibody against the N'" 
terminus of GLUT4 
3T3-Ll adipocytes were either left untreated (B), treated for 30 minutes with 1~ 
insulin (I), treated for 30 minutes with IJ.LM insulin, then washed for 5 minutes wHit 
KRMES Buffer pH 6 (section 2.2.4) (R5), treated for 30 minutes with IJ.LM insulin, then 
washed for 15 minutes with KRMES Buffer pH 6 (RI5) or treated for 30 minutes witlt 
IJ.LM insulin, then for 15 minutes with 50nM Wortmann in (W). ImmunoprecipitatiOns 
were perfonned as described in Materials and Methods (section 2.16), separated bY 
SDS-PAGE, and analysed by immunoblotting using the antibodies indicated. Fof tlte 
supernatant about 1I1Oth of a 10cm plate was loaded on the gel, for we 
immunoprecipitate about 1I3rd of a lOcm plate was loaded on the gel. The positiVe 
's 
control is 20J.Lg of total membrane of untreated 3T3-Ll adipocytes (no positive controll 
shown for GLUT4). 
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Figure 5.7 Immunoprecipitation using a random antibody as control for non-
specific binding 
3T3-Ll adipocytes were either left untreated (B), treated for 30 minutes with 1~ 
insulin (I), treated for 30 minutes with IJ,lM insulin, then washed for 5 minutes witb 
KRMES Buffer pH 6 (section 2.2.4) (R5), treated for 30 minutes with IJ,lM insulin, tben 
washed for 15 minutes with KRMES Buffer pH 6 (RI5) or treated for 30 minutes witb 
IJ,lM insulin, then for 15 minutes with 50nM Wortmannin (W). ImmunoprecipitatiOtlS 
were performed as described in Materials and Methods (section 2.16), separated bY 
SDS-PAGE and analysed by immunoblotting using the antibodies indicated. For the 
supernatant about 1I1Oth of a lOcm plate was loaded on the gel, for the 
immunoprecipitate about 1I3rd of a lOcm plate was loaded on the gel. The positive 
·s 
control is 20J,lg of total membrane of untreated 3T3-Ll adipocytes (no positive control 1 
shown for GLUT4). 
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Figure 5.8 A possible co-immunoprecipitation of IRAP with AP3 
3T3-LI adipocytes were either left untreated (B), treated for 30 minutes with l~ 
insulin (I), treated for 30 minutes with IJ.1M insulin, then washed for 5 minutes with 
KRMES Buffer pH 6 (section 2.2.4) (R5), treated for 30 minutes with IJ.1M insulin, thetl 
washed for 15 minutes with KRMES Buffer pH 6 (RI5) or treated for 30 minutes with 
IJ.1M insulin, then for 15 minutes with 50nM Wortmann in (W). ImmunoprecipitatiOtlS 
were performed as described in Materials and Methods (section 2.16) ), separated bY 
SDS-PAGE and analysed by immunoblotting using the antibodies indicated. For the 
supernatant about lIlOth of a lOcm plate was loaded on the gel, for tbe 
immunoprecipitate about 1I3rd of a lOcm plate was loaded on the gel. The positive 
control is 20J.1g of total membrane of untreated 3T3-Ll adipocytes. 
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Figure 5.8 
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CHAPTER 6 • OVERVIEW 
Insulin stimulates the uptake of glucose into storage tissues such as muscle and fat, and 
this is mediated by the insulin responsive glucose transporter GLUf4. In the absence of 
insulin GLUf4 is intracellularly sequestered and it is now well established that GLUf4 
occupies at least two different intracellular locations, one being of endosomal character 
and the other is thought to be a highly insulin responsive compartment, which is specific 
to GLUf4 and some other proteins such as IRAP. Insulin is known to cause the 
translocation of these GLUf4 storage vesicles (GSVs) to the plasma membrane and the 
subsequent insertion of GLUf4 in the plasma membrane. The fusion of GLUf4 vesicles 
with the plasma membrane occurs via a SNARE-type mechanism. It is thought that the 
v-SNARE V AMP2 together with the t-SNAREs syntaxin4 and syndet are responsible 
for fusion of the GSVs with the plasma membrane, while cellubrevin and corresponding 
t-SNAREs are important in the fusion of the endosomes with the plasma membrane. 
A new method for the separation of the two intracellular GLUT4 pools has been 
described recently (Hashiramoto & James 2000), and in Chapter 3 we confirmed the 
validity of this method for studies in 3T3-LI adipocytes and human adipocytes. 
Iodixanol gradient centrifugation analysis supports the hypothesis that the GSVs are 
indeed far more insulin sensitive than the endosomes and that V AMP2 is the SNARE 
protein responsible for GSV translocation while cellubrevin is found mainly localised to 
endosomes. In this Chapter we also looked at the differentiation of 3T3-Ll fibroblasts 
into adipocytes in order to determine at what time during differentiation the GSV 
compartment forms. Our data, using compartment ablation and iodixanol gradient 
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centrifugation, suggests that the GSVs form at about the same time that GLUT4 starts to 
get expressed. This confirms the idea that the insulin responsive compartment is defined 
by the presence of GLUT4, and IRAP gets sorted into this compartment during 
differentiation only once GLUT4 is present. Current studies are under way to look 
whether a tagged GLUT4 expressed in fibroblasts and during differentiation can drive 
the formation of the GSV or whether the expression of endogenous GLUT4 is needed 
for GLUT4 compartment formation. 
Type 2 diabetes mellitus is a rapidly growing disease in the Western world and is known 
to be due to a defect in the translocation of GLUT4 to the plasma membrane. Although 
there are a large number of sites that could lead to this defect, it is now thought that it 
might be due to either a defective GLUT4 translocation mechanism or a mis-targeting of 
GLUT4. In Chapter 4 we examined insulin resistant 3T3-Ll adipocytes and looked for 
cellular changes which might lead to this defect. We found that SNARE proteins, and 
particularly the SNAREs involved in the translocation of the GSVs to the plasma 
membrane, are upregulated. Although this might be an adaptive rather then a causal 
effect, we suggest that normal SNARE protein levels are important for their correct 
function. We further found that GLUT4 gets depleted specifically from the GSV 
compartment in insulin resistant 3T3-Ll adipocytes and that this can explain the 
decreased insulin sensitivity of those cells. This data also suggests a block in the sorting 
step from the endosomes to the GSV s in insulin resistant cells, due to the fact that IRAP 
now largely co-localised with the transferrin receptor. In order to further look into this 
effect it would be of great interest to examine insulin resistant muscle as this could 
explain whether there is indeed a defect in the GLUT4 sorting to the GSVs and whether 
GLUT4 is mis-targeted to a non-insulin responsive compartment. _ 
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Many membrane proteins constantly recycle between intracellular compartments and the 
plasma membrane and the targeting of these proteins to their correct location is therefore 
crucial for the functioning of the cell. It is now thought that clathrin adaptors are 
important in the targeting of the transferrin receptor, TGN38 and many other membrane 
proteins and this led us to examine these adaptors in some detail in Chapter 5. Although 
insulin did not have any effect on the gross distribution of the adaptors in 3T3-LI 
adipocytes, subtle effects in adaptor localisation may have been missed. It would be 
interesting to examine the distribution of the adaptors at different time-points after 
insulin administration using more sensitive methods, such as immuno- electron 
microscopy. The lack of an in vitro interaction between GLUT4 and the J.1 subunit of the 
adaptors may be explained a) by the fact that the p5QQI8 has not actually been shown to 
bind the J.1 chain of the adaptors although it is supposed to resemble the tyrosine-based 
motif and b) by the observation that the di-Ieucine motif is thought to bind the ~ subunits 
of the adaptors rather then the J.1 subunits. In vivo on the other hand we found an 
interaction between GLUT4 and API and AP3, as well as IRAP and AP3, but these 
results could not be repeated and therefore more work is required to confirm this 
observation. An interaction of a membrane protein with the adaptors. although expected, 
has only been shown for very few proteins. If the interaction between GLUT4 and API 
and AP3 is real this could provide more information on GLUT4 trafficking. A defect in 
this interaction could lead to mis-targeting of GLUT4 and this might be of great interest 
in the search for the cause of insulin resistance. 
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